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Abstract 
Foetal MRI represents a non-invasive imaging technique that allows detailed 
visualisation of foetus in utero and the maternal structure. This thesis outlines 
the quantitative imaging techniques used to investigate the effect of maternal 
diabetes and maternal smoking on foetal development at 1.5 Tesla. 
The effect of maternal diabetes on placental blood flow and foetal growth was 
studied. The placental images were acquired using Echo Planar Imaging and 
blood flow was measured using Intra Voxel Incoherent Motion. The results 
indicate that peak blood flow in the basal plate and chorionic plate increases 
across gestation in both normal and diabetic pregnancies. Conversely, diffusion 
in the whole placenta decreases across gestation, with a more pronounced 
decrease in diabetic placentae. 
Following this, a method was developed to use a Tl weighted fat suppressed MRI 
scan to quantify foetal fat images in-utero. In addition, HAlf Fourier Single-shot 
Turbo spin Echo (HASTE) and balanced Fast Field Echo (bFFE) were used to 
acquire images encompassing the whole foetus in three orthogonal planes. These 
scans were used to measure foetal volume, foetal length and shoulder width. The 
data shows that foetal fat volume and intra-abdominal fat were increased in 
foetuses of diabetic mothers at third trimester. 
The HASTE and bFFE sequences were also used to study the effect of maternal 
smoking on foetal development. Here, foetal organ volumes, foetal and placental 
volume, shoulder width and foetal length were measured using a semi automatic 
approach based on the concept of edge detection and a stereological method, the 
Cavalieri technique. The data shows that maternal smoking has significant 
negative effect on foetal organ growth and foetal growth, predominantly foetal 
kidney and foetal volume. 
The work described here certainly has a great potential in non-invasive 
assessment of abnormal placental function and can be used to study foetal 
development. 
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Chapter 1 
Introduction 
Magnetic Resonance Imaging (MRI) was introduced to the medical diagnostic 
world as a potential non-invasive imaging technique in the early 1970s. It is 
based on the concept of Nuclear Magnetic Resonance (NMR). Since then, MRI has 
undergone various scientific and technological advancements, emerging as a 
powerful diagnostic technique and an invaluable imaging modality to visualise 
the internal structure of the human body. Its ability to produce images with 
excellent and a wide range of image contrast has made it a modality of choice in 
the clinical and research environments to investigate function of the human 
body. Here, MRI was used to study foetal development. 
Foetal MRI was first performed in 1983 to primarily study foetuses' central 
nervous system. At that time, every case was a challenge due to the limitation of 
sequences with duration of several minutes. So, maternal sedation and foetal 
immobilisation were necessary to improve foetal image quality. However, with 
the advent of fast MR sequence such as HAlf Fourier Single-Shot Turbo Spin Echo 
(figure 1.1) that allows images to be acquired in a second, foetal MRI has been 
revolutionised. Since then, MRI has been progressively developed to study the 
foetal thorax, gastrointestinal tract, kidneys and cervical masses. In addition, 
development and application of Echo Planar Imaging, which was able to freeze 
physiological motion, broadened the horizon of foetal imaging area, enabling 
scientists and clinicians to study diffusion and perfusion of the foetal brain and 
placenta. With all this advancement, foetal MRI is gradually establishing itself as a 
complementary imaging tool with respect to ultrasound in detecting foetal 
disease and abnormalities in-utero. 
1.1 The Scope of this Thesis 
Figure 1.1: MR images acquired using HAlf Fourier Single-Shot Turbo Spin Echo 
(HASTE) sequence. 
1.1 The Scope of this Thesis 
2 
This thesis documents the work conducted by the author between the year 2008 
and 2011 at the Sir Peter Mansfield Magnetic Resonance Centre (SPMMRC) of the 
University of Nottingham. The main aim of the present study was to exploit the 
improved functionality of MRI to investigate the effect of maternal diabetes and 
maternal smoking on foetal development using quantitative imaging techniques 
at 1.5 Tesla using a Philips Achieva MRI system. 
Chapter 2 provides the background theory that underpins this thesis. It begins 
with the origins and fundamental principles of NMR with respect to the 
relaxation phenomena. Following this, basic principles of MRI are discussed 
based on magnetic field gradients (slice selection, phase encoding and frequency 
encoding gradients), k-space, the Fourier transform and development of imaging 
techniques. Finally, a review of the main MR hardware and its function is 
presented. 
Chapter 3 reviews the relative value of both M RI and Ultrasound in prenatal and 
perinatal diagnosis. This is discussed by addressing the advantages and 
disadvantages of each imaging modality in foetal imaging. The chapter also 
provides an overview of the risks of M RI exposure to foetuses and mothers. 
1.1 The Scope of this Thesis 3 
Chapter 4 explores the process of foetal growth and development of the 
placenta, foetal brain, respiratory system, liver and urinary system. This chapter 
serves as an introduction to the foetal studies conducted by the author. 
Chapter 5 describes the methods used to measure placental blood perfusion in 
the placenta, basal plate and chorionic plate. The first part of the chapter 
investigates the reliability and reproducibility of the program developed to 
measure placental perfusion. The second part of the chapter explains the 
methods used to acquire, process and statistically analyse the effect of maternal 
diabetes on placental blood flow, with respect to normal pregnancies. The 
chapter also reports the effect of maternal diabetes on placental growth. 
Chapter 6 discusses the methods used to acquire, process and estimate foetal 
adiposity using TJ weighted fat suppressed MRI scan and a MATLAB program 
developed specifically for this purpose. The first part of the chapter investigates 
the reliability and reproducibility of the measurements of foetal adiposity 
acquired using the MATLAB program. The second part applies this technique to 
study the effect of maternal diabetes on foetal adiposity. In addition, the chapter 
also reports the effect of maternal diabetes on foetal growth: shoulder width, 
foetal length and volume. 
Chapter 7 reports the effect of maternal smoking on foetal volume and foetal 
organ growth. The chapter describes the techniques applied to acquire, process 
and estimate foetal organ volumes, foetal and placental volume, shoulder width 
and foetal length. 
Chapter 8 summarises the findings obtained in chapter 5 to 7 and concludes the 
work described in this thesis, highlighting some areas for further development. 
Chapter 2 
Magnetic Resonance Imaging 
2.1 Overview 
This chapter aims to introduce readers to the basic principles of Magnetic 
Resonance Imaging as described in the literature [1; 2; 3; 4; 5; 6; 7; 8; 9; 10; 11; 
12]. The author starts with a brief description of nuclear magnetic phenomenon 
and its origin. Following this, the chapter will progress to discuss the relaxation 
mechanism and biophysical principles that affects the measurement of nuclear 
magnetic resonance. A section detailing the formation of MR images covering the 
theory of k-space and Fourier transform follows this. Then, the author details 
some relevant imaging sequence used in the experimental work of this thesis. 
Limitations of the magnetic field in MR imaging will also be visited. Finally, the 
author takes the initiative to detail the general aspects of MR hardware and its 
accessories to assist the understanding of the whole process of image formation 
in conjunction with the principles of MRI and NMR. 
2.2 Basis Principles 
Resonance Imaging 
of Magnetic 
2.2.1 Nuclear Magnetic Resonance Theory 
Magnetic Resonance Imaging is based on the principle of Nuclear Magnetic 
Resonance (NMR), which was independently discovered by Felix Bloch [13] from 
the University of Stanford and Edward Purcell [14] from the University of 
Harvard in 1946, for which they were jointly awarded the Nobel Prize in Physics 
2.2 Basis Principles of Magnetic Resonance Imaging 5 
in 1952 [12). NMR refers to the study of the resonant behaviour of nuclei under 
the influence of a magnetic field. 
The atom is a basic unit of matter. It consists of a central nucleus surrounded by 
clouds of negatively charged electrons. The nuclear mass consists of a mixture of 
positively charged protons and electrically neutral neutrons. Those atomic nuclei 
with an odd number of protons or neutrons or both have an intrinsic spin angular 
momentum, I called nuclear spin, while atomic nuclei with an even number of 
protons and neutrons have no net spin. This nuclear spin can be quantitatively 
described using the spin quantum number, I, that can take integer or half values 
depending on the number of protons and neutrons within the nucleus. If the total 
number of protons and neutrons is odd, the nucleus would have a half-integer 
spin. Conversely, if the total number of protons and neutrons is even, the nucleus 
would have an integer spin. The magnitude of total intrinsic angular momentum 
of a nucleus, pointing along the spin axis of each state is given by, 
(Eq 2.1) 
where h is the reduced Planck's constant ( !!..-), equivalent to 1.054 x 10-34 Js or 
2.n-
6.582 x 10-16 eVs. The intrinsic angular momentum value determines the 
magnitude, but not the axis of the intrinsic spin angular momentum. Since nuclei 
are electrically charged, they possess magnetic dipole moments, fA. , which are 
described by, 
J1 = yI 
(Eq 2.2) 
where r is the gyromagnetic ratio, which is a constant, unique for each nuclear 
isotope possessing a spin. Gyromagnetic ratio is the ratio ofthe nucleus' magnetic 
moment to its angular momentum, which can be described using the equation 
below: 
r=-q-B 
2mp (Eq 2.3) 
2.2 Basis Principles of Magnetic Resonance Imaging 6 
where q is the charge of 1 H nucleus, mp is the mass of the 1 H nucleus and 9 is the 
g-factor of the nucleus, which is 5.5855 for a free proton. The gyromagnetic ratio 
can be positive or negative: if y is positive, the I-' and I are aligned parallel to each 
other, otherwise they are aligned anti-parallelly. 
In order to be NMR sensitive, a nucleus must have spin. Hydrogen is the most 
commonly used active nucleus in clinical MRI. This is understandable since IH is 
the most abundant isotope in the human body, which is composed of 
approximately 75% - 80% of fat and water. Furthermore, the hydrogen nucleus 
consists of one proton that has a relatively large magnetic dipole moment and 
high gyromagnetic ratio, which is capable of generating relatively large NMR 
signals. While the IH isotope is favoured in MR imaging, NMR is primarily 
focussed on the elements with high gyro magnetic ratio. The most common MRI 
active nuclei are listed in Table 2.1, detailing their intrinsic spin properties, 
gyromagnetic ratio and natural abundance. 
Nucleus Intrinsic Spins, Gyromagnetic Ratio, y Natural Abundance 
I (MHz T1) (%) 
1H 1 42.58 99.98 
-
2 
2H 1 6.54 0.015 
3H 1 45.41 0 
-
2 
13e 1 10.71 1.11 
-
2 
14N 1 3.08 99.6 
15N 1 -4.32 0.37 
-
2 
170 5 5.77 0.04 
-
2 
19F 1 100 40.05 
-
2 
23Na 3 100 11.26 
-
2 
31p 1 100 17.24 
-
2 
Table 2.1: The properties ofa selection of nuclei used in MR [5]. 
2.2 Basis Principles of Magnetic Resonance Imaging 7 
The interaction of magnetic moments with the external magnetic field can be 
depicted using two models: Classical Model or Quantum Model. Here, Classical 
and Quantum Model will be considered based on lH isotope, since it is the only 
isotope used in the experiments of this thesis. 
2.2.1.1 Classical Model 
A nuclear magnetic moment in the presence of a magnetic field will experience a 
torque, which attempts to realign the magnetic moment with the field, causing 
the angular momentum to change at a rate dI. The resulting torque, 't can be 
dt 
expressed as, 
dI 
't=J.lxB=-
dt (Eq 2.4) 
where B is the magnetic field. Equation 2.4 can be simplified using equation 2.2 
to arrive at: 
(Eq 2.5) 
h h dI. d' I h . d' I T is means t at - IS perpen ICU ar to t e magnetic IpO e moment, .... and 
dt 
applied magnetic field, Bo and therefore I, since J.l is parallel to I. This 
phenomenon is known as the gyroscope effect; the same phenomenon that 
causes a spinning top to precess. The magnetic field exerts torque causing the 
magnetic dipole to precess around the applied magnetic field axis, Bo, at a 
resonant angular frequency or Larmor frequency, wc 
(Eq 2.6) 
This Larmor equation is true for a single spinning charged particle in an external 
field without any other influence. However, it must be modified in the presence of 
other local factors such as chemical shift, which will be discussed later. 
2.2 Basis Principles of Magnetic Resonance Imaging 
Boin 
z-direction 
x 
M 
8 
y 
Figure 2.1: Precession of a magnetic dipole moment, ~ about an applied magnetic 
field, Bo. 
In equilibrium, where the magnetic field is directed along the z-axis and 
independent of time, 
Equation 2.5 can be written in terms of its vector components as, 
which has solutions, 
d.ux = y.u 8 dt y 0 
d.uz = 0 
dt 
.ux (t) =.ux (0) cos(r 8 0 t) + .uA O)Sin (r 80 t) 
.uy (t) = -.ux (O)sin(r 80 t) +.uy (O)cos(y 80 t) 
CEq 2.7) 
CEq 2.8a) 
CEq 2.8b) 
CEq 2.8c) 
CEq 2.9a) 
CEq 2.9b) 
CEq 2.9c) 
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Therefore, the motion of a magnetic moment tracing out as a precessional cone 
resulting from net magnetisation, M can be written 
dM 
-=WL xM dt CEq 2.10) 
Chemical Shift 
Negatively charged electron clouds surround the nucleus. These electrons 
generally affect the shielding effect experienced by the nuclei in a static magnetic 
field, causing a shift in the Larmor frequency. This phenomenon known as 
chemical shift relies on the precise electron distribution within the molecule. 
Two independent research groups first observed this phenomenon in 1950 [15; 
16; 17]. 
The effective magnetic field, Beff, experienced by the spins can be described as 
(Eq 2.11) 
where a is the chemical shift shielding constant. It increases linearly with the 
induced field generated by the electrons of the molecules and the applied 
magnetic field. 
The chemical shift parameter, D, measured in parts per million (ppm) can be 
computed using the equation below: 
(Eq 2.12) 
where wref is the fixed reference frequency, which is normally the resonant 
frequency of a 1 H isotope in tetramethylsilane. This measureable chemical shift 
parameter is very useful in NMR spectroscopy. It provides information about the 
chemical compound of the nuclei in a sample. In clinical MRI, IH isotopes in water 
and fat molecules contribute to the formation of MR images. The chemical shift 
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between these two components is 3.5 ppm (approximately 220 Hz at 1.5 T) [10; 
12]. This is illustrated in figure 2.2. 
MRSignal 
220 Hz 
Fat 
_J\~ 
Chemical Shift (Hz) 
Figure 2.2: Chemical shift between protons in water and fat molecules. 
2.2.1.2 Quantum Model 
In an ordinary circumstance, the nuclear spins are randomly oriented. However, 
in the presence of an applied external magnetic field (Bo), the nuclear spins 
associated with magnetic dipole moments behave like tiny compass needles, 
experiencing an aligning force with the external field. Normally, the magnetic 
dipole moment in a quantum model can only have (2/ + 1) orientations, 
corresponding to (2/ + 1) energy levels, where / is the quantum number of the 
nucleus. Therefore, the IH isotope can adopt one of the two discrete orientations 
relative to Bo, since it has a quantum number I = lh. The two alignments occupy 
different energy levels. The spins can be parallel (spin up Ja)) or anti-parallel 
(spin down 1(3))' The measurable z-component of the magnetic dipole moment 
can be described as, 
(Eq 2.13) 
or 
I1z = yhm (Eq 2.14) 
where m represents the quantum number (m = -I, -/ + 1, ... , I). I1z can be aligned 
with or against the applied magnetic field, with magnetic dipole moment 
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precessing about Bo at an angular frequency WL. This precession is like a motion 
of spinning top. 
The differences in the energy, ~ E, between the two spin states is proportional to 
the applied magnetic field. For a 1 H isotope, the difference in the energy can be 
defined as, 
~E=-~.B 
-+; -I':]B. 
--[(+hH+h)]B. (Eq 2.15) 
Applying electromagnetic energy at the Larmor frequency, WL, can induce 
transitions between the two energy states, as shown in figure 2.3. This is the 
basis for an NMR experiment. 
(Eq 2.16) 
'~ tlE=hyBo=hw 
la) 
Figure 2.3: Energy level diagram for I = If.! system. 
Boltzmann Distribution 
The distribution of spins between energy states can be described using 
Boltzmann statistics. In an equilibrium state, the distribution of the spins 
occupying the two energy states is dependent on the temperature, T, and the field 
strength, Bo. Normally, the spins would prefer to occupy the lower energy state. 
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This is usually the spin up state, I a) for a 1 H isotope. The Boltzmann distribution 
at equilibrium can be described as, 
Nfl = exp(-flE) 
N" k8T 
( 
-liw ) =exp __ L 
k8 T 
(Eq 2.17) 
where Nfl is the number of spins in the higher energy state, Na is the number of 
spins in the lower energy state, k8 is the Boltzmann constant (1.38 x 10-23 J K-l) 
and T is the absolute temperature_ 
At room temperature, k8T» fl E, 
(Eq 2.18) 
Then, the population differences between spin up and spin down states (n) can 
be defined as: 
n=N -N 
a f3 
= NaliwL 
k8 T 
Nany Bz 
k8 T 
(Eq 2.19) 
Since the total number of spins in both energy states is given by Ntot = Na + Nfl' 
and Na:::: Nf3 at this limit, Ntot :::: 2Na. So, n can be described as: 
(Eq 2.20) 
At 310 K and field strength 1 T, the fractional excess for IH isotope is 
approximately 3.3 x 10-6 spins. The vector sum of the magnetic dipole moments 
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in the resulting spin population difference would give rise to a net magnetisation, 
IMI that can be detected for NMR. This net magnetisation is low and is the reason 
for intrinsically low signal to noise ratio in NMR experiments. At equilibrium, 
many individual spins are distributed around the precessional cone. Hence, there 
is no net magnetisation along the x- and y-axis, and the net magnetisation is 
aligned with the z-axis. The net magnetisation per unit volume of sample in an 
equilibrium state can be described as, 
where fiz{J = - I-lza 
= N a liux - N Ii liza 
=(N" -NIi)fiux 
(Eq 2.21) 
Since lizn = n; and using equation 2.20, IMlcan be described as: 
IMI = n fizu 
N tot (nyf Bz 
=-----'-......:...--
(Eq 2.22) 
Equation 2.22 encapsulates Curie's Law. 
2.2.2 Interaction with Oscillating Electromagnetic 
Field (8t) 
The applied static magnetic field, 80 is conventionally defined to lie along the z-
axis of the Cartesian coordinate system. Hence, the net magnetisation, Mo, at 
equilibrium is a result of the combined longitudinal magnetisation, which lies 
along the z-axis. It does not possess a transverse magnetisation component. In 
order to detect the NMR signal, the longitudinal magnetisation should be 
perturbed from its equilibrium state by applying an oscillating radio-frequency 
magnetic field, 8t. This field is perpendicular to the static magnetic field (80), and 
oscillates in phase with the precessing magnetic moments at the Larmor 
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frequency, WL. The oscillating magnetic fie ld, B1, is much smaller than the s tatic 
magnetic field, Bo C of the order of /IT). 
2.2.2.1 Laboratory Frame of Reference 
Application of an osci llating magnetic fi eld, BII to nuclear spin systems would 
induce transitions between two energy levels. B1(t) may be resolved into two 
rotating components : 
Ba (t) = B1 [iCOS(wt) + jSin(wt)] 
Be (t) = B1 [icos(wt) - jSin(wt)] 
CEq 2.23a) 
CEq 2.23b) 
Ba rotates in an anticlockwise direction and Be rotates in a clockwise direction. 
Th is is demonstrated in fi gure 2.4. 
y 
------r-------~------~--~ x 
Figure 2.4: An applied linearly polarised field, B1(t) decomposed into two counter 
rotating fields, Ba(t) and BbCt). 
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Since equations 2.5 and 2.8 are also applicable for oscillating magnetic fields, the 
motion of the magnetic moment resulting from net magnetisation can be defined 
as, 
CEq 2.24) 
With the understanding that Bo is much larger that B1 and rotation of B1 is of 
similar frequency to the precession on frequency of M, the counter-rotating 
component can be neglected (Ba) and only Be needs to be considered. Hence, the 
resulting torque from Be and M (provided they are of similar frequency) can be 
described as, 
CEq 2.25) 
This is shown in figure 2.5. 
z 
---
---
------- --- -.--- ----
T 
~-----~-----------~y 
x 
Figure 2.5: The torque experienced by the precessing magnetic dipole moment, ~ 
due to the effect of the B1 field. 
In the classical model, a continuum of orientations is available. Conversely, in the 
quantum model with spins-lh, only two orientations corresponding to I-la and I-lp 
are available. Hence, the torque due to Be induces transitions between a and ~ 
spin states, with the energy coming from the radio-frequency field. This 
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phenomenon is one of resonance because the effect of Be is strongest when OJ is 
equivalent to OJL . 
2.2.2.2 Rotating Frame of Reference 
In contrast to the laboratory frame, which has a coordinate of x, y and z, the 
rotating frame rotates clockwise around the z-axis in the xy plane at a 
frequency OJ. In the rotating frame of reference, the Bl and magnetic moment are 
considered to be stationary. To transform to the rotating frame, a fictitious field 
w 
of amplitude - - must be applied, which on resonance will cancel Bo. Hence, Bo 
y 
is removed from the equations of motion. The coordinates of the rotating frame 
of reference are denoted as x', y' and z. In this frame, Bl is stationary along the x' 
axis. The motion of M in the rotating frame can be described as, 
CEq 2.26) 
which can be written in terms of an effective magnetic field, Befr 
dM 
- =yMxB dt efT CEq 2.27) 
where IBefTl = IB1 1 on resonance. This precession of magnetisation around the axis 
of the BeJJ field, is shown in figure 2.6. 
z z' 
M ~~ __ ..... M 
x y x' 
Figure 2.6: Ca) Laboratory and (b) rotating frames of reference. 
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On resonance, when W = WL, the x-component of the field vanishes, causing the 
vector to precess around Bl in the zy' plane at an angular frequency, W = yB1. This 
resulting magnetisation rotates at an angle, (): 
CEq 2.28) 
where t", is the duration of the rotation. 
In order to rotate the magnetisation at different angles, the B1 field is applied for 
different times. The most commonly employed pulses are either 90° or 180°. 
Application of a 90° radio frequency pulse would tip the M previously aligned 
with the Bo field into the x'y' plane yielding a transverse magnetisation, Mxy. 
Similarly, application of a 180 0 radio frequency pulse (twice the amplitude or 
duration of a 90° pulse) would invert the longitudinal magnetisation to lie along 
the -z-axis. Therefore, 180 0 radio frequency pulses are also known as inversion 
pulse. 
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2.2.3 Free Induction Decay (FlO) 
Application of a 90° pulse or transverse magnetisation causes the spins making 
up the magnetisation, M to be in phase with each other. These spins precess in 
the transverse plane at WL. This results in the production of an electrical voltage 
in a coil tuned to the Larmor frequency. This voltage is the base to the observable 
MRI signal. The signal amplitude depends on the degree to which any 
longitudinal magnetisation can be tilted to the transverse plane directly after 
switching off the radio frequency pulse. Hence, this signal will persist until the 
spins have dephased and lost their transverse consistency. The representation of 
the signal decay is illustrated in figure 2.7. 
Tz' envelope 
.... 
". 
Figure 2.7: Free induction decay (FlO). 
The signal decay takes the form of a sine wave, which decays exponentially by 
exp ( - :,. ) at a base frequency. 
(Eq 2.29) 
where Wo is the frequency of the transmitter and r BL is the Larmor frequency of 
the samples. II W = 0 for an on resonance sample. 
2.2 Basis Principles of Magnetic Resonance Imaging 19 
2.2.4 Bloch Equations 
The Bloch equations are a set of equations introduced by Felix Bloch in 1946. 
They are used in NMR to describe the behaviour of nuclear magnetisation (Mx, My, 
Mz) during excitation and relaxation that are defined as a function of relaxation 
times, Tl and Tz. These equations are also known as the equations of motion of 
nuclear magnetisation, which can be described as, 
dM x = Y (M B _ M B ) _ M x 
dt y Z Z Y T
z (Eq 2.30a) 
dMy ( ) My 
-=Y M B -M B --dt Z x x Z T 
z (Eq 2.30b) 
dM z = (M B _ M B) _ M z - M 0 
dt Y x y y x T 
1 (Eq 2.30c) 
where Bx = Bl cos (wt), By = Bl sin (wt) and Bz = Bo [10; 13]. The magnetic field 
along the x-axis (Bx) and the y-axis (By) describes the rotation of the applied 
magnetic field, Bl, in the transverse plane. Here, equation 2.30a and 2.30b 
describe the transverse magnetisation behaviour during the excitation and 
relaxation periods by quoting T2, while equation 2.30c describes the longitudinal 
magnetisation resulting from excitation and relaxation by referring to Tl. 
2.2.5 Relaxation and Measurement of NMR 
Parameters 
Microscopically, the application of a radio frequency pulse increases the energy 
in the system, exciting low energy spins. However, when the radio frequency 
pulse is switched off, the spin system is only under the influence of the applied 
static magnetic field, Bo. This means the spins will return to the equilibrium state 
by losing the energy absorbed from the radio frequency pulse and realigning 
themselves with the Bo field, in accordance with the Boltzmann distribution. This 
process is known as relaxation. This relaxation process can occur through energy 
released between spins (spin-spin) and between spins and their surroundings 
(spin-lattice). These simultaneous and independent interactions result in two 
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relaxation components: transverse decay and longitudinal recovery. This will be 
discussed in detail in section 2.2.5.1 and 2.2.5.2. 
The most common physical mechanism that contributes to relaxation is the 
dipole-dipole interaction. It occurs between the magnetic moment of a nucleus 
and the magnetic moments of other nuclei or entities (electrons, atoms and 
molecules) surrounding it. It depends on the distance between nuclei and the 
orientation relative to the external magnetic field. The tumbling of the molecules 
within the sample causes the dipole-dipole coupling to constantly change as the 
vector relationships change, causing the production of fluctuating magnetic fields 
at each nucleus. When these fluctuations occur at the Larmor frequency, it will 
give rise to a radio frequency magnetic field that can produce nuclear relaxation 
through spin flipping. These dipole-dipole interactions occur commonly in 
protons since it has the highest magnetic dipole. 
The spin-spin, spin-lattice and dipole-dipole interactions are the mechanisms 
that generate the MR contrast. These images will provide signal intensities that 
will reflect the NMR characteristics of tissues. Here, the four most commonly 
used parameters; TI, Tz, Tz' and PD, will be discussed with respect to the manner 
these values vary in different types of tissue. 
2.2.5.1 Longitudinal Recovery (Tl Relaxation) 
The longitudinal or spin lattice relaxation is a process where the spin system 
returns to its Boltzmann equilibrium distribution after perturbation by a radio 
frequency pulse, which occurs through energy exchange between the spins and 
the thermal lattice. This process involves realignment of the magnetic moments 
with 80, causing the net magnetisation to align along the z-axis. The rate of the 
net magnetisation's growth towards its equilibrium value, Mo, is exponential and 
equivalent to the longitudinal recovery time, ri. 
Following a 90° radio frequency pulse, the longitudinal recovery of Mz can be 
described as, 
(Eq 2.31) 
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where TJ is the longitudinal relaxation time. It is the time required for 
approximately 63% of the longitudinal magnetisation, Mo, to be restored in the 
tissues [12]. The longitudinal recovery of the magnetisation Mz is shown in figure 
2.8. 
o ---- --------------------------------------
- Mo ....... -.... . 
Mz (O) =O 
Mz (0) = -Mo 
Figure 2.8: Relaxation of the longitudinal magnetisation Mz(t) for saturation 
recovery (red line) and inversion recovery (blue line). 
Measurement of Longitudinal Tl Relaxation Time 
Longitudinal relaxation time, h is an important intrinsic biophysical property of 
the tissues. This parameter is useful in various applications to study tissue 
characteristics and contrast agent uptake. Moreover, it is used to measure 
perfusion and blood volume. It is also important in sequence development. 
TJ can be measured by using the inversion recovery sequence. This sequence 
involves application of a 180° or inversion radio frequency pulse, that causes the 
longitudinal magnetisation, Mo, to be inverted to the -z-axis. Hence, Mz recovers 
from -Mo. This inversion pulse reverses the equilibrium magnetisation without 
inducing phase coherence (transverse magnetisation). In an inversion recovery 
sequence, a delay time called inversion time, TI, is allowed for the inverted 
longitudinal magnetisation to partially recover. Following this, a 90° radio 
frequency pulse is applied to flip the partially recovered longitudinal 
magnetisation into the transverse xy plane, as shown in figure 2.9. 
This will give rise to an FID with an amplitude proportional to the longitudinal 
magnetisation existing at time TI. The initial amplitude of the FID in an inversion 
recovery experiment depends on the size of Mz prior to the 90° pulse. 
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Figure 2.9: Schematic diagram of inversion recovery sequence. 
While the inverting pulse tends to invert the net magnetisation of all the tissue 
types within the selected slab, different tissues recover at different rates 
depending on their longitudinal relaxation times, h This is demonstrated in 
figure 2.10. By the time of 90° pulse application, these tissues will have different 
amounts of recovered magnetisation, resulting in different signal intensities in 
the final MR image. The relationship between TI and TI in inversion recovery can 
be described using the equation below: 
(Eq 2.32) 
To measure TI, it would be necessary to vary TI. However, a long repetition time 
(> 5 TI) should be allowed before applying the next inversion pulse. This is to 
allow the magnetisation to fully recover to its equilibrium state. On completing 
data collection, a mathematical fit can be performed to equation 2.32 for TI and 
Mo variables. 
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o TI 
-- Short T1 
-- Medium Tl 
-- LongT1 
- Mo 
~------------------------~ 
t = 0 
Figure 2.10: Longitudinal recovery of three different tissues. 
Inversion recovery can also be applied to suppress signals (null) from certain 
tissues: fluid (Fluid attenuated inversion recovery, FLAIR) and fat (short 
inversion time inversion recovery, STIR). In these cases, a predetermined Tl is 
applied resulting in signal from a specific tissue intercepting at the zero point 
along the z-axis . With Mz = 0, equation 2.32 can be used to derive the null Tl as, 
(Eq 2.33) 
It is important to note that all these are done with the assumption that flip angles 
are perfectly applied. Hence, inaccuracy in flip angle application could be a 
source of error. In addition, saturation recovery with at least 5 different 
repetition times, TRs (90 0 - TR - 900 - TR) can also be employed to measure h 
The magnetisation after a single TR can be described as [10], 
(Eq 2.34) 
However, the signal model needs to be modified to take account of shot to shot 
saturation in steady state. 
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2.2.5.2 Transverse Decay (Tz Relaxation) 
Transverse magnetisation, Mxy, is usually created following the application of a 
900 pulse, where spin-spin interactions cause the spins to lose their coherence as 
they exchange energy with each other, instead of releasing energy to the lattice. 
Mxy decays at a rate characterised by a transverse decay time, h which is an 
irreversible exponential process. It can be defined as the time required for 
approximately 63% of the magnetisation to decay, or 37% of the transverse 
magnetisation to remain for detection. 
The transverse magnetisation decay can be described as, 
TE 
M =M e T, 
"y 0 CEq 2.35) 
where TE represents the echo time. It is the time between the first excitation of 
radio frequency pulse and echo detection. Echo detection will be explained later. 
Measurement of Transverse Tz Relaxation Time 
In practice, Tz cannot be estimated by simply measuring the decay constant of the 
FlO since the NMR signals decay faster than predicted effect of Tz alone. This is 
because an extra de phasing originating from magnetic field inhomogeneity 
accelerates the FlO. This can be explained as, 
111 
-=-+-
T; T2 T~' CEq 2.36) 
where T2' is the relaxation time characterising the accelerated decay rate and r; 
is the decay rate arising due to the dephasing effect of the inhomogeneous static 
field, Bo. Since the extra dephasing, T~', is reversible, this factor can be removed 
with the application of a spin echo pulse sequence, which was introduced by 
Hahn in 1950 [18]. Figure 2.11 shows a basic sequence comprising a 90 0 pulse 
followed by a 1800 pulse after a TE time. The 1800 pulse is often referred to as a 
2 
refocusing pulse since it reverses the dephasing effects of the field 
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inhomogeneity. The only resulting in signal degradation is due to irreversible 
spin-spin interaction effects. 
MRSignal 
-
TE TE 
-
-
-
2 2 
: 
90 0 x' 1800 x' 
... .. :.:.: ... ................... . Tz envelope 
···· ·· ··············· ................. ......... 1.:: ............. ............ .. .. ......... . 
............. T] ' envelope ...... Tz' envelope 
", ........ . 
FID 
o CD 
Mo ® 
.. 
;- -', 900 pulse 
. ... ...... 
Echo 
" 
---_ .. 
, 
, 
, 
,,/1800 pulse 
Figure 2.11: A basic sequence comprising a 900 pulse followed by a 1800 pulse. 
On application of a spin echo pulse sequence, a 90° pulse is applied along the x'-
axis. This causes the magnetisation, M, to be tipped from the z-axis to the y'-axis 
as shown in figure 2.11. Following this, the magnetisation, M, starts to dephase 
with time constant T; due to 8 0 inhomogeneity and spin-spin interactions 
TE during a time In the laboratory frame, some nuclei at slightly higher 
2 
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magnetic field precess very fast at a frequency higher than WL, with the 
magnetisation vectors rotating clockwise in the xy plane in the rotating frame. 
Similarly, nuclei experiencing a slightly lower magnetic field precess slower at a 
frequency lower than WL, with the magnetisation vectors rotating anticlockwise 
in the xy plane in the rotating frame. Since there are a series of magnetic field 
values within the sample, the dephasing mechanism is like a 'fanning out' of 
magnetisation vectors. 
After a time TE following the 90 0 pulse, a 1800 pulse is applied along the x'-axis 
2 
causing the 'fan-like' magnetisation to rotate 1800 about the x'-axis. Hence, the 
dephased vectors tend to converge along the - y' -axis after a further time TE 
2 
following the 180 0 pulse. The amplitude of the spin echo is associated with the 
amount of transverse magnetisation available on the - y' -axis. This amplitude is 
smaller than the initial amplitude of the FID due to the irreversible spin-spin 
interactions. Moreover, the spin echo signals have an opposite phase to the FID 
since Mxy is converged along the - y' -axis. 
In order to measure Tz relaxation time, multiple spin echoes should be applied. 
Although this is achievable by varying TE in Hahn's spin echo sequence, this 
sequence is very sensitive to diffusion in field inhomogeneities, which also causes 
irreversible dephasing. 
2.2.5.3 Reversible Loss of Transverse Coherence (Tz* 
Relaxation) 
The applied magnetic field, 80, is never completely homogeneous. This gives rise 
to extra dephasing that leads to faster transverse decay. However, the signal 
decay due to magnetic field inhomogeneity is reversible. This can be described 
using another decay time constant, T2", that is depicted using the equation below: 
(Eq 2.37) 
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where!! Bo represents the field inhomogeneity. The variation in 80 is due to two 
factors: the engineering limitations of the magnet and the variation in the 
susceptibility properties of tissues used in the experiment. Nonetheless, the 
application of a spin echo sequence, short echo times, static field shimming and 
accurate slice positioning to avoid tissue-air interfaces can reduce the effect of 80 
variation. 
2.2.5.4 Proton Density (PD) 
Proton density or spin density refers to the number of protons per unit volume in 
a sample. It is proportional to the amount of magnetisation, Mo, before a 90° pulse 
excitation, the initial amplitude of the FlO following a 90° pulse and the density of 
water in tissue. 
2.2.6 Factors Affecting the Relaxation Times 
The Tl and Tz relaxation times can be affected by many intrinsic (tissue 
properties) and extrinsic (operator dependent) factors. Here, the main factors 
affecting the relaxation times will be discussed with respect to the field strength, 
water content, viscosity, temperature and paramagnetic component of tissues. 
2.2.6.1 Measurement Frequency (Field Strength) 
In 1968, Koenig et al. [19] published a paper demonstrating an increase in T1 of 
Nuclear Magnetic Relaxation Dispersion for a protein with increasing field 
strength (figure 2.12). In addition, the T1 relaxation process becomes more 
efficient when ic Wo = 1, where ic is the rotational correlation time. This result 
also agrees with an in vivo study conducted using five different magnetic field 
strengths in the range of 0.2 T to 7 T, that demonstrated an increase in T1 with 
increasing Bo [20]. In contrast to T1, which depends on the number of spins 
binding to the protein surface and magnetic field strength, T2 is less dependent 
on magnetic field strength but is greatly influenced by the number of protons 
binding to the protein surface [10; 19]. 
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Figure 2.12: Nuclear magnetic resonance dispersion data for a protein solution 
[19]. 
2.2.6.2 Viscosity and Temperature 
Koenig et al. [19] also studied the effect of temperature and viscosity of a 
diamagnetic protein on Tl relaxation time. Their work demonstrated an increase 
in the TJ with increasing temperature. Conversely, TJ is seen decreasing with 
increasing viscosity. This is due to the mobility effect of the molecules within the 
sample. Figure 2.13 shows the effect of temperature and viscosity on h 
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Figure 2.13: Temperature dependence of longitudinal relaxation rate in protein 
solution [19]. 
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2.2.6.3 Water Content 
TJ and Tz relaxation times vary between tissues due to variation in the amount of 
water binding in the tissue. In reality, the water molecules are usually in fast 
exchange between three states (structured, bound, free tissues) and the fraction 
of time spent in each state is proportional to water content in each state. Hence, 
the observed TJ is a weighted mean of the relaxation time at each state and can 
be described as, 
1 F bound F structure F free 
--=--+ +--
T obs T bound Tstructure T free 
1 1 1 1 
where F represents the fraction at each state. 
(Eq 2.38) 
Generally, since Tlbound is short, only a small fraction of water content in tissue is 
required to be in the bound compartment to decrease the observed TI. While a 
similar equation can be derived for Tz, the bound compartment of Tz is not 
directly observable in vivo. Moreover, fast exchange is not always achievable for 
Tz. Nonetheless, Tz can be investigated using magnetisation transfer technique 
that will allow indirect measurement of short Tz [10]. 
2.2.6.4 Paramagnetic Content 
Endogenous or exogenous paramagnetic material can affect TI and Tz relaxation 
times by influencing the relaxation of protons. Some of the most common 
endogenous substances used in MR imaging are Fe3+ and Mn2+ that are present at 
different concentrations in the human body. Conversely, exogenous 
paramagnetic components refer to contrast agents injected into the body to 
improve image contrast of normal and abnormal tissues. They are also used to 
differentiate the image contrast of normal tissues with each other. Paramagnetic 
gadolinium (which will be discussed later) and super-paramagnetic iron oxide 
are the two most commonly used contrast agents. Unlike most diamagnetic body 
tissues that are only weakly magnetised in the presence of a magnetic field, these 
two elements become strongly magnetised in the presence of a magnetic field 
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[10]. They can either have a positive or negative effect on the signal, by 
decreasing Tl, T2 and T2* times [21]. 
Paramagnetic contrast agents usually have unpaired electrons in the outer shell. 
These unpaired electrons have parallel spins that add together to produce net 
electron spin. This gives rise to a net electronic magnetic moment, J.l, that 
generates a strong, fluctuating, alternating magnetic field in the presence of 
protons, which stimulates their relaxation. Moreover, since the ratio of electron's 
charge to its mass is much larger than that of a proton (equation 2.3), the 
electron's gyromagnetic ratio is 653 times that of a proton. This affects the 
relaxation times greatly [1]. 
If the paramagnetic contrast agent is administered at low concentrations, the 
signal intensity of water-based tissues will increase in a Tl-weighted sequence 
due to a decrease in Tl relaxation time. Conversely, when this contrast agent is 
administered at a higher concentration, the Tz will be shortened causing the 
tissue signals to decrease. However, different metals affect the relaxation time 
differently. This is greatly dependent on the relaxivity of the contrast agent, 
which is defined as a change in relaxation time. This is produced by a change in 
concentration. 
Super-paramagnetic contrast agents are also recognised by the abbreviation 
SPlOs (small particle iron oxide) or USPlOs (ultrasmall particle iron oxide). They 
are usually available in a range of particle sizes and hydrodynamic diameters. 
This contrast agent is useful in liver imaging [22; 23; 24]. During imaging, the 
super-paramagnetic contrast agent is usually injected into the body in the form of 
suspended colloids of iron oxide nanoparticles to reduce the Tz signals of 
absorbing tissues. These super-paramagnetic contrast agents are composed of 
paramagnetic atoms in a crystal lattice that can increase the magnetic moments 
by a factor of 10 - 1000 in the vicinity of an external magnetic field. Following the 
removal of an applied magnetic field, the parallel spin alignments in the super-
paramagnetic contrast agents are disrupted by Brownian molecular motion. This 
results in zero net magnetisation [12]. 
Application of large diameter super-paramagnetic iron oxide particles (~ 50 nm) 
will shorten the Tz. causing substantial loss in signal intensity due to low 
relaxivity. Therefore, they are also known as negative contrast agents with most 
pronounced effect on Tz-weighted sequences. Conversely, application of small 
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diameter super-paramagnetic iron oxide particle (s 20 nm) can be used as 
positive or negative contrast agents [12]. They are currently being developed as 
blood pool contrast agents for MR angiography [25]. 
Gadolinium 
The gadolinium (Gd+3) based contrast agent has seven unpaired electrons in its 
outer shell and hence possess a large magnetic moment [26]. It also has 9 
coordination sites where the water can interact with the unpaired electrons. 
Gadolinium in its elemental state is toxic. However, it can be chelated to a ligand 
such as DTPA (diethylene triamine pentaacetic acid) that eliminates gadolinium's 
toxicity but preserves its paramagnetic properties. This results in a new 
arrangement with 8 occupied and 1 unoccupied coordination sites. Hence, there 
is only 1 possible site for water interaction, resulting in a decrease in 
gadolinium's relaxivity. Nonetheless, the water relaxation time is still greatly 
influenced by the large magnetic moment [10; 27]. 
The Gd-DTPA has high Tl relaxivity, stability, distributes rapidly in the 
extracellular fluid space and is quickly excreted via the kidneys [27]. Gadolinium 
behaves like any other element in inhomogeneous magnetic field; its dipole -
dipole interactions result in a decrease in Tl and Tz relaxation times of proton. 
Application of low concentration gadolinium will shorten the Tl and tissues 
accumulating this agent will create enhanced signal intensity on Tl-weighted 
images. However, at concentrations higher than 1 mmol kg'! gadolinium (ten 
times the standard dose), the effect on Tz starts to dominate causing a loss in the 
signal [10]. Gadolinium also shortens T;, but at a lesser extent compared to Tl. 
Moreover, since T; occurs very rapidly, its effect is only seen briefly when 
gadolinium first passes through the capillary bed [11]. However, it is important 
to note that the effect on r; is predominantly dependent on the inhomogeneity 
of the distribution. 
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2.3 Principle of MR Imaging 
Magnetic Resonance Imaging (MRI) has been recognised as one of the most 
important medical advancements of the last century. It has introduced mankind 
to a different level of study of human anatomy, revealing the structure and 
function of the human body. Since its development in the 1970s, MRI has evolved 
from an exclusively experimental imaging modality to a clinically important tool. 
It has undergone continuous development in pulse sequence and hardware 
design, in an effort to cater for different clinical applications. 
In 1973, Paul Lauterbur realised that the application of a varying magnetic field 
across a sample induces a variation in the proton Larmor frequency [28]. 
Subsequently, he proposed using gradients in the magnetic field to localise NMR 
signals in order to produce two-dimensional images of a sample. This was done 
by applying a linear gradient at different angles to a sample and combining these 
projections using a back prOjection reconstruction method. At a similar time, 
Peter Mansfield realised the relationship between the MR signal in a gradient and 
optical diffraction. He applied this to study solids and proposed several methods 
to selectively excite a slice through a sample, including the slice selection 
technique used in exact form at present [29]. Following this, Richard R. Ernst's 
group presented the first Fourier imaging method using non-selective excitation 
and orthogonal linear gradient to produce two-dimensional Fourier encoded 
images [30]. This served as a foundation to propose and develop the fast imaging 
technique that lead to the development of MRI. In 1977, Peter Mansfield 
introduced a fast imaging technique known as Echo Planar Imaging (EPI) that is 
capable of acquiring MR images in seconds. This imaging sequence will be 
discussed in detail in section 2.3.3.4. 
The contributions of Paul Lauterbur and Peter Mansfield to the development of 
MRI within the medical research community was recognised and awarded with a 
Nobel Prize in Medicine in 2003. Similarly, the effort of Richard R. Ernst in 
introducing Fourier Transform NMR spectroscopy was also awarded a Nobel 
Prize in Chemistry in 1991. 
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2.3.1 Magnetic Field Gradients 
Before NMR signals can be used to create an image of a sample, the precise 
location of the source of signals should be defined. This can be done by 
superimposing a small (of the order of mT m-1), spatially varying magnetic 
gradient field, G, onto the main magnetic field, Bo. This process known as spatial 
encoding is conducted to ensure that the magnetic field strength varies in a 
controlled way along the designated axis. 
In practice, each scanner has three orthogonal configured gradient coils, which 
produce field gradients when current flows through loops of wires situated 
around the magnet's bore. Each gradient field generates its own magnetic field 
(Gx, Gy, Gz) that interacts with the main magnetic field (by either adding or 
subtracting). This leads to linear variation of the field and Larmor frequency, WL, 
as a function of distance from the centre of the magnet bore. Ideally, the total 
resulting magnetic field is always along the z-axis, regardless of the direction of 
the applied gradient. This resulting magnetic field at a specific location (r) during 
the application of field gradients can be described as, 
where G can be described as, 
where 
and 
G = dB Z G "" dB Z G = _dB_z 
x dx' Y dy' Z dz 
r-xi+ yj+zk 
(Eq 2.39) 
(Eq 2.40) 
Hence, the Larmor frequency of the precessing spins in the sample will vary 
according to, 
(Eq 2.41) 
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The magnetic field gradient plays a number of important roles in MRI. It 
dephases and rephases the magnetic moments of nuclei, locates a slice within a 
selected plane of scan (slice selection), spatially encodes the NMR signals of 
anatomy along the long (frequency encoding) and short (phase encoding) axis, as 
well as motion and flow encoding. Moreover, it is important to note that the 
applications of these gradients are inter-changeable, so that imaging is possible 
at different angles including obliquely to the principle axes by linear combination 
of gradients. 
2.3.1.1 Slice Se lection 
A spatial selective radio frequency pulse can be employed for various functions in 
MR imaging. This includes excitation, refocusing, inversion and spatial 
presaturation of magnetisation, which are achievable through the application of 
slice selective gradients [31; 32; 33]. Garroway, Grannel and Mansfield initially 
introduced the slice selection technique in 1974 [34] . It is a technique to excite 
the spins in an isolated plane within the sample or patient that is being imaged. 
Slice selection is achievable with the application of a radio frequency pulse that 
only affects a limited part of the sample in the presence of a linear field gradient 
along the direction of the desired slice (figure 2.14) . This procedure excites those 
spins (dominated by their position) with Larmor frequency similar to the 
frequency of the applied radio frequency pulse. 
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Figure 2.14: Linear variation of the total magnetic field as a function of z. 
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To excite a transverse slice, the gradient magnetic field is applied along the z-axis, 
Gz, in the presence of 80. This causes a linear position-dependent variation in the 
Larmor frequency of the spins in the z-direction, corresponding to a slice 
thickness: 
(Eq 2.42) 
where 6. w is the bandwidth frequency centred at the carrier frequency, Wo. The 
carrier frequency establishes the position of the slice along the pre-determined 
direction and the transmit bandwidth determines the range of the spins within 
the slice that needs to be excited. Hence, the Larmor frequency in the slice along 
the z-direction is, 
(Eq 2.43) 
In order to select a slice, it is necessary to apply a strong radio frequency pulse 
over a narrow bandwidth frequency, so that only spins in that range of 
frequencies are excited. This principle is used in multi-slice imaging. Figure 2.15 
demonstrates the effect of increasing the amplitude of the slice-selection gradient 
on slice thickness for a fixed bandwidth frequency. 
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Figure 2.15: Larmor frequency versus the position along the slice selection 
gradient. Stronger gradient produces a thinner slice (/1 z). 
Following the application of a radio frequency pulse, the shape of the 81 envelope 
determines the distribution of the magnetisation along the z-axis. In order to 
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select a slice with a rectangular profile, spins within the slice should undergo 
uniform precession with a flip angle, {}, of 90° and the spins outside the slice 
should not be perturbed (zero flip angle). A sine [Si:(o) )Shaped pulse, where 
a = yGz ~z£ , is often used to achieve a near ideal slice profile. This modulation 2 
will produce a rectangular frequency slice profile for small flip angles, where the 
spin system responds linearly to the pulse. This system consists of several 
adjacent lobes of alternating polarity. However, the central lobe is the highest 
and widest lobe. To achieve a perfectly rectangular slice profile, a sinc pulse with 
infinite number of lobes should be applied. Unfortunately, application of a large 
number of lobes will increase the repetition time (TR) and echo time (TE). It will 
also increase the flow and off-resonance effects. 
The sinc pulse selection gradient introduces a linear phase variation, which 
causes a continuous phase shift resulting in loss of phase coherence. This 
problem can be overcome by applying a reversed slice gradient for half the 
duration of the initial slice selection period. This is shown in figure 2.16. 
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Figure 2.16: A negative gradient lobe follows the slice selection excitation to 
refocus the dephasing effects induced by the slice selection gradient. 
2.3.1.2 Spatial Encoding 
Following slice selection, the resulting signals do not have spatial information 
along the remaining two axes. Hence, the signals along these axes should be 
2.3 Principle of MR Imaging 37 
encoded using the spatial encoding technique that comprises two steps: 
frequency encoding and phase encoding. 
2.3.1.2.1 Frequency Encoding 
Frequency encoding is commonly used to acquire spatial frequency information 
following a radio frequency excitation. It is used in many MRI pulse sequences: 
projection acquisition [28] and Fourier imaging [30; 35]. Frequency encoding is a 
process of encoding signals along the long axis (x) of the anatomy. This can be 
achieved by switching on the frequency encoding field gradient while measuring 
the NMR signals (image readout). For this reason, the frequency encoding 
gradient is also called the readout gradient. 
The application of a constant linear frequency encoding gradient along the x-axis 
will change the precessional frequency of the spins making up the signal. This 
precessional frequency can be described using equation 2.43 as a function of 
position along the frequency encoding gradient axis (x). 
However, since the resulting signal consists of a mixture of different frequency 
components, the signal needs to be sampled (digitised) using an analogue-to-
digital converter (ADC) during the application of the frequency encoding 
gradient. This is done as soon as possible after removing the effect of the radio 
frequency pulse. Then, the computer performs a Fourier transform analysis. This 
results in a histogram demonstrating the quantity of signal present at a number 
of discrete, equally spaced frequency ranges. By using the Fourier transform, the 
position can be encoded into frequency resulting in a one-dimensional projection 
of the region of interest in the direction of the frequency gradient. 
In practice, the FID is usually measured as either a spin echo or gradient echo, 
since acquiring the FID right after the pulse will lead to errors in determining the 
phase of the data. Figure 2.17 shows the frequency encoding gradient applied to 
measure the gradient echo rather than the FID. The dephasing lobe generates a 
symmetrical gradient echo. The gradient echo normally lies in the centre of the 
frequency encoding gradient, provided the area under the negative lobe is half of 
the area under the positive lobe. The time between the excitation and echo 
measurement is known as the echo time (TE). In order to avoid signal loss due to 
relaxation processes, it is vital that the dephasing process occurs rapidly. 
2.3 Principle of MR Imaging 
RF 
Signal 
, 
, 
o 
TE 
G) 
, , 
, , 
•• 
, 
, , 
, , 
, , 
(0 0 
0 0 
Figure 2.17: Schematic representation of gradient echo sequence. 
2.3.1.2.2 Phase Encoding 
38 
Phase encoding plays an important role in localising the NMR signals orthogonal 
to the frequency encoding direction, with the intention of generating a two-
dimensional image. 
Following slice selection and frequency encoding, NMR signals have been located 
to a specific slice within a desired plane encoded along a pre-determined 
direction. The spins in the pixels of the same column are all in phase since all of 
these spins precess at the same frequency. However, application of a phase 
encoding gradient to the transverse magnetisation prior to frequency encoding 
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acquisition causes sampling to take place along an axis perpendicular to the 
frequency encoding direction. This field gradient produces the phase of the 
magnetisation with linear spatial variation that causes the spins in the same 
column to posses different amount of phase relative to each other and spins at 
the centre of the magnet. This is shown in figure 2.18. 
a l-I--~~ - -
-!-I- -1-
b 
/ 
-
......-
--
1 -
_1-
- - -
r-
--I - -
-... 
--
- -1- - -
"'" 
/ / 
~-~ 
......- ......-
- --
-... -... 
"'" "'" 
/ 
......-
-
-... 
"'" 
/ 
......-
--
-... 
"'" 
Phase 
encoding 
direction 
Figure 2.18: Transverse magnetisation of an object divided into 25 pixels. (a) The 
transverse magnetisation has the same phase (direction) in each pixel at the end 
of the radio frequency excitation pulse. (b) After a phase encoding gradient, the 
phase of the transverse magnetisation varies at each location along the phase 
encoding direction. 
The phase encoding gradient (y-gradient lobe) is usually applied just before 
sampling the signal. When the phase encoding gradient is switched off, the spins 
in the phase encoding direction will start precessing at different rates. Their 
subsequent precessional rates depend on the strength of any applied frequency 
encoding gradient, while their relative phase depends on the strength and 
duration of application of the phase encoding gradient and the spin's position 
along the phase encoding direction. 
At the end of the phase encoding pulse (t = T), the phase, ¢ (in radians) of the 
signal due to transverse magnetisation is given by, 
T 
¢{t)=yy fCAt)dt=kyY 
o (Eq 2.44) 
where ky is the k-space location. In contrast to frequency encoding that samples 
all of the data following a single radio frequency excitation pulse, phase encoding 
needs to be repeated a number of times corresponding to the number of k-space 
lines that needs to be sampled. 
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The resulting signals can be reconstructed using Fourier transformation to 
restore the spatial information of the sample or patient. Phase encoding can also 
be applied in three-dimensional volume acquisition. In this case, the sample will 
need to be reconstructed by three-dimensional inverse Fourier transformation. 
2.3.2 Fourier Transform and k-Space 
Jean Baptiste Joseph Fourier initiated the Fourier transform [36]. Fourier 
realised that complex signals can be rewritten as an infinite sum of simple 
sinusoidal waves [37]. The Fourier series describes complicated wave 
information in terms of simple sines and cosines. The Fourier transform 
decomposes a complicated signal into amplitude and frequencies of its simple 
wave components [38]. In MRI, this concept is used to encode the frequency and 
phase encoding information ofthe signals within k-space to construct MR images. 
2.3.2.1 Theory 
Grannel and Mansfield initially introduced the concept of reciprocal space in 
NMR in 1973 [29]. Then, in 1983, Ljunggren and Twieg independently introduced 
the k-space theory which is widely used in MRI [39; 40]. In MRI, k-space refers to 
the two or three-dimensional Fourier transform domain of an ordinary space, in 
which the time varying NMR signals resulting from precessing spins or 
magnetisation are stored in the form of a raw data matrix. In this Fourier space, 
the conjugate of the distance (r) in which the images are acquired before being 
Fourier transformed to Cartesian image space (x, y, z) is represented by a 
variable k (kx, ky , kz) and the domain representing the spatial frequency 
distribution of the MR image is called k-space. This concept brings simplicity to 
the understanding and application of many pulse sequences. 
The k-space is used to visualise the trajectories of the spins' phase under the 
influence of field gradients. The k-space of a two-dimensional image has two axes 
perpendicular to each other: the horizontal axis (frequency encoding axis) and 
vertical axis (phase encoding axis). The representation of the k-space of an image 
is shown in figure 2.19. When signals are measured using a frequency encoding 
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gradient, the horizontal lines are filled within the k-space. However, as 
mentioned before, this sequence will need to be repeated a number of times (N), 
with different phase encoding each time, resulting in N k-space lines 
corresponding to N amplitudes. This is conducted with the intention to fill in 
different vertical lines in k-space. 
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Figure 2.19: The relationship between image space and k-space. 
The central lines of the k-space are filled with information from low amplitude 
phase encoding gradients (small or zero dephasing) that consists of data with 
low spatial frequencies and high signal amplitude. Conversely, the outer lines 
appearing at the edge of the k-space are filled with information from positive and 
negative phase encoding amplitudes that consists of data with high spatial 
frequencies detailing the fine details of the image. 
When the magnetic field gradient is switched on for a time t along one dimension, 
the signal acquired at a location (r) is given by, 
(Eq 2.45) 
where the accumulated phase, "', due to application of a magnetic field gradient is, 
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t 
= -yr f c(t )dt (Eq 2.46) 
o 
Then, the one-dimensional signal can be written as, 
(Eq 2.47) 
where 
The total encoded signal,S, representing the spin density acquired in two 
dimensions at time t" and pseudo-time T can be described as, 
(Eq 2.48) 
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Figure 2.20: A k-space acquisition trajectory commonly used in the Echo Planar 
Imaging sequence. 
While the k-space trajectories navigate in a continuous path (figure 2.20). the 
signals are only sampled at discrete intervals along the path. The field of view 
2.3 Principle of MR Imaging 43 
(FOV) of the resulting image depends on the spacing of the measurements made 
in k-space. The field of view in the direction of frequency encoding (FOVFE) is 
given by, 
FOV = I1w 
FE yGFE CEq 2.49) 
where 11 0) is the image bandwidth and GFE is the strength of the frequency 
encoding gradient. The field of view in the direction of phase encoding (FOVPE) is 
given by, 
CEq 2.50) 
where Go is the phase encoding step size and iL is duration prior to signal 
sampling. Hence, the voxel size along the frequency encoding direction, 11 x, and 
phase encoding direction, l1y, is given by, 
and 
Ilx = FOVFE 
M 
I1w 
yGFEM 
l1y = FOVpE 
N 
2.7r 
CEq 2.51) 
(Eq 2.52) 
where M is the matrix size in the frequency encoding direction and N is the 
number of phase encoding steps. 
2.3.2.2 Signal Sampling 
MR images are acquired using an analogue-to-digital converter (ADC) and stored 
temporarily in the computer in the form of MR signals that are made up of pixels. 
The ADC acquires MR signals at a sampling rate corresponding to a sampling 
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frequency,fs, with a range of frequencies known as receive bandwidth, rBW. This 
can be described as, 
1 f =-=rBW 
S Ts (Eq 2.53) 
where Ts is the time space between two adjacent sample points. If Ts is large, the 
sampling rate is low and there is a possibility that high frequencies will be under-
sampled (aliasing). To avoid the aliasing phenomenon, overlapping of high and 
low frequency components, the sampling rate must satisfy the Nyquist Theorem. 
This theorem states that the maximum frequency signal that can be accurately 
digitised at a certain sampling frequency should be half of the sampling 
frequency. This is described as the Nyquist frequency,fN, that is given by, 
(Eq 2.54) 
Furthermore, low receive bandwidth is prone to cause chemical shift artefacts. 
Both aliasing and chemical shift artefacts will be discussed in detail in section 
2.3.4.2. 
2.3.3 MR Imaging Techniques 
Conventional MRI is a slow imaging technique. It is inadequate for imaging foetal 
and moving structures such as the heart, liver and stomach. The primary limits 
on these imaging times are caused by long relaxation times, SNR and spatial 
resolution. Hence, many new pulse sequences and imaging techniques have been 
developed in the mid 1980s to accelerate imaging procedure. Some of these 
techniques are being employed in current MR studies: Fast Low Angle Shot 
(FLASH) and Turbo Field Echo (TFE). 
MRI is also capable of acquiring three-dimensional volumes. This is achievable by 
simultaneously exciting a volume rather than a slice every TR time, along with 
application of additional phase encoding gradients along the volume selection 
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direction to provide the additional spatial encoding (section 2.3.1). The sample's 
spatial information (two phase and one frequency encodings) is stored in a three-
dimensional k-space and a three-dimensional Fourier transform can be used to 
reconstruct the MR images (section 2.3.2). With three-dimensional volume 
imaging, it is possible to image more slices and thin slices with improved profile. 
The latter is ideal for volume rendering and multiplanar reformatting. However, 
the disadvantage of three-dimensional images is that they are more susceptible 
to motion artefacts. 
2.3.3.1 Fast Low Angle SHot 
Fast Low Angle SHot (FLASH) is a spoiled gradient echo pulse sequence that was 
first presented by Axel Haase et al. in 1986 [41; 42]. This sequence is also known 
by a variety of names, including spoiled gradient echo (SPGR) in the GE system 
and TJ Fast Field Echo (TJ-FFE) in the Philips system. The abbreviation FLASH is 
commonly used in the Siemens system. This sequence is primarily used for fast 
anatomical imaging. Figure 2.21 shows a schematic representation of the FLASH 
sequence in three-dimensional Cartesian encoding. 
, , 
, . , , , I , , Gz ., ., 1/. , 
, 
, 
, 
, 
, 
, , 
, , 
, , 
Gx 1\ I .~ I 1/. II , , , 
Signal 
! ! If • . , 
, 
, ' 
, 
,.' 
l 1. , t 
, TE , TE , . 
:. 
-: , TR , 
Figure 2.21: Schematic representation of the three dimensional FLASH pulse 
sequence. 
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The FLASH sequence consists of a series of radio frequency pulses of flip angle, 0, 
with pulses separated by a time TR. In practice, this sequence uses an excitation 
pulse of flip angle in the range of 20° - 30° « 90°). Hence, the recovery of 
longitudinal magnetisation can take place in a shorter period of time and, 
therefore, the sequence will require a short repetition time, TR. Each excitation 
pulse is applied along with a z-gradient slice selection, which creates transverse 
magnetisation in the selected slice that produces a FID. Then, the FID is dephased 
and subsequently rephased into a gradient echo using a frequency encoding 
gradient, Gx • The y-gradient and z-gradient traces demonstrate the two 
perpendicular phase encoding lobes applied before the acquisition, and the 
opposite polarity phase rewinder lobe applied after the acquisition, in order to 
dephase all Mxy. 
The simplest method to produce a T; -weighting contrast is to make TE relatively 
long and select TR that is at least four to five times TJ, so that the longitudinal 
magnetisation recovers between excitation pulses. If TR is less that 5 Tz, spoiling 
will have to be used. Application of a low flip angle will give rise to sufficient 
transverse magnetisation. However, the longitudinal magnetisation remains 
relatively unperturbed. Following a sufficient number of excitation pulses, the 
longitudinal magnetisation, Mz, reaches a steady state [43]. Assuming perfect 
spoiling of the transverse magnetisation before each radio frequency pulse, the 
longitudinal magnetisation after each subsequent excitation for a spin ensemble 
with density Mo and longitudinal relaxation time Tl can be calculated using, 
(Eq 2.55) 
The steady state for the longitudinal magnetisation is reached when 
Mz (i) = M z (i + 1). Hence, 
( 
TR 1 M (i) = M 1- e T, 
z 0 ~ 
1- cos(O)e - T~ (Eq 2.56) 
It is important to predict the time required for a steady state to be achieved. This 
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information is useful in estimating the number of start up pulses required (those 
applied without data collection), so that k-space data is not collected when 
magnetisation is approaching a steady state. 
The flip angle that maximises the signal is called the Ernst angle, (h. This angle 
can be described as, 
(Eq 2.57) 
The Ernst angle lies in the range of 0° - 90° and monotonically increases with the 
ratio TR. When 8 < 8E, it is an indication that the signal can be increased by 
TI 
increasing the flip angle, since creating more transverse magnetisation 
compensates the further loss of longitudinal magnetisation. 
2.3.3.2 HAlf Fourier Single-Shot Turbo Spin Echo 
HAlf Fourier Single-shot Turbo spin Echo is a type of Single-shot fast spin echo 
(FSE). It is also known by the abbreviation HASTE in the Siemens system, SS-FFE 
in the GE system, and UFSE in the Philips system. The HASTE sequence is 
primarily used in two-dimensional imaging to freeze bowel and respiratory 
motion for abdominal imaging and improve temporal resolution in dynamic 
studies. The true temporal resolution, R, measured in frames per second for two-
dimensional phase encoded acquisition is given by, 
1 R=-----
N
shot TRNEX (Eq 2.58) 
where Nshot is the number of radio frequency excitations per complete k-space 
traversal and NEX is the number of signal averages. 
In HASTE, it is essential to maximise the echo train length (Net!) to acquire images 
with better spatial resolution. For fixed echo train duration, the maximal Netl can 
be increased with shortening of echo spacing (ESP). ESP can be minimised by 
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increasing the receiver bandwidth, increasing the slew rate and shortening the 
refocusing pulse width (often at the expense of reduced flip angle of degraded 
slice profile). Unfortunately, even with these changes, the Nett is often insufficient 
to acquire the desired number of phase encoding steps for the full k-space area. 
Therefore, asymmetric k-space sampling is usually used and images are 
reconstructed using half k-space reconstruction. 
HASTE uses a phase-alternated echo train combined with half Fourier acquisition 
to increase the frame rate to the range of 1 - 2 frames per second. The half 
Fourier acquisition enables us to acquire slightly more than half the data by 
missing half the phase encoding gradient steps (either positive or negative). So, 
the data is only collected and stored in the upper or lower half of the k-space. 
Then, the other half of the data can be estimated by using complex conjugate 
synthesis (property of Fourier transform of real functions). By doing this, 
approximately 50% of the scan time can be saved without a significant effect on 
spatial resolution. However, this will result in a 30% loss in SNR. HASTE can also 
be conducted in the form of three-dimensional acquisition by using a single shot 
along one spatial direction [10]. 
The series of refocusing pulses for HASTE carries significant radio frequency 
energy, especially at field strengths of 1.5 T or higher. In practice, the flip angles 
of these refocusing pulses are usually in the range of 1200 - 1600 « 1800 ). 
However, to further minimise patient heating in real-time, the flip angle of the 
refocusing pulse can be varied as a function of position in the echo train [44]. 
2.3.3.3 Balanced Fast Field Echo 
Balanced Fast Field Echo is a rewound gradient echo pulse sequence. It is also 
commonly known by the abbreviation bFFE in the Philips system, True-FISP in 
the Siemens system, and FIESTA in the GE system. It is primarily used in cardiac 
imaging, where it provides excellent SNR and contrast between blood and the 
myocardium [45; 46]. It provides greater signal than a FLASH sequence. often at 
an expense of reduced contrast. In this sequence, reversing the sign of the 
gradient lobes, or sometimes only reversing the phase encoding gradient. 
refocuses the transverse magnetisation. Hence, the resulting signal contains FID 
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enhanced with an echo containing coherent transverse magnetisation 
components. 
The gradient echo signal strength is given by [10], 
(Eq 2.59) 
where p is the number of nuclei per unit volume. In rewound gradient echo 
sequences, if TR is much smaller than TJ and T2, e 
can be simplified to [10], 
TR 
T, -1- TR and equation 2.59 
Tz 
(Eq 2.60) 
This means that the signal depends on the flip angle, 0, and the ratio of Tz , but is 
TI 
independent of TR. If 0 = 90° [10], 
Signal=-P-
1 + 2"'1 
Tz (Eq 2.61) 
At longer TR (> 100 ms) and TR> T2, there is not much difference between 
rewound and spoiled gradient sequences. In general, a rewound gradient echo 
produces images with good myelographic effect. It is also good for imaging high 
contrast between fluid and solid structures in rapid imaging, since the signals are 
relatively independent of TR. However, rewound gradient echo sequences are 
sensitive to motion and flow (destroys the steady state transverse coherence) 
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since they are formed from a combination of refocused and fresh transverse 
magnetisation. Fortunately, bFFE sequences employ balanced rewinding 
gradients in all three directions. Therefore, a three-dimensional Fourier 
transform can be applied by adding phase encoding and rewinding on the slice 
selection axis, which is in the rephasing lobes. A representation of a bFFE 
sequence is shown in figure 2.22 . 
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Figure 2.22: Schematic representation of a bFFE pulse sequence. 
The limitation of bFFE is that it requires high performance gradient technology to 
obtain good shimming and a very short TE. If this is not accomplished, images can 
become degraded with banding artefacts (spacing inversely proportional to the 
field inhomogeneity). 
2.3.3.4 Echo Planar Imaging 
Echo planar imaging (EPI) is the fastest pulse sequence with highest SNR per unit 
time known in MRI. It was first proposed by Peter Mansfield in 1977, following 
primary development conducted in the University of Nottingham [47; 48; 49; 50]. 
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EPI was first implemented with the aim of 'one shot imaging' using an echo 
Fourier transform imaging technique that has since been recalled. In 1983, 
Mansfield's group developed a high speed scanner operating at 4 MHz which 
incorporated an EPI sequence to image children's hearts at a resolution of 
32 x 32 pixels, and later at a resolution of 64 x 64 pixels for an adult heart [51]. 
The EPI sequences have been the basis of many advanced MRI applications, such 
as diffusion, perfusion and cardiac imaging, neurofunctional brain mapping and 
dynamic studies. 
In comparison to conventional pulse sequences, EPI maximises the use of 
transverse magnetisation without the application of additional radio frequency 
excitation. Moreover, it uses the most utili sable portion of the FlO within 2 
transverse magnetisation half-life times, where a half-life time is equal to 
r; In(2), while conventional gradient echoes only uses a small part of the FlO to 
sample one line in k-space following an excitation pulse. EPI uses a series of 
bipolar frequency encoding gradients along with a phase encoding gradient to 
generate a string of gradient echoes, with each gradient echo spatially encoded. 
With this, multiple k-space lines can be sampled under the envelope of an FlO 
following a single radio frequency excitation. In addition, EPI uses a gradient-
echo train instead of a radio frequency spin-echo train. These result in 
acceleration of data acquisition, enabling MR images to be acquired from the FlO 
in a fraction of a second. 
EPI pulse sequences can be used for either two or three-dimensional acquisition. 
However, the majority of EPI applications are based on two-dimensional 
sequences, which apply orthogonal slice selection, frequency encoding and phase 
encoding gradient waveforms. While the slice selection gradient waveforms are 
similar to the conventional gradient echo and spin echo sequences, the frequency 
and phase encoding gradients produce different k-space trajectories compared to 
conventional gradient waveforms. The resulting data needs additional processing 
before image reconstruction using a Fourier transform. The five types of EPI that 
will be discussed here are gradient echo EPI, spin echo EPI, inversion-recovery 
EPI, single-shot EPI, and multishot EPI. 
In general, EPI is more prone to artefacts (especially Nyquist ghosting) compared 
to conventional gradient echo and spin echo imaging. This will be discussed in 
detail in section 2.3.4.2. 
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Gradient Echo EPI 
Gradient echo EPI is also known as GE-EPI or GRE-EPI. It is a time efficient, low-
resolution T; -weighted pulse sequence with high SNR. The GE-EPI pulse 
sequence starts with an application of a selective excitation pulse that produces 
an FID signal. The flip angle of the excitation pulse is usually set to 90° to 
maximise the SNR on GE-EPI. Then, a series of spatially encoded gradient echoes 
are generated under the envelope of the FID using different combinations of 
frequency and phase encoding gradient waveforms. This determines the starting 
point of the k-space trajectory along the phase encoding direction (the first k-
space line to fill) . 
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Figure 2.23: Schematic representation of (a) blipped gradient echo EPI sequence 
and (b) its k-space trajectory. 
The frequency encoding gradient creates echoes, while the phase encoding 
gradient changes the acquisition of the k-space according to the trajectories. The 
blips of the phase encoding are shown in figure 2.23. In GE-EPI, each k-space line 
along the phase encoding direction is acquired using a different TE. Therefore, 
the amplitude of the corresponding gradient echo decays according to, 
(Eq 2.62) 
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where So is the signal at t = 0 and ne is the echo index in the echo train. Normally, 
at the end of the GE-EPI pulse sequence, a spoiler gradient is employed to 
dephase the remaining transverse magnetisation before applying the next 
excitation pUlse. 
Since GE-EPI is based on T2* contrast, it plays an important role in functional MRI 
such as Bold Oxygenation Level Dependent (BOLD) contrast that depends on 
susceptibility variations. 
Spin Echo EPI 
In comparison to GE-EPI, spin echo EPI (SE-EPI) differs in three ways. Firstly, SE-
EPI uses an additional refocusing radio frequency pulse with a flip angle of 1800 
along the transverse plane. Secondly, due to the application of a refocusing radio 
frequency pulse before signal acquisition (rather than an FlO), gradient echoes 
are formed under the envelope of a spin echo. As a result, SE-EPI pulse sequences 
are T2-weighted, while GE-EPI pulse sequences are predominately Tz* -weighted. 
Thirdly, unlike GE-EPI, which applies a prephase gradient lobe with opposite 
polarity, SE-EPI uses prephase frequency and phase encoding gradient lobes with 
the same polarity because these are usually applied prior to the refocusing pulse 
to reduce the TE. 
Similar to GE-EPI, SE-EPI requires crusher gradients that straddle the refocusing 
pulse to dephase the unwanted FlDs from the refocusing pulse. A schematic 
representation of spin echo EPI is shown in figure 2.24. 
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Figure 2.24: Schematic representation of spin echo EPI sequence. 
Inversion-Recovery EPI 
Inversion-Recovery EPI (IR-EPI) is another form of EPI pulse sequence used to 
attenuate cerebrospinal fluid (as in FLAIR), measure tissue perfusion with 
arterial spin labelling, prepare Trweighted images and produce Tl maps. As its 
name suggests, this sequence uses an inversion recovery module prior to a GE-
EPI or SE-EPI pulse sequence [52]. 
Single-Shot EPI 
Single-shot EPI was initially developed as a single-shot pulse sequence, where 
only a single radio frequency excitation pulse is applied to acquire an entire two-
dimensional data set needed for image reconstruction. Single-shot EPI provides 
excellent temporal resolution. However, it is prone to producing images with 
compromised quality (low SNR, low spatial resolution and pronounced artefacts) 
and places stringent requirements on the gradient and radio frequency hardware 
(gradient amplitude, slew rate and receiver bandwidth). In single-shot EPI, the 
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acquisition time for each echo must be kept to a minimum to maximise the echo 
train length (ETL) without prolonging the total acquisition window. 
Multishot EPI 
In multishot EPI, a fraction of k-space is acquired per single excitation pulse [53). 
Hence, multiple shots or segments, Ns, are required to fill up the whole k-space, 
adopting possible values for k-space designs; such as mosaic and interleaved 
(parallel or anti-parallel). So, the total number of phase encoding steps, Ny, 
depends on Ns and the echo train length, ETL (number of lines in each segment). 
(Eq 2.63) I 
In contrast to single-shot EPI. the echo train length does not restrict multishot 
EPI. Multishot EPI also places less stringent requirements on the gradient and 
radio frequency hardware compared to single-shot EPI. Therefore, multishot EPI 
with shorter ETL than single-shot EPI is capable of producing images with 
reduced blurring, reduced ghost intensity, less distortion and better SNR. 
Multishot EPI with shorter ETL will increase the imaging time by a factor of Nshots. 
The scan time is given by, 
Scan Time = TR x N packages X N shot X NEX (Eq 2.64) 
where NEX is the number of signal averages and Npackages represents the number 
of acquisitions of passes. As a result, the combination of k-space from different 
shots makes multishot EPI much more sensitive to motion artefacts. 
2.3.3.5 Pulsed Gradient Spin Echo 
Pulsed gradient spin echo (PGSE) is the most commonly employed method for 
producing diffusion-weighted contrast. Stejskal and Tanner initially introduced 
this sequence in 1965 [54]. The PGSE sequence is made up of a pair of 90° and 
2.3 Principle of MR Imaging 56 
1800 radio frequency pulses to form a spin echo, with large and equal gradient 
lobes applied on either side of the 1800 pulse (figure 2.25). 
The basic idea of the PGSE sequence is that the spins are dephased following the 
fi rst grad ient. Then, the 1800 pulse is applied to refocus any reversible losses in 
spin phase coherence. Here, the 1800 pulse effectively changes the sign of the 
subsequent gradient pulse and therefore the two pulsed gradients are practically 
equal and opposite. However, the spins would not experience an equal and 
opposite gradient if they have moved during or between the applications of the 
two pulsed gradients . 
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Figure 2.25: Schematic representation of PGSE sequence. 
The PGSE sequence can be used to measure velocity. Consider a spin at an initial 
position, Yo, moving along the y-axis with velocity v. After a time t, the spin has 
moved a d istance vt. It experiences a shift in phase (¢) when it encounters the 
first pulsed gradient. This gradient, initiated at t = 0, reaches its maximum, Gy, 
and remains at Gy for a time T. Hence, the phase shift from the first gradient is 
given by, 
(Eq 2.65) 
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Then, after t = 6, the application of the second gradient pulse, equal and opposite 
to the first gradient, shifts the spin's phase by, 
Ii+T 
l/J2 = y G y f (Yo + v t ) dt 
<1 
(Eq 2.66) 
Hence, the resulting net phase shift is, 
(Eq 2.67) 
Normally in a flow with coherent motion, where all the spins in a voxel are 
displaced in the same direction and same distance (vt), the spins will all 
experience the same equal and opposite gradients and will remain coherent. 
Therefore, there will be no loss in signal since these spins will remain aligned 
with respect to each other, whilst accumulating the same shift in phase. 
Conversely, spins with incoherent motion (for example, varying velocities) will 
accumulate different phase shifts. In the case of true Brownian motion diffusion, 
the phase shifts have a Gaussian distribution of displacements (vt described in 
the equation above). Here, when the net phase shift of each individual spin is 
averaged over each voxel, the phase shifts arising from incoherent motion will 
partially cancel out each other. This results in attenuation of the spin echo. 
The degree of diffusion weighting (b-factor) can be controlled by manipulating 
the strength of the gradient (G), the pulse width (6) and the timing element (a). 
The value of b in the PGSE sequence is given by, 
(Eq 2.68) 
The diffusion-weighted contrast behaves slightly like reverse Tz contrast. Tissues 
with high water concentration have very mobile molecules that give rise to lower 
signal intenSity, while tissues with solid and static tissues give a stronger signal. 
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The signal strength of the PGSE sequence is given by, 
(Eq 2.69) 
where S(b} is the signal for a particular b-value and D is the apparent diffusion 
coefficient or self diffusion coefficient of the tissue (mm2 S-l). In practice, 
although PGSE measurements are modelled as diffusion, this measurement 
contains contributions from other movement sources, such as microcirculation in 
pseudo-random capillary systems that also gives rise to intra voxel incoherent 
motion (IVIM). The diffusion and microcirculation that occurs simultaneously in 
each voxel affects the signal attenuation of the PGSE sequence. This signal 
attenuation can be described as, 
(Eq 2.70) 
where D* is the pseudo-diffusion coefficient and f is the perfusion fraction or 
fractional volume occupied by incoherently moving spins in the voxel. To 
measure the apparent diffusion coefficient it is necessary to apply a range of b-
values and perform a 'least squares' fit. Then, D, D* and f can be estimated by 
fitting the signal intensities obtained for images acquired using different b-values 
to the equation in 2.70 [55]. 
2.3.4 MR Artefacts 
As with any imaging modality, magnetic resonance imaging suffers from a 
number of artefacts that are either caused by the patients, signal processing 
inadequacy, or the limitations of the scanner itself. An artefact is an artificial 
features appearing in an image that is not actually present in the original object. 
It can affect diagnostic quality and sometimes can be confused with pathology. 
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2.3.4.1 Patient Related MR Artefacts 
Motion Artefacts 
One of the most common artefacts in MRI is the motion artefact that either causes 
ghost images or diffuses noise in the image in the phase-encoding direction. This 
artefact originates due to a significant difference between the acquisition time in 
the frequency encoding and phase encoding direction. Normally, sampling at all 
of the rows in the matrix in the frequency encoding direction takes place during a 
single echo (milliseconds), while sampling in the phase encoding direction takes 
several seconds or minutes. This complete set of k-space data is then converted 
to an MR image by the application of a Fourier Transform. Since major 
physiological movements occur in seconds, it is too slow to affect the frequency 
encoding, but has a substantial effect in the phase encoding direction [56]. 
Ghost images are caused by pulsating or periodic motion such as the movement 
of blood vessels, cardiac motion and cerebrospinal fluid (CSF), while non-
periodic motion can result in diffuse image noise as shown in figure 2.26. The 
intensity of the ghost image increases with extent of movement and signal 
intensity from the moving tissue [56]. The fractional separation (SEP) between 
the ghost can be described as, 
TRxN xNEX SEP= y 
T(motion) 
or 
SEP = acquisition time 
T(motion) 
(Eq 2.71) 
(Eq 2.72) 
where T (motion) represents the period of motion of the structure [57]. 
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Figure 2.26: Motion artefact (indicated using arrow) due to foetal motion. 
Several methods can be used to reduce motion artefacts. The simplest solution is 
to request the patients to remain as still as possible, or immobilise the patients 
using pads and immobilisation straps (if necessary, sedating patients in pain) and 
use glucagon in the abdomen to reduce artefacts due to bowel peristalsis [57]. 
Alternatively, motion correction using cardiac or respiratory gating (triggering) 
could be incorporated into scanning protocols. Additionally, motion artefacts can 
be overcome by suppressing the signals of the tissues causing the artefacts, using 
a shorter dimension of matrix in the phase-encoding direction, applying view-
ordering or phase-reordering methods, and switching the frequency and phase 
encoding directions to move the artefacts out of the field of interest [56; 58]. 
Flow Effects 
Flow effects in MRI may produce a range of artefacts: altered intravascular signal 
(flow enhancement or flow related signal loss) or motion artefacts (ghost images 
or spatial misregistration). Flow enhancement (inflow effect) results when fully 
magnetised protons enter the imaged slice yielding high signal in comparison to 
the rest of the surroundings, while the stationary protons have not fully regained 
their magnetisation. Conversely, flow related signal loss occurs when high 
velocity flow causes the protons entering the image to be removed before the 
application of a 1800 pulse. Consequently, the magnetisation effect on these 
protons does not contribute to the echo [56]. 
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The easiest way to avoid flow artefacts is to apply spatial saturation bands 
outside the field of view or in the slice direction. In such cases, before the 
application of the radio frequency imaging pulse, the spatial saturation bands 
apply a 90° pulse to all the tissues within the band. Therefore, the blood flowing 
from the saturation band into the imaging slice will not have time to recover its 
magnetisation in the z-direction and consequently will not produce any signal. It 
is important to note that spatial saturation bands raise pulse sequence time. This 
reduces the number of slices that can be possibly imaged in a given TR. It also 
increases the specific absorption rate (SAR), so care should be taken in dealing 
with such imaging sequence in foetal MRI and patients with impaired 
thermoregulation conditions or who are febrile [10]. 
Alternatively, de phasing effects can be corrected by employing a technique called 
gradient moment nulling (gradient moment rephasing or flow compensation). 
Here, extra gradient pulses with carefully calculated strengths and durations are 
incorporated into the pulse sequence in attempt to produce zero net phase effect 
from moving and static protons. This reduces the velocity induced phase angles, 
producing a single image of the vessel on the final image. While application of 
gradient moment nulling does not increase the SAR, the extra gradients will 
increase the minimum TE, and therefore will reduce the number of slices that can 
be possibly acquired [10]. 
Magic Angle Artefacts 
Magic angle artefacts are most frequently seen in ligaments and tendons (rotator 
cuff and patellar tendon) that are oriented at a certain angle (55°) relative to the 
main magnetic field. The majority composition of tendons is collagen that 
possesses an anisotropic property. The T2 of tendons depend on the orientations 
of this structure. However, the properties of this structure vary with the direction 
of measurement causing T2 of the tendon to be slightly increased at the magic 
angle. While this effect is negligible at long TE, it increases the signal intensity 
when TE is short causing the tendons to appear brighter in Tl and PD weighted 
images. This increased intensity artefacts can potentially be confused with 
pathology [57]. 
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Susceptibility Artefacts 
Susceptibility artefacts occur at interfaces between tissues with different 
magnetic susceptibilities that cause local magnetic fields to distort the external 
magnetic field, altering the precession frequency in the tissue leading to spatial 
mismapping of information. Metal artefacts are a special case of susceptibility 
artefacts. Most metals have much higher susceptibilities compared to body 
tissues, creating larger magnetic field inhomogeneities around the metal object. 
The extent of image distortion depends on the pulse sequence, imaging 
parameters, type of material (stainless steel inflicts a greater distortion effect 
compared to titanium alloy) [59] and type of interface (the greatest effects are at 
soft tissue-metal interfaces). Metal artefacts are caused by internal (surgical clips, 
spinal hardware and orthopaedic devices) or external ferromagnetic (cobalt 
containing make up) materials. Metal artefacts are variable; it can result in image 
distortion, total image loss and peripheral high signal [56]. Moreover, metals are 
generally good conductors. They absorb energy from the radio frequency 
excitation pulses and can pose safety hazard. This will be discussed in detail in 
section 3.3 of Chapter 3. 
Susceptibility artefacts can be reduced by aligning the long axis of an implant or 
metal device parallel to the long axis of the external field. This is possible with an 
open magnet and mobile extremity imaging [60; 61]. Alternative methods include 
choosing the appropriate frequency encoding since susceptibility artefacts are 
most distinct in this direction, applying fast imaging sequences, using smaller 
voxel sizes, increasing readout bandwidth, avoiding application of gradient echo 
imaging in presence of metal, and using only spin echo sequence in cases where 
the images are severely degraded by metal artefacts [10; 59; 60; 61]. In addition, 
a metal artefact reduction sequence (MARS) can be employed, where additional 
gradients are applied along the slice selection direction at the time the frequency 
encoding is applied [56; 61]. 
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2.3.4.2 Signal Processing Dependent Artefacts 
Aliasing 
Aliasing or wrap around results when the selected field of view is smaller than 
the body part that is being imaged in the phase encoding direction. The body part 
outside the field of view will be exposed to certain magnetic field gradients that 
may correspond to a higher frequency than the maximum frequency ([max) that is 
being sampled. This Nyquist limit was discussed in section 2.3.2.2, and the 
sampling rate must be twice the maximum frequency that occurs in the body 
(Nyquist sampling rate). Since the computer cannot recognise frequency above 
Imax and below Imin, any frequency outside the bandwidth's frequency range will 
be aliased to a frequency existing within the bandwidth. Hence, the higher 
frequency will be identified as a lower frequency and lower frequency as higher 
frequency within the accepted bandwidth. The apparent frequency,fA is given by, 
(Eq 2.73) I 
where IT is the actual frequency andIN is the Nyquist frequency [57]. As a result, 
the body part that lies beyond the edge of the field of view is projected to the 
opposite side of the image. 
In practice, scanners usually apply a low pass filter with Nyquist frequency to 
avoid aliasing. This is done to remove the high frequency components (> IN) of 
the signal in the frequency encoding direction. If this filter is applied on its own, 
the signal at the periphery of the FOY will weaken since the filter has a sloping 
edge close to the Nyquist frequency known as 'filter roll-off. Therefore, 
oversampling technique is normally employed to overcome aliaSing problem. 
Frequency oversampling involves increasing the sampling frequency of the ADC, 
which results in an increase in the Nyquist frequency (cut-off frequency). While 
this filtered signal at the new cut-off frequency still have a roll-off edge, the 
remaining signals at initial cut-off frequency is accurately represented and have 
no attenuation due to filtering. In contrast, the only way to avoid aliasing artefact 
in phase encoding direction is to avoid having signals from outside the FOY. 
While this is achievable by increasing the number of phase encoding steps, it can 
increase the image time and reduce signal to noise ratio (SNR). 
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Chemical Shift Artefact 
Chemical shift artefacts commonly occur at the fat-water interfaces along the 
frequency or phase encoding direction. These artefacts are generally noticed in 
the spine at the vertebral body end plates, in the abdomen or the orbits where fat 
and other tissues form borders. Chemical shift artefacts appear due to different 
resonance environment between protons in fat and water; the protons in water 
resonate at higher frequency than those in fat. Since the polarity of frequency 
encoding is in the x-direction, higher frequencies are misregistered to right and 
lower frequencies are misregistered to the left. So, water protons are relatively 
shifted to the right towards higher frequencies and fat protons are shifted to the 
left towards lower frequencies. This shifting will result in variation in signal void 
and overlap, that leads to formation of dark and bright bands on the Tl weighted 
or PD weighted conventional spin echo image. For example, in the spine, chemical 
shifts cause one end of the plate to appear thicker than the opposite end. In the 
abdomen and orbits, chemical shifts forms a black border at one fat-water 
interface and a bright border at the other end [57]. 
In EPI, chemical shifts artefacts usually occur along the phase encoding direction 
because of very low bandwidth. For spins with a chemical shift of frequency 
separation, !J./cs (in Hertz), relative to reference frequency, the chemical shift 
produces a spatial shift (!J.Ycs) along the phase encoding direction which can be 
described as, 
~y ,.. ~/es L 
e5 ~ y 
V phase (Eq 2.74) 
== tesp ~/es L 
N Y 
shots (Eq 2.75) 
where ~ fes .. Y x Bo x D 
(Eq 2.76) 
where tesp is the echo spacing, !J.Ycs is the bandwidth and Ly is the field of view 
along the phase encoding direction. Since equation 2.74 shows that chemical 
shifts are inversely related to number of shots (Nshots), multishot EPI is less 
sensitive to chemical shift artefacts [8). 
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Chemical shift artefacts depend on magnet's field strength and the shift is greater 
at higher field strengths. Therefore, the receiver bandwidth should be larger than 
the frequency offset of fat (fl.j), so that the chemical shift artefacts are 
represented by fewer voxels. Alternatively, fat suppression techniques can be 
employed to overcome this artefact by eliminating the fat signals. This can be 
achieved by applying spectrally selective pulses prior to the imaging sequence. 
Provided that the pulse's bandwidth is wide enough to cover the fat frequencies, 
the spectrally selective pulse will only flip the longitudinal magnetisation of fat 
into the transverse plane. Then, the transverse magnetisation of fat is destroyed 
using one or more spoilers. This is achieved by quickly applying subsequent 
excitation pulse that will flip the longitudinal magnetisation vector of water 
protons only into the transverse plane and avoid the recovery of the longitudinal 
magnetisation of fat. To offset the fast recovery of fat magnetisation, the time 
between the saturation pulse and readout pulse is normally short [62]. 
Gibbs Phenomenon 
Gibbs phenomenon or truncation artefacts are caused by the under-sampling of 
high frequencies at sharp boundaries in the image [63; 64]. The lack of 
appropriate high frequency components gives rise to an oscillation at a sharp 
transition known as a ringing artefact. This phenomenon normally occurs near 
the sharp boundaries, where high contrast interfaces or transition occur in the 
body (brain or skull, (SF or cord, fluid or meniscus in the knee) and causes 
regularly spaced parallel alternating bright and dark bands that slowly fade away 
with distance. However, these bright and dark signals can be mistaken for lesion 
(pseudo syrinx of the spinal cord or pseudo tear of the knee meniscus). The 
ringing artefacts are more pronounced in smaller digital matrix sizes [56; 57). 
Gibbs artefacts can be corrected by increasing the matrix size for a given field of 
view, flltering the k-space data prior to Fourier transform, employing 
Gegenbauer reconstruction and Bayesian approaches [65; 66; 67]. 
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Partial Volume 
Partial volume artefacts arise when the dimension of voxel is larger than the size 
of the structure that is imaged. Hence, the object loses its identity in the MR 
image when the signal over the voxel is being averaged causing loss of detail and 
spatial resolution. Using smaller pixel size or slice thickness can reduce these 
artefacts, but it also results in poorer SNR in the image [56]. 
2.3.4.3 Hardware Related Artefacts 
External Magnetic Field Inhomogeneity 
MR imaging is conducted based on the assumption that external magnetic field 
(80) is homogeneous. When the 80 is inhomogeneous, it leads to mismapping of 
tissues that results in intensity variation, spatial distortion, or both. This non-
uniformity of the 80 is usually due to improper shimming, environmental factors, 
or the far extremes of newer short-bore magnets. Spatial distortion occurs from 
long-range field gradients, which cause spins to resonate at Larmor frequencies 
that are different than the Larmor frequencies prescribed by the imaging 
sequence. Intensity distortion results when the field homogeneity in a location is 
less or greater than in the rest of the imaged object. The Tz• in this region is 
different and thus, the signal will tend to differ [56; 57]. 
Gradient Field Artefacts 
As previously mentioned, magnetic field gradients are used to spatially encode 
the location of signals that arise from excited protons within the imaged volume. 
While the slice selection gradient defines the desired slice, phase encoding and 
frequency encoding gradients provide the spatial information in the remaining 
two axes. Any deviation in the gradient would result in image distortion. 
The gradients usually produce a linear magnetic field gradient over a limited 
distance. Therefore, very large field of view may comprise regions with nonlinear 
gradient and the field strength is loss at the periphery as the distance increase 
from the centre of applied gradient. This effect of nonlinearity at the periphery 
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leads to image distortion when anatomical compression takes place at the edge of 
the field of view, which is more prominent in coronal and sagittal imaging due to 
increased distance from isocentre. Although many systems apply a correction to 
the image to stretch out the pixels onto a rectangular field of view, a curved edge 
is formed on the image. Several approaches can be taken to correct gradient field 
artefacts. These include reducing the field of view by lowering gradient field 
strength or decreasing the frequency bandwidth of radio frequency signal [10; 
56]. 
Radio Frequency Noise 
Radio frequency noise artefact is caused when an unwanted stray external radio 
frequency signal (for example from TV channels, radio, computers, medical 
devices, mobile phones and fluorescent lights) is detected. This artefact is similar 
to the radio frequency feed through, but it occurs at a specific frequency or 
specific frequencies of the stray external radio frequency rather than at zero 
frequency. Normally, narrow band noise is projected perpendicular to the 
frequency encoding direction, while broader noise disrupts the image over a 
larger area. For this reason, it is important to plan the shielding of the scanner 
room by implementing proper installation and radio frequency shielding 
(Faraday cage) to eliminate unwanted stray radio frequency interference [56; 57; 
68]. 
Some of the most common radio frequency noise artefacts are zero line, star 
artefacts and zippers. Zero line and star artefacts are due to system noise or any 
cause of radio frequency pollution within the scanner room (e.g.: originating 
from sparking). If these artefacts perSist, it is advisable to check the sources of 
the system noise such as bad electronics, loose connections to surface coils or 
source of radio frequency pollution [56; 68]. Zippers appear as a band of 
alternating bright and dark dots (sometimes two or three pixels wide) extending 
across the image in the phase encoding direction. They are usually through the 
image centre and are caused by an imperfect Faraday cage with radio frequency 
pollution originating from outside the cage. This is generally due to the scanner 
room door being left open. It can also occur due to a break in the radio frequency 
screened room (the imperfect metal shield built into the walls, floor and ceiling of 
the scan room). In such a case, the artefacts will be present on all images and the 
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manufacturer's engineers should be called to investigate the problem [10; 56; 
68]. 
2.4 Components of a Magnetic Resonance 
Imaging System 
To have a good understanding of the image formation process, it is important to 
understand the physical principles of MRI and NMR, with knowledge of basic 
features of the MRI scanner. The essential components of an MRI system include 
the magnet that generates the static field, gradient coils for spatial encoding, a 
radio frequency system that exci tes and detects the nuclear induction signals and 
computer for system control, data acquisition, image reconstruction and post-
processing [12]. Figure 2.27 is a schematic representation of a typical MRI 
system. 
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2.4.1 Magnet 
The magnet is the main component of the MRI system. It generates the magnetic 
field. At present, magnets for clinical MRI are available at field strength between 
0.2 T and 3.0 T, while magnet for research purposes can be of higher field 
strengths (currently up to 9.4 T). Normally, the SNR increases with increasing 
field strength since the nuclear magnetisation is increased. There are two types 
of magnet: permanent and electromagnetic magnet (electromagnet can be 
resistive or superconducting). For practical use, all of the magnets in use should 
achieve three main requirements: strength, uniformity (homogeneity) and 
stability. 
Magnetic field strength is measured in Tesla, where 1 T = 10000 gauss. 1 T is 
approximately 20000 times the earth field, which is 0.5 gauss. The magnetic field 
strength does not fall abruptly outside the bore of the magnet; instead it fades 
away gradually with increasing distance. The magnetic field homogeneity of a 
magnet is quoted in parts per million over a given diameter of a spherical volume 
(DSV). It is given by, ( A:', )10' ppm where A B, is the field variation, which is 
proportional to the minimum spectral bandwidth. The magnetic field 
inhomogeneity increases with decreasing ratio of magnet length to diameter, but 
primarily depends on the magnet design. Magnetic field stability measured in 
ppm per hour represents the consistency of the magnet over a time period, and 
the drift should not exceed a specific value [10]. 
Superconducting magnets use special properties of certain materials such as 
Niobium-Titanium (NbTi), which exhibit zero electrical resistance below a 
certain temperature known as transition temperature, which ranges from 10 K -
20 K for NbTi. The 80 field is generated by a solenoid coil in which the electrical 
currents flow indefinitely without resistance in the absence of an external power 
source. These coils become superconducting when immersed in liquid helium 
(boiling point at 4.2 K) and permanently cooled to near absolute zero. The helium 
is enclosed in a high-vacuum cryostat that is thermally insulated and shielded 
against radiation. Modern magnets are equipped with a cryorefrigerator (cold 
head) that stabilises the shield temperature (- 20 K). Superconducting magnets 
produce a strong, stable and highly homogeneous magnetic field. 
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During installation, the superconducting magnet is ramped up or energised to the 
required field strength using an external electrical field. Once the desired field 
strength is achieved, the external electrical power can be removed. However, the 
current will continue flowing with a long decay constant, A: 
L A=-
Re (Eq 2.77) 
where L is the inductance and Re is the electrical resistance. The stored energy of 
the magnet, E (Joule) is given by, 
(Eq 2.78) 
where L is the wire's inductance (in henrys) and I is the electrical current (in 
amps). 
The magnet cannot be rapidly switched off in emergency. Magnet quenching 
occurs when any part of the superconducting coils heats up causing 
superconductivity loss that leads the electrical resistance to rise and impede the 
current flow in the coil. The rapid drop in current flow and subsequent loss of 
field strength would cause the stored magnetic energy to convert to heat, which 
causes rapid boil-off of the liquid helium forming gaseous helium that expands 
very quickly. This evaporated helium should be vented outside of the magnet 
room to avoid suffocation and cold burns. Magnet quenching is a serious event 
that can occur due to a projectile aCcident, failure of the cooling system, 
mechanical vibrations or induced field. However, with the recent architecture of 
superconducting magnet incorporating the state-of-the-art magnet technology, 
quenching is becoming a rare event [9; 69]. 
Shielding is very important in MR systems since all magnets produce a fringe 
field (stray magnetic field) that extends beyond the magnet in all three directions 
(x, y, z). This stray field can affect the equipment in adjacent rooms and increases 
the risk of the projectile effect. The magnetic field can be shielded using two 
approaches. The first approach is a passive method that involves attaching very 
heavy iron layers around the magnet room and covering the magnet room with a 
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layer of stainless steel. This is mainly used at ultra-high field. The second method 
involves active shielding using secondary coils. These coils would produce a 
magnetic field opposing the fringe field's direction. This sort of shielding reduces 
the fringe fields by limiting the spatial distribution of the magnet outside the 
magnet room. However, it will also reduce the internal magnetic field [9; 10; 70]. 
Most magnets suffer from some inhomogeneity as a result of design limitations 
or compromises. Therefore, shimming is important to improve a magnet's 
homogeneity. This can be achieved using fixed passive and active shimming at 
installation. The former involves placing pieces of steel or iron at certain 
locations within the magnet bore and outside the scanner's surface. The amount 
and location of these materials are normally determined using a simulation 
process run on a computer. The latter involves adding additional 
superconducting coils inside the magnet bore where currents of accurately pre-
determined magnitude can flow. These secondary superconducting coils can also 
be placed in the cryostat. The scanner's homogeneity can also be adjusted by 
conducting 'scan by scan' shimming, which is performed by the scanner at the 
beginning of scan on a per-patient basis using dynamic shimming. Here, the 
gradient coils are used to produce specific magnetic field homogeneity. Both 
techniques will optimise magnetic field homogeneity and therefore, reduce image 
geometric distortion [9; 10; 69; 70]. 
2.4.2 Gradient System 
As discussed in section 2.3.1, spatial localisation of the MR signal is only 
achievable with the assistance of the gradient system. This system is made up of 
three orthogonal linear magnetic field gradients, each with its own amplifier that 
alters the magnetic field strength along the x, y and z directions. These gradients 
can either be switched separately or together to define and image a slice. 
Generally, the gradient along the axis of the superconducting magnet is called the 
slice selection gradient (z-axis), the left-right direction is called the frequency 
encoding gradient (x-axis) and the top-bottom direction is called the phase-
encoding gradient (y-axis). While these gradients are oriented orthogonal to each 
other, each gradient produces a magnetic field parallel to the main magnetic field, 
Bo. The gradient's magnetic field is produced from current flowing in the loops of 
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coils placed inside the magnet bore. Each gradient has its own magnetic field, 
which interacts with the main magnetic field by adding to or subtracting from 80, 
causing the magnetic field and Larmor frequency to vary linearly as a function of 
distance from the centre of the magnet bore. The geometric centre of the magnet 
is called the isocenter (null point) where the field strength is not affected by any 
of the three gradients. 
Although the gradient coils generate magnetic fields that are relatively small 
compared to the main magnetic fields, these coils still need currents of several 
hundred amperes. The gradient field measured in mT m- l depends on the amount 
of electric current flowing through the gradient coils and the gradient coil size 
and efficiency, while its direction depends on the sign of the electric current. The 
gradient performance is measured based on maximum gradient strength, rise 
time (time to maximum gradient amplitude, which depends on inductance) and 
slew rate (maximum gradient amplitude per rise time). The high currents are 
required since the gradient should be strong enough to overcome the main 
magnetic field inhomogeneity and short enough to prevent signal loss due to 
relaxation, predominantly T2•• Moreover, the gradient fields should be extremely 
stable to avoid image distortion [9; 69]. 
2.4.3 Radio Frequency System 
The radio frequency system comprises a radio frequency transmitter and 
receiver along with radio frequency coils. This system generates the oscillating 81 
field that excites the sample and detects the resulting NMR system. This process 
starts with the formation of the radio frequency pulse in the transmission unit. 
Initially, a modulator mixes the pulse envelope from the waveform controller to 
the reference waveform produced by an adjustable frequency synthesizer that is 
resonating at a frequency near the Larmor frequency. Then, the radio frequency 
pulse passes through an amplifier that amplifies it by a certain gain. Following 
this, the radio frequency current from the power amplifier flows through the 
radio frequency coil, generating a magnetic field. This homogenous oscillating 
magnetic field excites the sample. Subsequently, the system switches to receiver 
mode and the receiving unit detects the weak rotating magnetiC field generated 
when the magnetic moments release their energy while returning to their initial 
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energy state. This received energy is converted back to an electrical signal via 
Faraday induction. 
The signal is amplified by a sensitive, low noise pre-amplifier, so that it is less 
sensitive to external interference. Then, the amplified signal and input from the 
system reference oscillator are sent to a quadrature demodulator where the 
frequency is demodulated by the Larmor frequency leaving the envelope 
available for further processing steps. The demodulator has two inputs: one 
representing the real part and the other representing the imaginary part of the 
signal. The imaginary part is at off-phase by 90° relative to the reference 
oscillator. The quadrature detection allows measurement of both frequency and 
phase of the NMR signal. Then, the demodulator signal is low pass filtered to 
avoid image wrap around or aliasing in the frequency encoding direction. Finally, 
the outputs of the anti-aliasing filters are digitised using an Analogue to Digital 
Converter before being sent to the host computer [10]. 
2.4.4 Computer System 
The MRI scanner is controlled by a computer workstation. This computer is very 
important in controlling and coordinating scans. Its main roles include 
controlling the gradients and radio frequency coils via a waveform controller (a 
series of Digital to Analogue Controllers), acquiring data and reconstructing and 
storing the images of the scanned object. The scanner interface enables the 
radiographers to adapt the sequence during imaging (for example: motion 
correction or for a larger field of view). Three dimensional and functional studies 
would require a high capacity computer with large memory and high data 
transfer rates. In addition, there is also a physiological monitoring system to 
monitor the patient inside the scanner room. 
2.5 References 74 
2.5 References 
[1] P.G. Morris. (1986). Nuclear Magnetic Resonance Imaging in Medicine and 
Biology. Oxford Sciend Press. Oxford. 
[2] P. Mansfield. and P.G. Morris. (1982). NMR Imaging in Biomedicine. Academic 
Press. New York. 
[3] F. Bloch. (1946). Nuclear Induction. Physical Review Online Archive (ProIa) 
70460-474. 
[4] N. Bloem bergen. E.M. Purcell. and RV. Pound. (1948), Relaxation Effects in 
Nuclear Magnetic Resonance Absorption. Physical Review 73679-712. 
[5] M.H. Levitt. (2001). Spin Dynamics: Basic of Nuclear Magnetic Resonance, 
John Wiley and Sons. Ltd .. Chishester, UK. 
[6] JA Koutcher. and C.T. Burt. (1984), Principles of Nuclear Magnetic 
Resonance. Journal of Nuclear Medicine 25 101-11I. 
[7] P.T. Callaghan. (1991), Principles of Nuclear Magnetic Resonance Microscopy, 
Oxford Science Press. 
[8] MA Bernstein. K.F. King, and X.J. Zhou. (2004), Handbook of MRI Pulse 
Sequences. Elsevier Academic Press. USA. 
[9] M. NessAiver. (1997), All you really need to know about MRI Physics, 
Baltimore. 
[10] D.W. McRobbie. EA Moore, M.J. Graves, and M.R Prince. (2003), MRI From 
Picture to Proton, Cambridge University Press. Cambridge, United 
Kingdom. 
[11] C. Westbrook, C.K. Roth, and J. Talbot. (2005), MRI In Practice, Blackwell 
Publishing Ltd. Oxfrod. 
[12] E.J. Rummeny, P. Reimer, and W. Heindel. (2006), MR Imaging of the Body, 
Thieme, Stuttgart, Germany. 
[13] F. Bloch, W.W. Hansen, and M. Packard. (1946), Nuclear Induction. Physical 
Review 69127-127. 
[14] E.M. Purcell, H.C. Torrey, and RV. Pound. (1946), Resonance Absorption by 
Nuclear MagnetiC Moments in a Solid. Physical Review 6937-38. 
[15] S.-i. Nagaoka. (2007), A Short History of Three Chemical Shifts. Journal of 
Chemical Education 84 801. 
[16] W.G. Proctor, and F.e. Yu. (1951), On the Nuclear Magnetic Moments of 
Several Stable Isotopes. Physical Review 81 20-30. 
2.5 References 75 
[17] W.e. Dickinson. (1950), Dependence of the 19F Nuclear Resonance Position 
on Chemical Compound. Physical Review 77736-737. 
[18] E.L. Hahn. (1950), Spin Echoes. Physical Review 80580-594. 
[19] S.H. Koenig, and W.E. Schillinger. (1969), Nuclear Magnetic Relaxation 
Dispersion in Protein Solutions. Journal of Biological Chemistry 244 
3283-3289. 
[20] W.D. Rooney, G. Johnson, X. Li, E.R. Cohen, S.-G. Kim, K. Ugurbil, and C.S. 
Springer. (2007), Magnetic field and tissue dependencies of human brain 
longitudinal lH20 relaxation in vivo. Magnetic Resonance in Medicine 57 
308-318. 
[21] c. Burtea, S. Laurent, L. Elst, R.N. Muller, W. Semmler, and M. Schwaiger. 
(2008), Contrast Agents: Magnetic Resonance Molecular Imaging I, 
Springer Berlin Heidelberg. 
[22] H. Nakamura, N. Ito, F. Kotake, Y. Mizokami, and T. Matsuoka. (2000), 
Tumor-detecting capacity and clinical usefulness of SPIO-MRI in patients 
with hepatocellular carcinoma. Journal of Gastroenterology 35849-855. 
[23] A. Tanimoto, G. Wakabayashi, H. Shinmoto, S. Nakatsuka, S. Okuda, and S. 
Kuribayashi. (2005), Superparamagnetic iron oxide-enhanced MR 
imaging for focal hepatic lesions: a comparison with CT during 
arterioportography plus CT during hepatic arteriography. Journal of 
Gastroenterology 40371-380. 
[24] T. Araki. (2000), SPIO-MRI in the detection of hepatocellular carcinoma. 
Journal of Gastroenterology 35874-876. 
[25] P. Loubeyre, S. Zhao, E. Canet, H. Abidi, S. Benderbous, and D. Revel. (1997), 
Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood 
pool contrast agent for MR angiography: Experimental study in rabbits. 
Journal of Magnetic Resonance Imaging 7 958-962. 
[26] J.A. Pople. (1959), High-resolution nuclear magnetic resonance McGraw Hill, 
New York. 
[27] H.J. Weinmann, R.C. Brasch, W.R. Press, and G.E. Wesbey. (1984), 
Characteristics of gadolinium-DTPA complex: a potential NMR contrast 
agent. American Journal of Roentgenology 142619-624. 
[28] P.C. Lauterbur. (1973), Image Formation by Induced Local Interactions: 
Examples Employing Nuclear Magnetic Resonance. Nature 242 190-191. 
[29] P. Mansfield, and P.K. Grannell. (1973), NMR 'diffraction' in solids? Journal of 
Physics C: Solid State Physics 6 L422. 
2.5 References 76 
[30] A Kumar, D. Welti, and RR Ernst. (1975), NMR Fourier zeugmatography. 
Journal of MagnetiC Resonance 18 69-83. 
[31] P.c. Lauterbur, D.M. Kramer, W.v. House, and C.-N. Chen. (1975), 
Zeugmatographic high resolution nuclear magnetic resonance 
spectroscopy. Images of chemical inhomogeneity within macroscopic 
objects. Journal of the American Chemical Society 976866-6868. 
[32] P. Mansfield, A.A. Maudsley, and T. Bains. (1976), Fast scan proton density 
imaging by NMR Journal of Physics E: Scientific Instruments 9 271. 
[33] 0.1. Hoult. (1977), Zeugmatography - criticism of the concept of a selective 
pulse in presence of a field gradient. Journal of Magnetic Resonance 26 
165-167. 
[34] AN. Garroway, P.K Grannell, and P. Mansfield. (1974), Image formation in 
NMR by a selective irradiative process. Journal of Physics C: Solid State 
Physics 7 457-462. 
[35] W.A. Edelstein, J.M. Hutchison, G. Johnson, and T. Redpath. (1980), Spin warp 
NMR imaging and applications to human whole-body imaging. Physics in 
Medicine and Biology 25751-6. 
[36] R.N. Bracewell. (1978), Fourier transform and its applications, McGraW-Hill, 
New York. 
[37] J.F. James. (2002), A student's guide to Fourier transforms with applications 
in physics and engineering, Cambridge University Press, Cambridge, UK 
[38] T.A. Gallagher, AJ. Nemeth, and L. Hacein-Bey. (2008), An Introduction to the 
Fourier Transform: Relationship to MRI. American Journal of 
Roentgenology 190 1396-1405. 
[39] S. Ljunggren. (1983), A simple graphical representation of Fourier-based 
imaging methods. Journal of MagnetiC Resonance 54338-343. 
[40] D.B. Twieg. (1983), The k-trajectory formulation of the NMR imaging 
process with applications in analysis and synthesis of imaging methods. 
Medical physics 10610-21. 
[41] A. Haase, J. Frahm, D. Matthaei, W. Hanicke, and KD. Merboldt. (1986), 
FLASH imaging. Rapid NMR imaging using low flip-angle pulses. Journal 
of Magnetic Resonance (1969) 67 258-266. 
[42] J. Frahm, K.D. Merboldt, H. Bruhn, M.L. Gyngell, W. Hanicke, and D. Chien. 
(1990), 0.3-second flash mri of the human heart. Magnetic Resonance in 
Medicine 13 150-157. 
2.5 References 77 
[43] W. Hanicke, K.D. Merboldt, D. Chien, M.L. Gyngell, H. Bruhn, and J. Frahm. 
(1990), Signal strength in subsecond FLASH magnetic resonance imaging: 
the dynamic approach to steady state. Medical physics 17 1004-10. 
[44] RF. Busse, S.J. Riederer, J.G. Fletcher, A.E. Bharucha, and K.R Brandt. (2000), 
Interactive fast spin-echo imaging. Magnetic Resonance in Medicine 44 
339-348. 
[45] J.r. Barkhausen, S.G. Ruehm, M. Goyen, T. Buck, G. Laub, and J.r.F. Debatin. 
(2001), MR Evaluation of Ventricular Function: True Fast Imaging with 
Steady-State Precession versus Fast Low-Angle Shot Cine MR Imaging: 
Feasibility Studyl. Radiology 219 264-269. 
[46] V.S. Deshpande, S.M. Shea, G. Laub, O.P. Simonetti, J.P. Finn, and D. Li. (2001), 
3D magnetization-prepared true-FISP: A new technique for imaging 
coronary arteries. Magnetic Resonance in Medicine 46 494-502. 
[47] M.J. Stehling, A.M. Howseman, R.J. Ordidge, B. Chapman, R. Turner, R. Coxon, 
P. Glover, P. Mansfield, and RE. Coupland. (1989), Whole-body echo-
planar MR imaging at 0.5 T. Radiology 170 257-263. 
[48] P. Mansfield. (1977), Multi-planar imaging formation using NMR spin 
echoes. Journal of Physics C: Solid State Physics 10 55-58. 
[49] P. Mansfield. (1984), Real-time echo-planar imaging by NMR. British medical 
bulletin 40187-90. 
[50] M.K. Stehling, R Turner, and P. Mansfield. (1991), Echo-planar imaging: 
magnetic resonance imaging in a fraction of a second. Science 25443-50. 
[51] R Rzedzian, P. Mansfield, M. Doyle, D. Guilfoyle, B. Chapman, RE. Coupland, 
A. Chrispin, and P. Small. (1983), Real-time Nuclear Magnetic Resonance 
Clinical Imaging in Paediatrics. The Lancet 3221281-1282. 
[52] M.K. Stehling, R.I. Ordidge, R. Coxon, and P. Mansfield. (1990), lnversion-
recovery echo-planar imaging (IR-EPI) at 0.5 T. Magnetic Resonance in 
Medicine 13514-517. 
[53] G.C. McKinnon. (1993), Ultrafast interleaved gradient-echo-planar imaging 
on a standard scanner. Magnetic Resonance in Medicine 30 609-616. 
[54] E.O. Stejskal, and J.E. Tanner. (1965), Spin Diffusion Measurements: Spin 
Echoes in the Presence of a Time-Dependent Field Gradient. Journal of 
Chemical Physics 42 288-292. 
[55] R. Turner, D. Le Bihan, J. Maier, R. Vavrek, L.K. Hedges, and J. Pekar. (1990), 
Echo-planar imaging of intravoxel incoherent motion. Radiology 177 
407-414. 
2.5 References 78 
[56] L.J. Erasmus, D. Hurter, M. Naude, H.G. Kritzinger, and S. Acho. (2004), A 
short overview of MRI artefacts. South African Journal of Radiology 8 13-
17. 
[57] R.H. Hashemi, W.G. Bradley, and C,J. Lisanti. (2004), MRI: the basics, 
Lippincott Williams & Wilkins, Philadelphia. 
[58] T.D. Nguyen, G. Ding, R. Watts, and Y. Wang. (2001), Optimization of view 
ordering for motion artifact suppression. Magnetic Resonance Imaging 19 
951-957. 
[59] J.S. Suh, E.K. Jeong, K.H. Shin, J.H. Cho, J.B. Na, D.H. Kim, and C.D. Han. (1998), 
Minimizing artifacts caused by metallic implants at MR imaging: 
experimental and clinical studies. American Journal of Roentgenology 
1711207-13. 
[60] A.M. Viano, SA Gronemeyer, M. Haliloglu, and FA Hoffer. (2000), Improved 
MR imaging for patients with metallic implants. Magnetic Resonance 
Imaging 18 287-295. 
[61] S.D. Chang, M.J. Lee, P.L. Munk, D.L. Janzen, A. MacKay, and Q.-S. Xiang. 
(2001), MRI of spinal hardware: comparison of conventional Tl-weighted 
sequence with a new metal artifact reduction sequence. Skeletal 
Radiology 30 213-218. 
[62] TA Bley, O. Wieben, C,J. Fran~ois, J.H. Brittain, and S.B. Reeder. Fat and 
water magnetic resonance imaging. Journal of Magnetic Resonance 
Imaging 314-18. 
[63] S.J. Lee. (1998), An improved method for reduction of truncation artifact in 
magnetic resonance imaging. Proceedings of SPIE: Applications of Digital 
Image Processing 4360587-598. 
[64] R.A. Elgavish, and D.B. Twieg. (2003), Improved depiction of small anatomic 
structures in MR images using Gaussian-weighted spirals and zero-filled 
interpolation. Magnetic Resonance Imaging 21103-112. 
[65] R. Archibald, and A. Gelb. (2002), A method to reduce the Gibbs ringing 
artifact in MRI scans while keeping tissue boundary integrity. Medical 
Imaging, IEEE Transactions on 21305-319. 
[66] T. Bakir, and S.J. Reeves. (2000), A filter design method for minimizing 
ringing in a region of interest in MR spectroscopic images. Medical 
Imaging, IEEE Transactions on 19 585-600. 
2.5 References 79 
[67] RR Schultz, and R.L. Stevenson. (1994), A Bayesian approach to image 
expansion for improved definition. Image Processing, IEEE Transactions 
on 3233-242. 
[68] E. Pusey, RB. Lufkin, RK. Brown, M.A. Solomon, D.O. Stark, RW. Tarr, and 
W.N. Hanafee. (1986), Magnetic resonance imaging artifacts: mechanism 
and clinical significance. Radiographics 6 891-911. 
[69] D. Weishaupt, V.D. Kochli, and B. Marincek. (2006), How Does MRI Work? An 
Introduction to the Physics and Function of Magnetic Resonance Imaging, 
Springer, Verlag Berlin Heidelbery, Germany. 
[70] A.D. Elster, and J.H. Burdette. (2001), Questions & Answers in Magnetic 
Resonance Imaging, Mosby, Missouri. 
Chapter 3 
Foetal Magnetic Resonance 
Imaging 
3.1 Overview 
This chapter gives a brief review of the increasing usage of MRI with respect to 
ultrasound in prenatal diagnosis. With obstetricians often faced with question on 
which imaging modality is better in diagnosing the various prenatal conditions, 
the author has taken the opportunity to discuss the advantages and 
disadvantages of each modality with respect to their importance in foetal 
imaging. 
In addition, the author will provide an overview of the risks of MRI exposure 
during pregnancy to the mother and foetus. A detailed discussion on how the 
static field, time varying magnetic field and radio frequency fields interact with 
the human body, particularly the foetus will be presented in this chapter. 
Following this, reviews of recent studies on outcomes of MRI scans conducted in 
foetuses, adults and animals will be presented. Finally, the author will discuss 
some other factors that may compromise foetal well-being. 
3.2 Introduction to Foetal Imaging 
Driven by ongoing technical and scientific advancement, foetal MRI is emerging 
from being an exclusive prenatal research modality to a clinically important tool. 
MRI surfaced as a potentially powerful non-invasive diagnostic technique in 
prenatal and perinatal studies in 1983 [1; 2]. It has been widely employed to 
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study the development of the foetal central nervous system, gastrointestinal 
tract, genitourinary system, respiratory system and placental abnormalities [3; 
4]. 
On the other hand, ultrasound arrived as the predominant imaging modality in 
Obstetrics and Gynaecology in the 1960s, after Professor Ian Donald published a 
breakthrough paper describing the use of ultrasound in diagnosing abdominal 
masses in The Lancet in 1958 [5]. Since then, ultrasound has been used 
extensively in monitoring and diagnosing foetal abnormalities in prenatal and 
perinatal medicine. 
The construction of ultrasound images is very different from MR images. Unlike 
MRI, ultrasound is based on sound waves. The ultrasound transducer converts 
the electrical power into high frequency sound waves that are transmitted into 
the body. These sound waves are inaudible to human ears since they are in the 
range of 2 MHz to 15 MHz. They propagate through tissue and are partially 
reflected from the interface between tissues with different sound conducting 
characteristics, returning to the transducer as echoes. The scanner produces the 
ultrasound images by determining the direction of the echoes and calculating the 
time taken for the echoes to travel back to the transducer from the time the 
sound waves were transmitted. This information is used to calculate the depth of 
the tissues interfering with the echoes and to subsequently produce an image of 
the tissues. Lower frequency sound waves have longer wavelengths and are 
capable of travelling deeper into the body, but produce images with low 
resolution. Conversely, higher frequency sound waves have shorter wavelengths 
and a larger attenuation coefficient. Hence, they can image smaller structures 
with high resolution, but are limited by the depth of penetration of the sound 
wave into the body. 
Normally, transabdominal ultrasound is the first choice for obstetric scans. It 
generally involves placing and moving a transducer, covered with warmed 
lubricant jelly, on the pregnant abdomen. The movement of the transducer will 
enable the sonographers to visualise the foetal organs and placenta, and measure 
the biparietal diameter, femur length, abdominal and head circumference and 
crown-rump length (CRL) [6; 7; 8]. However, in early pregnancy, transvaginal 
ultrasound (a higher frequency ultrasound) is preferred due to its ability to 
produce images with higher spatial resolution, even if it is limited by lower 
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penetration capability. This is essential when the foetal organs are small because 
transvaginal probes are able to get closer to the foetus, to overcome the lack of 
penetration. Conversely, in later stage of pregnancy, ultrasound with greater 
penetration capability is essential to see deeper into the foetus. 
With improvement in technical and image quality in both MRI and ultrasound, 
questions have surfaced on which modality is better in prenatal assessment. In 
this review, the advantages and disadvantages of both imaging methods will be 
put into perspective with respect to the most important imaging factors. 
3.2.1 Availability and Accessibility 
At present, ultrasound is more established in clinical use due to its widespread 
availability and established safety. It is recognised as a non-invasive, cost-
effective, bedside imaging tool that is capable of producing images with high 
anatomical resolution in real-time [1]. On the contrary, although MRI has been 
recognised as an imaging tool to complement ultrasound, MRI is very expensive 
and is not widely available. For these reasons, ultrasound is ideal as a screening 
tool. 
3.2.2 Maternal Imaging Factors 
Ultrasound scans are known to be difficult and technically limited when dealing 
with obese mothers, patients with multiple pregnancy and patients suffering 
from oligohydramnios (deficiency of amniotic fluid) or polyhydramnios (excess 
of amniotic fluid). In these cases, the image quality of ultrasound is compromised 
due to interference of the ultrasound beam and inconsistent penetration through 
maternal structures. Normally, the sonographers will need to use high frequency 
transabdominal ultrasound for high-resolution images of the foetus. However, 
high frequency ultrasound will not be able to penetrate deep inside the maternal 
pelvis where the foetus is buried. Although sonographers can employ 
transvaginal ultrasound scans, critics have raised concerns on the safety of the 
transducer being much closer to the foetus compared to transabdominal 
ultrasound. Nonetheless, this technique produces better images of the foetus in 
3.2 Introduction to Foetal Imaging 83 
the first and second trimester, but proves to be challenging in the third 
trimester [1; 9]. 
While MRI has been recognised as an imaging tool to assist ultrasound in cases 
involving obese mothers, there are similar issues and limitations in performing 
foetal M RI in these patients. The main concern is that the large mother may not 
fit inside the MRI unit, especially when placed in the decubitus position, since the 
upper limit of the abdominal circumference in the supine position is about 
140 cm and the table weight is usually limited to 150 kg (this varies for different 
types of scanner). On the other hand, if the mother was successfully positioned in 
the scanner, the image quality of the intrauterine regions of interest may still be 
compromised. If scanning using phased array coils (for example.: cardiac coils) 
fails, an integrated coil can be used. Although this will enable the investigator to 
examine a bigger area of interest, it will lead to a reduction in the image 
resolution [4; 9]. Moreover, the mother's tissues will be near the edge of the bore 
where the RF gradient and static magnetiC fields are inhomogeneous. 
3.2.3 Gestational Age 
After decades of advancement in obstetric imaging, ultrasound still remains as 
the primary imaging choice in the first trimester. Ultrasound is particularly useful 
in producing images with clear representation of the foetal gestation and nuchal 
translucency in the first trimester. On the contrary, due to the restrictions of the 
slice thickness and partial volume averaging, MRI does not have adequate 
resolution to produce images with accurate foetal anatomy in the first trimester. 
In addition to this, there is insufficient evidence of safety during the vulnerable 
first trimester when the foetuses are generally sensitive to teratogens. For these 
reasons, most obstetric practices have opted to avoid MRI scans in the first 
trimester, unless the benefits outweigh the potential risks [4]. 
In contrast, ultrasound imaging of the abdomen and uterine appendages becomes 
more difficult with advancing gestation, especially in the third trimester. This is 
due to the displacement of the gas filled bowel by the enlarging uterus and 
decrease in the amniotic fluid. Consequently, sonographers often encounter 
problems while imaging the foetal brainstem from the midline sagittal view, 
which is important in evaluating the foetal brain. Although the foetal position is 
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an important criterion in the success of foetal brain imaging using ultrasound, 
foetal position cannot be altered unless it is medically necessary. Therefore, the 
anterior border of the brainstem may not be optimally observed due to beam 
attenuation [4]. Moreover, despite the little space available in the pregnancy sac 
at late gestation, foetal head movements are more pronounced, possibly 
disrupting ultrasound and MR images. However, with current advancement in 
ultrasound and fast imaging MR sequences, foetal images can be captured by 
freezing foetal motion. 
For MRI, mothers at later gestation may experience difficulty in remaining still 
during the scan. Moreover, foetal MRI can also be challenging when the foetal 
head is engaged within the lesser pelvis at late gestation: poor signal may result 
from unfavourable coil geometry when the coil is positioned on the decubitus 
maternal abdomen [4; 9]. 
3.2.4 Image Resolution 
Ultrasound employs high frequency probes that are capable of imaging small 
foetal structures, such as hair and eyelashes. They are also useful for imaging 
nuchal translucency in the first trimester [4]. This is particularly true for 
transvaginal ultrasound images, which are obtained by transducer placement 
into the vagina. They produce images with better resolution. Nevertheless, 
ultrasound images are still occasionally criticised for insufficient contrast to 
provide detailed information on foetal anomalies. Ultrasound is also limited in 
accurate prediction of lung development and maturation, in terms of determining 
whether the foetal lung has attained sufficient development to sustain neonatal 
survival. This is commonly related to congenital diaphragmatic hernia, 
oligohydramnios or lung parenchyma [10; 11]. 
As for foetal MRI, the smallest voxel size that can be obtained with the current 
technology is about 0.8 mm x 0.8 mm x 3.0 mm. In addition, foetal MRI is also 
restricted by the slice thickness, which limits the imaging of smaller and thinner 
foetal structures [4). For example, identification of meningeal lining in 
meningoceles can be very difficult, due to partial-volume averaging of thinned 
meningeal leafs with the adjacent cerebrospinal fluid and amniotic fluid [12). 
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3.2.5 Three Dimensional Rendering of Surface 
Anatomy 
At present, the ultrasound produces planar and volume rendered 3-dimensional 
images that are able to undergo multi planar reconstruction to produce 3- and 4-
dimensional foetal surface anatomy. Although MRI can produce 3-dimensional 
reconstructed images, the images obtained from foetal MRI lack anatomical 
details due to the application of dynamic sequences with a thick slab. For this 
reason, the foetal facial portrayal would be less detailed [4; 13; 14]. 
3.2.6 Operator Dependence 
The quality and accuracy of ultrasound imaging is greatly operator dependent 
and requires expertise in sonography. Sonographers will have to acquire and 
interpret images in real time. In comparison to ultrasound, MRI is somewhat less 
operator dependent. Although expertise is required to position slices and acquire 
data during the course of the scan, interpretation of MR images can be done at a 
later time by a radiologist [4; 15]. Nonetheless, in cases involVing artefacts that 
may represent true pathology, both ultrasound and MRI operators would require 
advice from experts (radiologists or physicists). 
3.2.7 Duration of the Examination 
Normally, the detailed ultrasound screening carried out in the second trimester 
in singleton pregnancies takes approximately an hour. However, this procedure 
can extend to 2 hours or more depending on foetal position, multiple pregnancy 
or anomalies detected. In some cases, foetal echocardiography may be required, 
or the patient may be requested to return for further diagnostic sessions if 
images obtained were not satisfactory. Conversely, foetal MRI in singleton 
pregnancies can be conducted in a shorter period. In our department, basic foetal 
anatomical imaging using HASTE and FISP is completed in 15 to 20 minutes, 
whilst the scan sessions take about 30 minutes. This includes repetitive 
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sequences because of foetal motion. The scan period is shorter in foetal MRI since 
it employs fast imaging sequences that compensate for foetal motion [4]. 
3.2.8 Other Issues 
Unlike ultrasound, foetal MRI can be very challenging for patients suffering from 
back pain and claustrophobia. This condition can be enhanced in the third 
trimester of pregnancy, when pregnant patients may have difficulty lying 
supinely and are traumatised when placed in a magnet considered to be small for 
their size. Conversely, they may also display anxiety when confronted with the 
magnet for the first time. In our experience, claustrophobia is a minor problem 
when patients are given adequate briefing and comforted before examination [4; 
12]. In some cases, patients are calmer when an MR assistant is present by their 
side in the scanner room throughout the scan. Additionally, foetal MRI cannot be 
performed in cases involving maternal pacemakers and ferromagnetic implants. 
3.2.9 Conclusion 
In conclusion, ultrasound is ideal for screening, while MRI is a complementary 
screening modality employed in suspected pathology or complex cases in 
addition to ultrasound in prenatal diagnosis. In addition, MR images are easier to 
interpret compared to ultrasound images, and have proved to be useful in patient 
counselling and management [16; 17; 18; 19; 20; 21]. 
3.3 Safety of Foetal Magnetic Resonance 
Imaging 
Foetal MRI has certainly gained an important role in the management of 
complicated pregnancy development. Nonetheless, the endless advancement in 
foetal MRI technology has alerted medical practitioners to possible adverse 
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effects on the developing foetus, mother and MR workers. In 2007, the Health 
Protection Agency released safety guidelines for patients and volunteers 
undergoing MRI procedures. These guidelines highlighted restrictions that are 
required to be implemented when imaging infants, pregnant women, febrile 
patients and in other impaired circumstances [22]. 
The uterine environment contains electrically conductive and thermally 
insulating fluids. If foetal development is interrupted during the process of cell 
differentiation and migration, it may lead to fully developed organs with 
compromised functionality. This issue often gives rise to doubts on the safety of 
any intervention in early pregnancy, including MRI. Moreover, unlike adults 
participating in MR scans, foetuses are unable to provide informed consent for 
themselves. Hence, the investigators are expected to be more responsible and 
cautious in ensuring the safety of the MR exposure to the foetus. 
The Health Protection Agency has paid attention to three main safety 
considerations in conducting foetal MRI. These areas of concern include static 
fields, pulsed radio frequency and time-varying electromagnetic gradient fields. 
As discussed in Chapter 2, the static field plays an important role in polarising the 
nuclear magnetisation, the radio frequency fields are used to excite the nuclear 
spins to obtain a signal, and the time varying magnetic field arises from the 
switching of magnetic field gradients that are essential for image encoding [9; 
23]. 
3.3.1 Static Field 
All human beings are continually exposed to the magnetic field of the earth, 
which is approximately 0.5 G or 5 x 10.5 T. This field is weak and people are 
generally unaware of its existence, unless if alerted by magnetic compasses [24]. 
The production of strong magnetic fields was made achievable with the discovery 
of electromagnets in the early 19th century. However, the available power 
supplies and the heating of the current carrying coils limited the fields available 
until superconductors were discovered in the mid 20th century. Subsequently, at 
that point of time, fields of the order of tesla became available [25]. 
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Initially, only a handful of people were exposed to these strong magnetic fields. 
They were individuals involved in specific professions, such as experimental 
high-energy physics. However, with 1.5 T MRI entering the clinical world in the 
1980s, people were introduced to a new degree of human exposure to magnetic 
fields [25]. Since then, the exploration and expansion of MRI applications has led 
to a growth in the number of scanners used throughout the world. This has 
subsequently contributed to the increase in the number of people receiving MR 
scans and an increase in the level of exposure to the participants and the MR 
workers. 
The primary danger in MRI is associated with acceleration of ferromagnetic 
materials positioned in close proximity to the stray field of the magnet. The 
outcome of accelerating metal objects can be very severe. It may inflict life-
threatening injuries to the patient lying in the MR scanner and potentially to the 
foetus. The probability of this risk is increased when scanning pregnant patients 
since there is an increased likelihood of other healthcare professionals with no 
MR background accompanying the subject into the scanner room. For these 
reasons, it is important to train the staff meticulously and implement all the 
appropriate local working rules. It is also vital to regularly monitor and maintain 
a non-magnetic scanner room layout [9]. 
Following the issue described above, there are also concerns pertaining to the 
torques or translational forces on metal objects implanted in the body. These 
magnetised implants will tend to rotate in the scanner, such that their magnetic 
moment will come into alignment with the scanner's magnetic field. This twisting 
may produce local tissue irritation that can lead to oedema formation [9; 25]. 
Moreover, similar translational effects may occur in these foreign bodies, 
potentially harming the subject's health. For instance, displacement or distortion 
of prostheses such as cochlear implants and intra-cranial vascular and surgical 
clips, can occur (26). 
Nonetheless, the utmost concern is the threat to the functionality of medical 
metal or electronic implants. There is a strong possibility of erratic and 
inappropriate pacemaker functionality during and after scanning [26]. However, 
these risks can be mitigated with a careful pre-MRI screening procedure 
conducted by MR staff. They should take extra care in checking biomedical 
implants, devices and components associated with lead wires that have or have 
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not obtained FDA approval and claim to be MR safe or compatible. The MR scans 
involving these implants should be conducted based on manufacturers guidelines 
and recommendations. Besides this, staff should also request patients to remove 
all body piercings that may be harmful to their health [9; 25; 27]. 
There have also been concerns about the threat following the changes in the 
force on blood moving through the static field, called the magnetohydrodynamic 
effect. Normally, the force, F, produced by current flowing in tissues is [25] 
F= JxB 
CEq 3.1) 
where J represents the electric current density and B is the magnetic field. The 
electric current density of tissues is determined using the tissue's electrical 
conductivity (0) and the electric field, E [25]: 
J=aE (Eq 3.2) 
However, in cases involving tissue movement with velocity, v the motion induced 
electric field would be in terms ofv x B. Hence, the electric current density would 
be [25]: 
CEq 3.3) 
At very high fields (> 16 T), when an electrically conducting fluid, such as blood 
flows in an applied magnetic field, a transverse electromotive force (EMF) is 
developed. As a consequence, patients may experience compensatory changes in 
blood pressure and encounter small electric voltages on the body surface as a 
result of small-induced current density produced in the tissues. This induced 
EMF is proportional to the magnetic field strength and the velocity of blood 
flow [9; 25]. 
At present, there is no consistent clinical evidence demonstrating any Significant 
magnetohydrodynamic effect at the field strengths currently used. In addition, 
the EMF's are largest at the surface and not at the centre of the magnet where the 
foetus is positioned. Nevertheless, this may be an issue if foetuses were scanned 
at higher field strengths since they are more sensitive to these effects compared 
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to adults. Foetuses have their own aortic blood flow system, which is similar to 
adults [28]. However, since the foetal blood pressure is somewhat lower than in 
adults, any force inflicted on the blood might be more significant. Moreover, 
unlike adults lying in scanner configurations, the foetus can lie in any orientation 
with respect to the direction of the static field. As the magnetohydrodynamic 
effect is largest when the field and velocity of blood are perpendicular, the effect 
will be increased if the foetus is aligned in such way that the direction of flow is 
perpendicular to the magnetic field [9; 29; 30]. In adults, this often occurs in the 
aortic arch but in a foetus it may occur in the body of the aorta if the foetus is 
lying transverse to the static field. 
Furthermore, users of high field MRI scanners (> 2 T) are known to experience 
disorientation or subtle perception of movement while working close to or 
within the magnet's bore. This effect is called magnetic-field-induced vertigo, 
which is an outcome of either an induced EMF, by a weak magneto hydrodynamic 
force affecting the endolymphatic tissues of the inner ear, or diamagnetic 
anisotropy of the otoliths of the inner ear receptors [22; 31]. Other effects include 
the effect on sensory organs leading to a metallic taste in the mouth, and 
sometimes magnetophosphenes where subjects experience flashes of light. In 
some cases associated with longer exposure, nausea or motion sickness, which 
may last for a few hours, can accompany the sensation of vertigo. Although these 
effects are transient and do not cause health hazards, scanner manufacturers 
often advise staff to move the patient's bed slowly into the magnet to keep the 
peak rate of change of field to less than 1 T S·l. This should not be an issue in 
foetal MRI, since pregnant patients are scanned using low field MR scanners and 
they are more likely to move slowly while climbing onto the MR bed [9; 23; 32]. 
In addition to the issues discussed so far, the major concern of foetal MRI is the 
effect of high-level exposure to the static field, which might result in detrimental 
effects on embryogenesis, chromosomal structuring and foetal development. 
Although several human foetal studies have been conducted in recent years to 
identify foetal growth retardation in pregnant mothers exposed to MRI in late 
gestation period, there is no clear evidence of disability or retardation in human 
foetuses [33]. Nonetheless, investigations conducted on pregnant mice 
demonstrated reduction in foetal weight and crown-rump length. There was also 
evidence of increased abortion rate and some deleterious effects on 
spermatogenesis and embryogenesis in mice [34). A study conducted on frog 
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eggs in a static magnetic field provided data suggesting alteration in early 
segmentation of the frog embryo. This could be an outcome resulting from 
variations in magnetic susceptibility of the different components in a cell 
involved in segmentation. However, this effect did not persist to impede in later 
development [35]. 
Besides the foetus and pregnant subjects, scientists have also recognised the 
importance of studying the effects of static fields on pregnant MRI staff members. 
In 1993, a group in the USA conducted a survey consisting of four questionnaires 
that covered 1421 pregnancies. This study investigated the effect of static field 
exposure to the fertility, length of gestation, birth weight, pregnancy outcomes 
and offspring's gender of the female MRI staff in frequent contact with the 
scanner. The data collected from this study did not demonstrate any statistically 
significant effect on the offspring of these pregnant MR staff [36]. Nonetheless, 
pregnant workers are advised to avoid remaining within the MRI scanner room 
during the actual scanning process. They should also be given an option not to 
enter the scanner room [23; 37]. 
At present, there is no consistent evidence suggesting magnetic field exposure is 
harmful to foetuses. The few cases of injuries reported relating to humans are 
due to the inadvertent presence of ferromagnetic materials or cardiac 
pacemakers. Nevertheless, with advancement in MR technology and field 
strengths used in human studies, scientists should continue their efforts to 
regularly inspect for signs of unexpected field-related health issues. 
3.3.2 Time-Varying Magnetic Gradient Fields 
The gradient coils used in MRI add approximately linear variations to the static 
field. They are time-varying magnetic fields that are of low frequency range (0 -
1 kHz), and can induce electric currents within conducting objects, including the 
human body [23; 38; 39; 40]. At sufficiently high amplitudes, the gradient 
induced electric fields are known to stimulate nerves or muscles in adults. In 
addition, at extremely high levels, cardiac stimulation or even ventricular 
fibrillation can occur. These stimulation thresholds for scanners are usually 
determined by examining adults. Hence, there is a possibility that the differences 
in the geometry of pregnant women could lead to an increased risk of 
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stimulations in certain conditions. Although this is not a life threatening risk to 
pregnant mothers, it can be very uncomfortable. As for the foetus, the induced 
current will be lower since it is near the centre of the coil [9; 39; 40]. 
A major concern with time-varying gradient fields is that the acoustic noise 
generated can reach up to 120 dBA. This occurs due to rapid switching of the 
currents within the gradient coils and the strong magnetic field, which combine 
to produce Lorentz forces that cause the coils to vibrate and produce loud 
knocking noises. This loud sound depends on electric field, magnetic field and 
time varying magnetic field (dB). Since the foetus' ear is completely formed by 
dt 
the 20th gestation week, it will be able to detect and respond to sounds [41] 
received through airborne noise transmitted across the maternal body wall and 
mechanical vibrations experienced because the mother is lying in contact with 
the scanner bed. At present, research has shown that foetuses respond to low 
frequency sounds (100 Hz, 250 Hz, 1000 Hz and 3000 Hz), but there is no 
evidence suggesting abnormalities in foetus' hearing function [9; 33; 42]. The 
noise level reaching the foetal cochlea is suppressed because the foetus is 
insulated by the mother's abdominal wall. More importantly, the amniotic fluid 
filling the foetal ear will attenuate the noise in a frequency dependent manner, 
preventing the normal amplification of sound by the ear. Nevertheless, care 
should be taken to limit the noise level exposure to the foetus. It should be noted 
that if high noise levels are applied frequently throughout pregnancy, there is a 
possibility of poor pregnancy outcome [43; 44]. 
In addition to protecting the foetus from noise, pregnant women participating in 
MRI should also be given adequate hearing protection to reduce maternal noise 
exposure. Moreover, they should be mechanically isolated from the scanner's bed 
by using dense mattresses. This will reduce the mechanical vibration experienced 
by the pregnant women and foetus. Furthermore, during pulse sequence 
development, it is essential for MR staff to assess the loudness of the pulse 
sequences applied in foetal MRI. It is advisable to avoid loud pulse sequences if 
other alternatives exist [9]. 
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3.3.3 Radio Frequency Fields 
The major concern with radio frequency (RF) fields is the production of relatively 
large heat deposition that may lead to thermal heating of the tissues, causing 
local burns. The RF fields induce eddy currents in the tissues, and these increase 
molecular motion and generate heat, resulting in absorption of RF energy. The 
average RF exposure is simply described in terms of Specific Absorption Rate 
(SAR) [45]: 
SAR = 0.5(" ,,' f~' B: D 1 
(Eq 3.4) 
where f = Larmor frequency, r = conductor loop radius B1 = RF field strength, D = 
duty cycle or total RF pulse times/TR and p = mass density. 
In the last few decades, several studies have been conducted to identify the effect 
of RF heating on adults and foetuses. These include monitoring the temperature 
of poorly vascularised tissues such as the eye lens and heating sensitive 
structures such as the testes and organs with no pain sensors such as the brain 
[33]. These studies found evidence suggesting that the human body has the 
capability to lose heat through the skin by conduction and increased cutaneous 
blood flow. Nonetheless, RF burns can develop in adults when they are in close 
contact with the RF coils or extraneous electrical conductors such as ECG leads, 
RF coil leads and metal implants. RF burns can also take place in adults with 
tattoos. The colours on tattoo pigments are created with organic substances; 
some contain iron oxide, which seems to be related to heating during MRI scans. 
These effects occasionally happen when the pigment's material are arranged in a 
ring or loop pattern [46; 47; 48; 49]. This loop-like structure, formed through 
physical contact or a looped tattoo, promotes electric conduction that may result 
in RF burns [9; 47]. 
The mechanisms discussed above do not operate as a threat to foetuses in the 
well-insulated maternal body. The foetal and maternal circulations are 
independent of each other. For this reason, it is particularly difficult to predict 
the temperature change in foetuses. The foetus' body temperature exceeds the 
maternal temperature due to the heat produced by the foetus' metabolism. 
Unlike adults, foetuses lose heat by conducting heat into amniotic fluid and 
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across the uterine wall. They also lose heat via the large blood flow through the 
placenta and umbilical cord. However, heat loss in foetuses is relatively 
inefficient. Hence, pregnant patients should be scanned in a scanner with good 
air flow through the bore, reasonable room temperature, and not be covered with 
a blanket during scans [50; 51]. 
Moreover, until further information is available, foetal MRI should only be 
conducted using low SAR sequences « 2 W kg-I), since this requires lower RF 
power and reduces the production of heat [52; 53). SAR level can be reduced by 
reducing the number of slices, increasing TR, reducing RF tipping angle and 
reducing echo train length in rapid imaging sequences such as HASTE [54). If 
application of high SAR sequences is necessary, the sequence should be applied 
for as short a time as possible and the high SAR sequences should be interleaved 
with low SAR sequences. In addition, foetal MRI should be conducted with care or 
avoided if possible in non-urgent cases involving pregnant patients with 
impaired thermoregulation conditions or who are febrile [50). 
3.3.4 General Safety 
While considering the safety of MRI, it is important to inspect the risks and 
benefits of other techniques employed in foetal MRI. Over the years, many MR 
scans have been performed using intravenous contrast agents, since it is 
particularly useful in improving the visibility of abnormal structures or lesions in 
the body. Studies have shown that approximately 30% - 40% of more than 7 - 10 
million MR examinations performed every year included administration of 
gadolinium chelates such as Magnevist (Gd-DTPA), ProHance (Gd-HP-D03 A) or 
Omniscan (Gd-DTPA-BMA) [55). 
In 2006, the usage of gadolinium based contrast agents was linked to 
Nephrogenic SystemiC Fibrosis (NSF). It is a disease arising in patients with renal 
failure, especially patients with severe kidney impairment [56; 57; 58; 59]. 
Neonates and infants up to 1 year of age are exposed to the NSF risk since their 
kidneys are not completely developed [60]. In the case of the foetus, only minutes 
after administration of a gadolinium based contrast agent to the mother, this 
contrast agent is transported into the amniotic fluid almost exclusively by 
glomerular filtration and foetal kidney excretion. Subsequently, the amniotic fluid 
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is swallowed by the foetus causing the contrast agent to continuously alternate 
within the foetal gastrointestinal tract and foetal urinary system, causing it to be 
retained within the pregnancy sac [55; 61]. Although there is no data to uphold 
the hazard of this mechanism, the safety of this situation is questionable, 
particularly given the known issues of long-term exposure to gadolinium in an 
adult. For this reason, usage of gadolinium is not recommended in foetal MRI. 
In the year 2000, a study on Magnevist conducted on rats (at 2.5 times the human 
dose, 0.1 mmol kg· I ) and rabbits (at 7.5 times the human dose) demonstrated 
delay in foetal development without evidence of congenital anomalies [62; 63). 
Moreover, there is data suggesting increase in foetal loss when the ProHance 
dose is increased [63]. Considering all these risks, the use of contrast agents 
during pregnancy should be discouraged unless there are compelling clinical 
reasons [60). 
While the safety issues related to magnetic fields and hardware have been 
addressed in detail, it is essential to practice some common safety procedures to 
reduce the anxiety experienced by the mothers participating in the MR scans. 
This will impact on the foetal well-being during scans. MR practitioners should 
pay importance to investigating the patient's previous health conditions and 
identifying the psychological risk of claustrophobia. If necessary, an MR assistant 
should be assigned to accompany and remain with the patient throughout the 
scan procedure. It is also vital to identify syncopal symptoms. Pregnant patients 
lying supinely are exposed to the risk of aortacaval compression. The gravid 
uterus may compress the inferior vena cava and aorta causing a decrease in 
blood returning to the heart. This leads to a decrease in cardiac output that may 
result in a feeling of faintness. However, tilting the patient onto her side or 
elevating the right hip by 15 - 20 cm usually overcomes this problem [9; 64). 
3.3.5 Conclusion 
In conclusion, determining the safety of MR imaging is challenging since it is not 
possible to prove its safety, only to disprove it. At present, there is no clear 
evidence suggesting foetal MRI leads to foetal mortality or morbidity. 
Nonetheless, it would be wise to take precautionary measures to avoid potential 
hazards while conducting foetal MRI. This includes limiting the total scanning 
3.3 Safety of Foetal Magnetic Resonance Imaging 96 
time for safety reasons and patient comfort, and applying sequences with 
reduced amplitude for low frequency switching gradients to reduce the sound 
levels, vibration effects and the risk of nerve stimulation. It is also advisable to 
avoid foetal MRI in the first trimester to avoid the risk of teratogenic effects. All 
the safety measures described in this chapter were practiced in these studies. 
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Chapter 4 
Anatomy and Development of 
Foetus 
4.1 Overview 
Pregnancy is a pivotal part of human development. The mother's body must 
create, nurture, oxygenate and adequately nourish foetuses to prepare for the 
challenges of life outside the womb. The purpose of this chapter is to provide 
readers with concise information on the phases of foetal development in the 
uterus. The author will explore the process of foetal growth and development of 
placenta, foetal brain, respiratory system, liver and urinary system by reviewing 
the response and adaptation of the foetuses to potential stressful intrauterine 
environment. This chapter will serve as an introduction to the foetal studies 
conducted by the author for her PhD project. 
4.2 Introduction to Foetal Imaging 
The average duration of foetal development is 38 weeks or 266 days [1], that 
starts with fertilisation of two haploid living cells: an oocyte (female germ cell) 
and a spermatozoon (male germ cell). The ooctye is a large cell consisting of 23 
chromosomes, surrounded by a thick membrane called the zona pellucida. It is 
approximately 120!-lm in diameter. Conversely, the spermatozoon is a small-
specialised male cell, which also has a total of 23 chromosomes. It has a head of 
3 - 4 !-lm diameter and 5!-lm long. The head of the spermatozoon contains the 
nucleus, which bears the DNA information, and it moves using the flagellum or 
tail that is on average 55 !-lm in length [1]. 
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Fertilisation takes place in the ampullary region of the fallopian tube. The results 
of the fertilisation process are: determination of offspring's sex, restoration of the 
diploid number of chromosomes and initiation of cleavage. Fertilisation is 
initiated when a single spermatozoon penetrates through the zona pellucida, in 
an attempt to integrate with the oocyte. This integration results in the 
establishment of pronuclei containing either the maternal or paternal 
chromosomes. After approximately 30 - 36 hours of encounter with a 
spermatozoon, the pronuclei fuse to restore a single diploid nucleus containing a 
full set of chromosomes. This is the start to embryo formation. Subsequently, the 
embryo goes through a series of mitotic cell divisions called cleavage that 
increases the number of cells without significantly increasing their size. This 
leads to the formation of blastomeres that become smaller with each division and 
undergo compaction [1; 2; 3]. 
Following this, the compacted blastomeres continue to divide to form a morula 
that enters the uterus. A hollow sphere is formed in this cell mass in preparation 
for implantation into the uterine wall; at this stage the cell mass is known as a 
blastocyst. The blastocyst develops into two layers: the external cell layer 
(trophoblast) and the inner cell mass (embryoblast). On the seventh day of post-
fertilisation, when the zona pellucida surrounding the morula is disrupted, the 
blastocyst sinks into the uterine lining allowing implantation to occur and 
signifying the start of the official embryonic stage. The trophoblastic cells 
differentiate into two layers, the cytotrophoblast and syncytiotrophoblast, which 
erodes into maternal tissue to establish the future placenta and is responsible for 
the uteroplacental circulation. Then, the embryoblast undergoes further 
differentiation between the 7th and 20th day to produce external and internal 
germ layers known as ectoderm, mesoderm and endoderm in a process called 
blastogenesis [1; 2; 3]. 
The third to eighth weeks of development are known as the embryonic 
organogenesis period, which involves modification of the ectoderm, mesoderm 
and endoderm germ layers. This period marks the beginning of foetal 
development where the major organs of the body are established. The 
ectodermal germ layer is responsible for formation of organs and structures that 
maintain contact with the outside world: peripheral nervous system, central 
nervous system, skin (including hair and nails), sensory epithelium of the eye, 
nose and ear, pituitary, mammary and sweat glands and enamel of the teeth [3]. 
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It also forms the amniotic sac [1]. The mesoderm forms all the supporting tissues 
of the body such as muscle tissue, subcutaneous tissue of the skin, cartilage and 
bone. It also gives rise to the vascular system (heart, arteries, veins, blood, lymph 
vessels and cells), urogenital system (kidneys and gonads), spleen and cortex of 
the suprarenal glands. Similarly, the endodermal germ layer generates the 
epithelial lining of the respiratory tract, gastrointestinal tract, urinary bladder, 
tympanic cavity and auditory tube. The endodermal layer also produces the 
parenchyma of the thyroid, parathyroids, pancreas and liver. During organ 
development, particularly the central nervous system, the initial flat embryonic 
disc begins to fold cephalocaudally and transversely to establish the head, tail 
and rounded body form. This embryonic organogenesis period normally ends 
with the foetus' face appearing as human [3]. 
The ninth week of gestation until birth involves rapid growth and maturation of 
organ systems, along with a relative slowdown in foetal head growth. During this 
period, the foetus grows in length and increases the weight gradually. The third, 
fourth and fifth months embark in the greatest increase in length (approximately 
5 em per month), whereas the striking increase in weight occurs in the eighth 
and ninth month (approximately 700 g per month) [1; 3]. Although the foetus is 
continuously developing throughout the gestation period, it is not capable of 
physically living outside the uterus before the 22nd gestation week. However, if a 
foetus was delivered at 25 weeks, with an average body weight of 500 g, it may 
survive with intensive care [4]. Although survival rate increases with increasing 
total body weight and gestational age at delivery, some foetuses are left with 
disability and some die [5]. A study conducted in the UK and Ireland in 2006 
documented a survival rate of 7% for 22 weeks, 42% for 24 weeks and 78% for 
babies born at 28 weeks [6]. Normally, a foetus is delivered at the 40th gestational 
week when its average body weight is roughly around 3400 g, with boys usually 
heavier than girls [1; 3]. 
The process of giving birth is divided into three stages that starts with effacement 
and dilatation of the cervix, continues with active labour until delivery of the 
foetus and ends with delivery of the placenta and foetal membranes. Once the 
foetus is delivered, it is known as a neonate for the first 28 days of its life after 
delivery. During this period, it will need to adapt to the extrauterine 
environment. As a foetus, the oxygen is received via the placenta. Conversely, in 
the neonatal period, the newborns will have to breathe oxygen from the 
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atmosphere through their lungs; a mechanism to which the respiratory system 
has to acclimatise [1; 3]. 
4.2.1 Placenta 
The placenta was named after a Latin word, "circular cake" by an Italian 
professor and surgeon, Realdus Columbus in 1559 [7]. Its name justifies the 
appearance of a full term placenta: a blue-red coloured discoid shaped organ 
weighing on average between 500 g to 600 g, with a diameter of 15 cm to 25 cm 
and approximately 3 cm thick at delivery [8; 9]. Similar thickness is observed 
using MRI at late gestation. Throughout the pregnancy, the placenta gradually 
enlarges by increasing its thickness and surface area approximately proportional 
to the expanding uterus; a growth that adapts to the increasing metabolic 
requirements of the growing foetus. Hence, the placenta often covers 15% to 
30% of the internal surface of the uterus during the whole gestation [2; 3]. The 
placenta's role ends at birth, when the placenta becomes separated and is 
delivered safe from the uterine environment minutes after the baby. 
The placenta is the only organ biologically developed by the mother and child, 
consisting of foetal and maternal parts that establish symbiotic dependence in 
the intrauterine environment. It plays a vital role in nurturing the growing foetus, 
provides immunological defence and acts as a partial barrier against cell transfer 
from the foetus to mother and vice verse, during gestational period. Its main 
functions include acting as the foetal lung to exchange gaseous products between 
the maternal and foetal bloodstreams, assisting in metabolic exchange by 
providing substrates for foetal metabolism and disposing waste products and 
being responsible for hormone production [2; 3]. 
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Figure 4.1: A schematic representation of matured human placenta. BP: basal 
plate, CP: chorionic plate, IVS: intervillous space, S: placental septum, J: junction 
zone, UC: umbilical cord, P: perimetrium, M: myometrium, CL: chorion laeve, A: 
amnion and MZ: marginal zone between the placenta and foetal membrane [10]. 
Placental development begins with the implantation of the blastocyst into the 
maternal endometrium on the sixth to seventh day following conception. The 
outer layer of the blastocyst, the trophoblast, is the coating responsible for the 
formation of the placenta. Initially, trophoblast is composed of mono-nucleated 
cells (cytotrophoblast) that undergo differentiation into oligo-nucleated 
syncytiotrophoblast. The inner layer of mononuclear cytotrophoblast cells is 
known as the base for cell division. These cells begin to migrate into the 
syncytiotrophoblast layer where they fuse. Subsequently, the cell membranes are 
lost to form the multinucleated outer syncytiotrophoblast layer [11]. This layer 
will undergo expansion to produce spaces, where the maternal blood supplying 
the placenta will eventually flow [1; 2]. 
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The cytotrophoblast and syncytiotrophoblast are crucial features within the 
placenta. They are liable for the formation of primary villi that branch gradually, 
enabling maturation of the placental villous structure. Once the basic placental 
system is developed, three villous structures will be present within the placenta: 
a chorionic plate of cytotrophoblast from which villi arise, a basal plate where 
some villi are attached (anchoring villi) and intervillous spaces where villous 
branches project (floating villi); through this intervillous space maternal blood 
will soon flow [2]. As the pregnancy extends, the placenta will soon consist of two 
sections, decidua basalis (the maternal site) and villous chorion or chorion 
frondosum (the foetal site) . The intervillous lakes of maternal blood occupy the 
space between the decidual and chorionic plates [3]. 
Intermediate 
Villi 
Figure 4.2: Arrangement of foetal capillaries in a group of terminal villi branching 
from a central mature intermediate villous [12]. 
While the placenta remains essential in foetal development, the most important 
element in placental blood flow is the villi in the intervillous space. These villi are 
indirectly in contact with spiral arteries that change their compliance and 
undergo remodelling (figure 4.3), so that there is a low resistance maternal blood 
flow in the utero placental unit [13]. This villous area is often in the range of 4 m2 
to 14 m2 [3]. Furthermore, scientists have identified a few villous parts through 
histology studies: stem villi, immature and mature intermediate villi and terminal 
villi. Although all these villi contribute to maternal-foetal exchange (with 
exception to stem villi), the key villi in intrauterine circulation are the terminal 
villi that form the final branches of the villous tree since it is in the predominant 
site for maternal-foetal exchange. It comprises 50% of the villous' surface area 
[2]. In addition, the intervillous lakes of the fully-grown placenta can hold up to 
4.2 Introduction to Foetal Imaging 109 
150 ml of maternal blood. This maternal blood will be renewed every three to 
four times per minute to facilitate the foetal-maternal exchange [3]. 
Anchoring Villous 
Syncytiotrophoblast 
Cytotrophoblast 
Extravillous trophoblast 
Endothelium 
Spiral Arte ry 
Ea rly End of 1't Mid- 3rd 
pregnancy tri meste r gestation trimeste r 
Decidu a Basalis 
Myometrium 
Figure 4.3: Spiral artery remodelling during pregnancy. The two types of 
extravillous trophoblasts are found outside the villous at early pregnancy stage: 
endovascular and interstitial trophoblasts. The endovascular trophoblast invades 
and transforms the spiral arteries during pregnancy, creating low resistance 
blood flow. Interstitial trophoblast invades the decidua and surrounds spiral 
arteries [14]. 
Besides the detailed structure of the villi, the rate of foetal-maternal exchange 
across the placenta depends on a few other factors. These include the delivery of 
maternal blood to the placenta, foetal blood flow and foetal blood volume. These 
factors are in turn dependent on the pattern of maternal blood movement within 
the intervillous space, the resistance of spiral arteries, the resistance of venous 
drainage system and the resistance of the placental vascular bed. A malfunction 
in the development of the uteroplacental unit can lead to complications in 
pregnancy. Some of the most common placental disorders include placenta 
accreta, placenta praevia, placental abruption, pre-eclampsia and intrauterine 
growth restriction (IUGR) [13; 15; 16]. 
In conclusion, the placenta is essential in nourishing the growing foetus and 
maintaining an excellent foetal-maternal communication throughout pregnancy. 
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4.2.2 Foetal Brain 
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Figure 4.4: A schematic representation of a human brain [17]. 
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Central to the human nervous system is the brain, which lies within the skull. It is 
a very complex organ that weighs roughly 3 lb or 1.5 kg in an adult, while it is 
only 25% off its adult weight at birth [2]. The average adult brain volume of a 
male and female (excluding meninges, cerebral spinal fluid (CSF), and other non-
brain tissue) is approximately 1260 cm3 and 1130 cm3, respectively [18]. The 
brain is attached to the spinal cord that makes up the central nervous system 
(CNS) . The eNS starts developing in the middle of the third week of pregnancy 
with the appearance of neural plate, originating from ectoderm. Then, edges of 
the neural plate fold, leading to appearance of neural folds, one on each side of 
the midline. These fuse into the neural tube that spreads both cranially and 
caudally [3; 19]. 
When the cranial and caudal ends close, the caudal portion forms the spinal cord 
and the cephalic portion forms the brain. The brain consists of three vesicles: the 
rhombencephalon (hindbrain), mesencephalon (midbrain) and prosencephalon 
(forebrain) . The rhombencephalon is responsible for the formation of medulla 
oblongata, involved in autonomic functions (respiration rate, cardiac rate, 
perspiration, digestion); cerebellum, that acts as a coordination centre for 
posture and movement; and pons, that provides a pathway for nerve fibres 
between the spinal cord and cerebellar cortices and the cerebrum. The 
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mesencephalon acts as a communication centre for visual and auditory reflex 
actions. As for prosencephalon, it is liable for formation of cerebral hemispheres, 
pituitary, thalamus, hypothalamus, epiphysis, optic cup and stalk [3]. 
The central nervous system is a vulnerable structure. Its development during and 
after birth is greatly influenced by malnutrition, hypoxia, exposure to radiation 
and viruses, hyperthermia, growth factors and variations in circulating hormone 
levels. Its weight after birth varies accordingly with proliferation of axonal and 
dendritic processes, multiplication of glial cells and myelination ofaxons, 
synaptogenesis and increase in cell size. All these processes are pliable to 
environmental factors [2]. 
The human brain is an information-processing centre that assists with learning 
and memory. Its development is an on-going process that starts in the womb and 
progresses throughout one's life. It is important in exerting control of all other 
organs in the body, such as breathing, sleeping, circulation, cardiac cycle, 
swallowing and sucking. It also plays an important role in sustaining vital bodily 
functions. These processes begin during foetal development and will continue to 
take place when the baby emerges from the protective intrauterine environment. 
It is also responsible as an information processing centre that assists with 
learning and memory. 
4.2.3 Foetal Respiratory System 
The survival of the foetus at birth is dependent on the sufficient development of 
the respiratory system in utero [20]. The human respiratory system consisting of 
two lungs of a light, porous and spongy texture, located near the backbone on 
either side of the heart is developed in the late embryo stage; fourth week of 
pregnancy. The weight of adult lungs differs between genders with the right lung 
slightly larger than the left lung. The lungs are usually heavier in male compared 
to female, with a weight proportion of 1 to 37 and 1 to 43 respectively to the size 
of the body [21]. Adult lungs weigh a total of 2.3 kg and have a total surface area 
of 70 m2, It contains approximately 2400 km of airways, comprising 300 to 500 
million alveoli [22]. At birth, the lungs appear pinkish white. However, this colour 
gradually becomes dark slate gray, mottled in patches and this mottling becomes 
black with advancement in age and carbon deposition [21]. 
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This respiratory system begins at the nasal cavity and branches out into two 
parts: conducting portion (nasal cavity, pharynx, larynx, trachea, bronchi and 
bronchioles) and respiratory portion (respiratory bronchioles, alveolar ducts, 
alveolar sacs and alveoli). Although the respiratory system is reasonably 
developed by the second trimester [19], it lies dormant throughout foetal life. 
However, once the umbilical cord is cut at birth, the respiratory system should be 
prepared to acclimatise and become fully functional to accommodate the infant's 
gas exchange needs. 
The lung development occurs in five stages: embryonic stage (4th - 7 th weeks), 
pseudoglandular stage (8th - 16th weeks), canalicular stage (17th - 26th weeks), 
terminal sac stage (26th week - 36th week) and alveolar stage (late foetal to 
childhood). Its development results from the outgrowth of the ventral wall of the 
foregut: endoderm and mesoderm [3]. The embryonic stage marks the initial 
formation of the respiratory diverticulum and the major bronchopulmonary 
segments within the bilateral pleural cavities. By the end of fourth week, the end 
of the laryngotracheal tube bifurcates into two bronchial buds. These bronchial 
buds develop into primordial right and left primary bronchi that then undergo 
branching morphogenesis to form three secondary bronchi and lobes in the right 
side and two secondary bronchi and two lobes in the left side. This branching 
process progresses throughout the seventh week into the pseudoglandular stage 
to form a brochopulmonary segments [19; 23]. 
By the end of pseudoglandular stage, the major structures of the lungs are 
formed and lined with the columnar epithelial cells. At this stage, the pulmonary 
arterial system will also be present but not ready for gas exchanges. Hence, a 
foetus delivered at this stage will not be able to live. During the canalicular stage, 
the mesoderm undergoes transformation to develop the pUlmonary capillaries 
and connective tissue components of the respiratory system. In addition to this, 
the respiratory bronchioles will be developed through progressive differentiation 
and subdividing of bronchi, while the epithelial cells undergo thinning. These 
respiratory bronchioles gradually divide to form alveolar ducts. By this point, the 
blood vessels grow intensively into the developing lungs and are in contact with 
the walls of the respiratory bronchioles. Although the lungs are almost functional 
by the end of canalicular stage, the immaturity of the foetal respiratory system 
may risk the survival of the foetus delivered at 24 weeks [19; 23]. 
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The terminal sac stage is associated with differentiation of the epithelium lining 
of the alveoli into two types of cells: type I alveolar pneumocytes (squamous 
epithelium) cells that are responsible for gas exchange after birth and type II 
alveolar (secretory epithelial) cells that produce pulmonary surfactant, the 
material spread over the surface of alveoli. The pulmonary surfactant reduces the 
surface tension of the alveoli and assists with breathing; preventing the collapse 
of alveoli during expiration by reducing the inspiratory force required to inflate 
the alveoli. The greatest production of pulmonary surfactant in one's life takes 
place in the last few weeks before birth. At this stage of pregnancy, the foetus' 
respiratory passageways are usually filled with 90% to 95% amniotic fluid [19]. 
In addition, the formation of alveoli increases greatly in the last four weeks of 
pregnancy, resulting in an exponential increase in the respiratory surface area of 
the lung. All these developments are important in the preparation and adaptation 
of the newborn's first breath [19; 23]. 
Lung development is an ongoing process that progresses after birth. This period 
is called alveolar stage. It is dominated by an increase in the number of 
respiratory bronchioles and alveoli, rather than expansion in the size of each 
alveolus. The main mechanism for increasing alveolar numbers during this 
period is the formation of secondary connective tissue septae that are 
responsible for the division of the existing alveolar sacs. Initially, the secondary 
septa are qUite thick but they then transform into thin mature septa that are able 
to participate in full respiratory exchange. They are also responsible for the 
development of approximately 90% or 300 million alveoli found in matured 
human lung. It is estimated that only one-sixth of alveoli present in adults are 
developed before birth, the remaining alveoli are formed during the first 10 years 
of postnatal life [3; 19]. 
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Figure 4.5: A schematic representation of a human respiratory system [24]. 
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4.2.4 Foetal Liver 
Pancreas 
Gallbladder 
Figure 4.6: A schematic representation of a human liver [25]. 
The liver is a reddish brown organ located behind the ribs in the upper right 
quadrant of the abdominal cavity, lying to the right of the stomach and below the 
diaphragm. It is the largest and heaviest internal organ in an adult, weighing 
approximately 1.5 kg. The liver is divided into four lobes and plays a vital role in 
the human digestive system [26]. It is involved in processing nutrients by 
producing bio-chemicals necessary for food digestion, synthesising protein and 
removing toxins from our body. The liver is supplied by two large blood vessels: 
the hepatic artery that carries blood from aorta to the liver and the portal vein 
that transports blood containing digested nutrients from the gastrointestinal 
tract, spleen and pancreas to the liver. 
Liver development starts early in the third week of pregnancy. It results from the 
sudden outgrowth of the endodermal epithelium, also known as hepatic 
diverticulum or liver bud that originates at the distal end of the foregut. This 
hepatic diverticulum consists of rapidly proliferating cells that pierce through the 
mesodermal plate connecting the pericardial cavity and the stalk of the yolk sac 
called the septum transverse. While this process continues, the connection 
between the foregut and hepatic diverticulum is constricted, reSUlting in the 
formation of the bile duct that is responsible for development of a small ventral 
outgrowth. This outgrowth gives rise to the development of cystic duct and 
gallbladder. At approximately the 12th week of gestation, the hepatic cells starts 
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producing bile largely through the breakdown of haemoglobin. The dark green 
bile stored within the gallbladder is now ready to be released to the 
gastrointestinal tract. This is one of the characteristics of the meconium, the 
earliest stool of an infant [3; 19]. 
In this course of advancement in the development, the epithelial liver cords 
interact with the umbilical veins and vitelline that forms hepatic sinusoids. 
Subsequently, liver cords undergo differentiation to form liver cells that are 
responsible for formation of the biliary ducts. The invasion of liver cells through 
the septum transversum causes the organ to project caudally towards the 
abdominal cavity. Following this, the mesoderm of the septum transversum 
differentiates to form a peritoneal connection between the foregut, liver and 
abdominal wall. Together they are known as the ventral mesentery. At the end of 
this differentiation, the liver will still be in contact with the septum transversum. 
The area of septum with densely packed mesoderm will form the central tendon 
of the diaphragm. The liver's surface area in contact with the future diaphragm is 
known as the bare area of the liver. Unlike the majority of liver's surface area, the 
bare area is never covered by peritoneum [3]. 
During the tenth week of development, the foetal liver weighs approximately 
10% of the total foetal body weight. Although this may be due to the presence of 
large number of sinusoids, there is also a large composition of proliferating cells 
that lie between the hepatic cells and walls of the vessels within the liver. They 
play an important role in hematopoietic function, which involves production of 
red and white blood cells, but this activity gradually subsides while approaching 
the last two-months of pregnancy [3; 19]. 
The liver plays an important role in the human digestive system. Although it is 
only 5% of the total body weight at birth, it is an essential organ for survival, 
supporting every other organ in the body. 
4.2.5 Foetal Urinary System 
Homeostasis is an equilibrium property that needs to be achieved to ensure that 
the internal organs in living organisms function properly. Like other creatures, 
humans are required to take in nutrients and water for survival. However, this 
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intake should be regulated through homeostatic functions that include regulating 
temperature, blood acidity and other variables. This homeostatic function is 
assisted by the urinary system that plays an important role in excreting fluids 
and chemicals, maintaining the acid-base homeostasis and regulating the 
electrolytes in the body. The human's urinary system consists of two kidneys, 
two ureters, bladder and urethra. The kidneys lie below the ribcage and close to 
the lumbar spine. They are reddish brown bean shaped organs that are about the 
size of a human fist [27]. They are surrounded by the peri-nephric fat and receive 
blood from the renal arteries that a re supplied by the abdominal aorta. The 
weight of an adult kidney differs between genders with the left kidney being 
slightly larger than the right kidney [28] . The weight of a female kidney is 
between 11S g and iSS g, while the male kidn ey weighs between 12S g and 170 g 
[29]. The weight of the two adul t kidneys in proportion to the body is 
approximately 1 to 240 [21]. 
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Figure 4.7: A schematic representa tion of a human kidney [30]. 
The urinary system is developed from mesodermal tissue of the early embryo in 
the pelvic basin. During foetal life, its development takes place in three 
overlapping stages from the cranial to caudal segments: pronephros, 
mesonephros and metanephros (the definite kidney). The development of 
pronephros begins on the 23 rd to 24th day of gestation. At this stage, seven to ten 
solid cell groups are present in the cervical region. They form vestigial excretory 
units, nephrotomes that are non-fun ctional. In the fourth week of gestation, when 
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the pronephric system gradually disappears, the first excretory tubules of the 
mesonephros and mesonephric ducts are derived from the intermediate 
mesoderm in the thoracic and lumbar regions. The tubules lengthen rapidly and 
attain a cluster of capillaries that will form a glomerulus that will later be placed 
in Bowman capsule. This structure establishes the renal corpuscle with a large 
excretory unit (nephron) with its own collecting duct, mesonephric duct. These 
tubules and ducts function briefly in the human urinary system. However, they 
transform to operate as tubes for sperm transportation from the testes to the 
urethra in a male. Conversely, these ducts regress and gradually disappear in the 
female body [2; 3; 19]. 
The metanephros begins developing in the fifth week of gestation. It starts when 
the ureteric bud (metanephric diverticulum) grows as a result of metanephric 
outgrowth. This bud is responsible for the formation of the entire collecting 
system (ureter, renal pelvis, calyses and collecting tubules). It establishes good 
connections between the collecting and excretory tubule system that are 
essential in kidney development. In normal foetal development, the nephrons are 
developed from metanephrogenic diverticulum, metanephrogenic blastema and 
in-growing vascular endothelial cells. They continue to form throughout foetal 
life. Moreover, they mediate the induction of the metanephrogenic mesoderm 
and terminal branches of the collecting duct system. As the embryo transforms 
into a foetus, the kidneys are gradually shifted from the pelvic basin into the 
abdominal regions where they become associated with the adrenal glands; while 
the urinary bladder forms from the base of the allantois [3; 19]. 
The human kidney in an adult ideally receives 1.3 litres of blood supply per 
minute and produces 2.9litres of urine over 24 hours [31]. However, this amount 
can vary accordingly under different circumstances that disrupt the water loss 
mechanism, such as sweating or kidney abnormalities. This includes congenital 
anomalies of the urinary system that occurs in 3% to 4% of all human birth. One 
of the most severe renal abnormalities is renal agenesis where the kidneys are 
not present in the body due to faulty production in the embryo. Other kidney 
malformations include multicystic dysplastic kidney and hypoplastic kidney. In 
cases where the kidneys have migrated abnormally, patients can have pelvic 
kidneys, horseshoe kidney and other ectopic kidneys. It is important to note that 
renal tract malformation can occur in all stages of life (foetal. neonatal. childhood 
and adulthood) [19; 32]. 
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The kidneys play a dominant role in maintaining body's fluid balance by 
regulating the composition and volume of the extracellular fluid by separating 
mineral, toxins, urea, salt and waste products from the blood system. It is 
undoubtedly one of the most important organs in human body. 
4.3 Conclusion 
With numerous studies suggesting foetal development in the intrauterine 
environment plays an important role in determining one's health later in life, 
embryology studies are becoming more important. Here, the effect of maternal 
smoking and maternal diabetes will be discussed by studying the foetal growth 
and development of placenta, foetal brain, liver, lungs, and kidneys. 
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Chapter 5 
The Effect of Maternal 
Diabetes on Placental Blood 
Flow 
5.1 Overview 
This chapter will discuss the methods used to explore placental blood flow by 
measuring blood perfusion in the entire placenta, basal plate and chorionic plate. 
The chapter starts with a short literature review of placental MRI and its 
application to study uteroplacental disturbances in compromised pregnancies. 
Previous methods used for quantifying blood flow will also be covered: Doppler 
Ultrasound and Spin Labelling. Following these discussions, this chapter will 
progress to the introduction of Intra Voxel Incoherent Motion (IVIM), the 
placental assessment technique that was applied in this study. 
This chapter is divided into two sections. The first part aims to investigate the 
reliability and reproducibility of the measurements of placental perfusion 
acquired using the IVIM program. The motivation to perform the reliability tests 
originated from a lack of published studies investigating such reliability. The 
author, with the help of two other observers, Dr Nia Wyn Jones and Dr Ruta 
Deshpande, conducted the data analysis for the reliability tests. The second part 
demonstrates the application of the IVIM technique to study the effect of 
maternal diabetes on placental blood flow. The author will address the methods 
used to acquire, process and statistically analyse placental perfusion. In addition, 
the author also measured the placental volume to demonstrate the effect of 
maternal diabetes on placental growth. Finally, the chapter is concluded by 
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demonstration and discussion of the results obtained from analysing the data of 
both the non-diabetic controls and diabetic patients involved in this study. 
The MATLAB code for the IVIM program was originally written by Professor 
Penny Gowland but has since undergone various modifications. The author has 
modified the program to increase the accuracy of data analysis by automatically 
removing data points corrupted due to noise or movement, as well as to optimise 
the processing time for data collection and data storage. These modifications will 
be discussed in detail in section 5.3.3. 
5.2 Introduction 
Uteroplacental and fetoplacental blood flows are essential reqUisites for 
successful foetal growth and development. This complex system has been 
extensively studied using invasive methods such as the distribution of 
radioactive microspheres, angiography [1], monitoring disappearance of 
diffusible indicators such as Xenon-133 injected locally into intervillous space [2; 
3; 4], measurement of variations in heat conductance with electromagnetic 
transducers [5] or thermistors [6; 7] and time activity analysis of short-lived 
radiotracers such as indium-133m injected intravenously [7; 8]. However, with 
development in technology, non-invasive ultrasound and MRI have been 
employed as diagnostic tools to understand the pathophysiological mechanisms 
that affect foetal growth. Recent advances in research have focussed on 
identifying the symptoms and aetiologies of pre-eclampsia along with abnormal 
placental perfusion in intrauterine growth restriction (IUGR) [9; 10; 11; 12; 13; 
14; 15] and maternal diabetes [16; 17]. These studies are conducted throughout 
gestation [12; 15; 18; 19] and after delivery [15; 20] to monitor the effect of 
transformations of the placental system during gestation on health and disease. 
In diabetic pregnancy, foetal growth throughout gestation seems to be abnormal 
due to hyperglycemia and hyperinsulinemia effects [21]. Hence, placental 
structure and function undergo various transformations depending on a number 
of factors in the intrauterine environment: the quality of glycemic control 
achieved across the critical periods of placental development, the method of 
treatment for diabetes and the degree of diabetic management [16]. Normally, 
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the placenta is embedded into the uterine wall and placental development starts 
with the formation of villous and extravillous structures that originate from 
proliferation and differentiation of trophoblast. Following this, the spiral arteries 
in the uterus are remodelled to be low resistance vessels [22]. Then, in the 
second half of the gestation, the villi undergo various steps of maturation and 
result in placental mass expansion [23; 24]. These steps of maturation are 
described in detail in section 4.2.1. 
The placenta is the only organ that can store excess foetal glucose in the 
fetoplacental system. It converts the glucose to glycogen and stores it around the 
villous vessels and capillaries. However, excessive foetal growth may occur if 
hyperglycemia, hyperinsulinemia or dyslipidaemia exceeds the capacity of 
placenta to protect the foetus [16]. Understanding the importance of the placenta 
in foetal development, many obstetricians and clinicians have devoted their time 
to examine the placental system in various pregnancy conditions, in order to 
identify foetuses at risk of complicated pregnancy. 
In recent years, three-dimensional (3D) Power Doppler sonography has been 
used as a research tool to investigate in vivo placental perfusion. It is also known 
as amplitude based colour Doppler, angio-mode, colour Doppler energy and 
colour power imaging [25]. The received signal in Power Doppler depends on the 
amplitude component that represents the number of moving scatterers in the 
blood volume [26]. The theory behind the computation ofthe number of moving 
blood cells representation is based on power integration that originates from 
intensity, strength, energy and amplitude of Doppler shifted ultrasound signals 
[27]. These signals correspond to the zero lag of autocorrelation instead of the 
mean Doppler frequency shift, and eliminates the information regarding velocity 
and flow direction [27; 28]. 
Power Doppler sonography is very sensitive to blood flow. Its ability to detect 
small blood movements with low blood flow is one of the many reasons for its 
success as a non-invasive placental imaging technique [15; 29]. Power Doppler is 
also angle independent [30; 31], enabling better detection and visualisation of 
indirect branching of the vessels in placenta. This is because Power Doppler is 
based on amplitude of the scatterers, which is velocity independent. Hence, the 
number of scatterers in the volume remains the same when the Power Doppler 
angle is changed, causing the power to be consistent. [32]. Power Doppler is very 
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dependent on the pulse repetition frequency setting. It is not affected by aliasing 
because it has no information on velocity [25; 30; 31; 32]. 
Nonetheless, motion artefacts are a major limitation in the Power Doppler 
imaging technique. This may result from unavoidable foetal movement, maternal 
breathing movements, bowel peristalsis or transducer motion [29; 33]. 
Furthermore, obstetric scans can become increasingly challenging to perform 
across gestation since there is a demand for a bigger field of view for the growing 
foetus or placenta [12]. Moreover, issues relating to increased foetal depth and 
variation in tissues intervening between the transducer and region of interest are 
often common in late gestation. This is because ultrasound relies on absorption 
and scattering characteristics of specific tissues to determine the penetration 
depth of the ultrasound beam [34]. Nevertheless, all these concerns with 
ultrasound can be overcome using MRI. 
While ultrasound remains the primary diagnostic tool for placental development 
and function, MRI has been suggested as an alternative to ultrasound [35]. Being 
an imaging procedure using non-ionising radiation, it is apparently safe for 
pregnancy studies [7]. Postnatal follow up studies after MRI scans have 
established that there is no evidence of increased occurrence of disease or 
disability (including hearing deficiency) to the children [36; 37; 38; 39; 40; 41]. 
Moreover, as a fast imaging modality, unavoidable foetal motion and maternal 
movements do not significantly degrade the image quality [42; 43; 44; 45; 46]. 
MRI is also capable of acquiring images with greater tissue contrast in larger field 
of view than ultrasound [44; 47]. This is advantageous in measurements of 
placental perfusion. 
Initially, MRI was employed in assessment in placenta praevia. This work was 
published in 1986 [48]. Following this, in 1995, Baker et al. [49] reported the use 
of MRI in quantifying in-utero foetal liver, brain and placental volumes. Since 
then, its role in clinical research into placental function has expanded to placental 
spectroscopy and perfusion in an effort to understand placental function and 
pathophysiological mechanisms that cause delay in foetal development. Until 
1998, the only possible way to monitor placental blood flow was by using a 
radioisotope technique [48; 50; 51]. This was potentially dangerous for the 
foetus. However, later that year, the foetal MRI research group at the University 
of Nottingham applied a high speed imaging technique, Echo Planar Imaging 
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(EPI) to image foetuses using short imaging times. This technique was 
advantageous in many ways. The foetal scans were achievable in a reasonable 
imaging time, less than 15 minutes. It was also capable of freezing physiological 
motion and producing images with limited movement artefacts since the 
susceptibility of the uterine environment is almost similar to that of the foetus 
[51]. A detailed theory and application of EPI is described in section 2.3.3.4. 
Besides EPI, placental perfusion has also been measured using an arterial spin 
labelling technique. This technique is based on application of flow sensitive 
alternating inversion recovery (FAIR), which compares the rate of magnetisation 
recovery following selective and non-selective inversion pUlses. It is particularly 
useful in measuring perfusion in one directional blood flow. However, in the 
placenta, perfusion can be overestimated since blood flows in a variety of 
directions. Nevertheless, this technique can be advantageous in measuring blood 
movement within the placenta, since it is this movement that ensures the 
maternal blood circulates effectively around the foetal villi [35]. 
In this study, we applied EPI to investigate the effect of maternal diabetes on 
placental blood flow. The acquired EPI images were analysed using Intra Voxel 
Incoherent Motion (IVIM), a method developed by learning spin echo signals are 
sensitive to motion [52]. The reliability and reproducibility of this method was 
tested with the aim of establishing if the measurement errors from the test were 
small enough for the protocol to be used in a clinical environment. Section 5.2.2 
of Chapter 5 details the concept of reliability testing. Following the reliability 
tests, the IVIM method was applied to study the effect of maternal diabetes on 
placental blood flow. 
5.2.1 Intra Voxel Incoherent Motion (IVIM) 
The IVIM method was adapted from the sequence developed by Stejskal and 
Tanner; a spin echo pulse sequence in which pulsed magnetic gradients are 
employed to make the spin echo amplitude dependent on the spins' random 
Brownian motion [53]. Spin echo amplitude depends on gradient pulse strength 
and duration. It can be used to measure molecular diffusion coefficient, with unit 
mm2 S·l. The IVIM method applies a principle that monitors the movement 
(diffusion) of blood within tissues and models them as random motion. In 
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practice, IVIM will be sensitive to any motion leading to net dephasing of spins 
(non zero curl of the velocity field) [54]. 
The quasi-random movement of blood detected using the lVIM method should 
result in a bi-exponential spin echo signal attenuation curve [37; 55; 56; 57], 
which arises from the two (water) compartments within the region of interest: 
fast and slow decaying components. The fast decaying component arises from the 
effect of spins from blood, which is characterised as pseudo-diffusion coefficient 
or decay rate constant (D"'), while the slow decaying component arises from non-
blood spins moving between and within cells, which is characterised as the 
apparent diffusion coefficient or self-diffusion characteristic (D). The signal 
attenuation due to the pulse gradient is also linked to the perfusion factor (I). It 
represents the fraction of voxels associated to fast decaying components, given in 
terms of fraction of spins within the volume of interest, which are in the blood 
compartment [54]. In other words, it is the percentage volume of flowing blood in 
each voxel compared to the total voxel volume of water. 
The perfusion factor (I) is dependent on the range of displacements of the 
molecules in the vascular geometry, direction to which the sequence is sensitised, 
time intervals between the diffusion gradient application and the velocity of the 
blood water molecules [54]. The pseudo-diffusion coefficient (D*) related to the 
Signal attenuation at the lower pulse gradient amplitude is associated with the 
macroscopic circulation of blood in capillaries. This is a measurement of the 
blood flowing inside a single voxellinked with randomly oriented vessels with a 
variety of velocities and diffusion mimicked on a relatively large scale. In cases 
where the voxels are associated with vessels with higher velocity blood and wide 
distribution of velocities, the pulse gradient amplitude will quickly dephase, 
resulting in zero affect to the IVIM analysis. On the other hand, the apparent 
diffusion coefficient CD) relates to the signal attenuation at higher values of pulse 
gradient [37; 58]. Mathematically, the signal attenuation resulting from 
circulating blood and water diffusion in a particular sample can be expressed as 
below: 
(Eq 5.1) 
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where S(b) represents the signal intensity for different diffusion weighting factor, 
band 5(0) is the signal intensity when b = O. For a more detailed description and 
application of IVIM, readers are advised to refer to section 2.3.3.5 of Chapter 2. 
The focus of this study was to measure the perfusion, / and self-diffusion, D 
factors for each pixel within the placenta, basal plate and chorionic plate since 
the blood movement through the placenta is incoherent resulting in similar 
signal attenuation to diffusion [37]. The self-diffusion characteristic was 
investigated having seen data from Dr Caroline Wright of University of 
Manchester (personal communication), highlighting an interesting pattern of the 
D parameter in pregnant patients suffering from pre-eclampsia. Although 
measurement of D* is saved from the computational analysis, it was not used in 
this study since previous work has demonstrated an unacceptably high, error in 
fitting for D* due to noise in the fit, reducing the significance of D* measurements 
[37; 59]. For this reason, only results from/and D are presented here. 
All these measurements were conducted on different pulse gradient amplitudes, 
with the objective of producing and studying placental blood flow maps in 
normal and diabetic pregnancy. Our hypothesis was that the placental blood flow 
would be greater in diabetic pregnancy. 
5.2.2 Reliability and Reproducibility 
The term reliability refers to the study of the consistency of repeated measures 
with respect to the mean value of all the measurements [60]. A reliable 
measuring method would signify that measurements are reproducible at 
different time intervals (test-retest reliability) and the observers conducting the 
measurements produce repeated results: reliability of the measurements for the 
same observer over a period of time (intra-observer reliability) and reliability of 
measurement between different observers on the same subject (inter-observer 
reliability) were assessed [61]. 
Reproducibility is a type of reliability that describes the repeatability of the 
measurements made on a subject under different conditions: measurement made 
by different observers, measurement conducted using different measuring 
methods or measurement made over a period of time that can be indirectly 
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influenced [60]. Reliability and reproducibility can be studied using several 
indicators. This includes intra-class correlation coefficient (ICC), limit of 
agreement (LOA) and the Bland Altman plot [60; 62; 63]. 
Intra-class correlation is a correlation statistic that gives the ratio of between-
group variance to the total variance (eg: intra or inter-observer variance of the 
total variance in mean/measurement). The ICC results can vary in the range of 0 
(no agreement) to + 1 (perfect agreement). The measurement of these variables 
are interchangeable [61; 64]. ICC can be classified as follows; values less than 
0.20 represent poor correlation, 0.21-0.40 fair, 0.41-0.60 moderate, 0.61-0.80 
good and 0.81-1.00 very good correlation [64]. The ICC assessment is conducted 
to test the agreement between more than one variable or target with no intrinsic 
connection (the measurements are interchangeable such that the test-retest 
reliability can be conducted) [61; 65]. The ICC measurements can be expressed as 
below: 
ICC = (BMS-EMS)+(BMS+[ l-k] EMS) (Eq 5.2) 
or 
ICC = subject variability + (subject variability + random error) 
where BMS represents between target mean square, EMS is the error mean 
square that gives the error between targets and k is the number of observers 
[63]. Although the ICC is a clear method of assessing agreement between 
measurements of two or more observers or methods, it suffers from a high 
dependence on the inconsistency between targets of the results. Hence, the ICC 
value will be greater if the variability between the targets (BMS) is greater whilst 
the error variance (EMS) remains unchanged. Moreover, it does not provide an 
indication of the magnitude of agreement between observers or measurements 
[61; 63]. 
Limits of agreement (LOA) and Bland Altman plots are techniques employed to 
study the randomness of the measurement obtained. The LOA gives the range in 
which 95% of values lie, computed from differences between measurements 
obtained from two different methods [60]. In order to calculate LOA, one needs to 
calculate the mean and standard deviation of the differences between the 
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measurements (paired differences). If these paired differences are normally 
distributed, LOA can be calculated using the equation below: 
LOA =d±(1.96xSDdiff ) (Eq 5.3) 
where d represents mean difference and SDdiff is the standard deviation of the 
differences [66]. 
The Bland Altman plots allow observers to graphically observe extreme outliers 
affecting the sampled data, although ICC is better at computing the heterogeneity 
of the measurements [61]. Once the LOA is calculated, the Bland Altman graph is 
plotted by drawing the mean of two measurements on x-axis and the differences 
between the two measurements on the y-axis. Then, solid horizontal lines are 
drawn to indicate the mean difference and dashed horizontal lines are drawn to 
represent the upper and lower LOA. This graph will assist as an illustration of 
bias between the measurements by providing a graphical representation of 
values for the reliability tests and statistical results generated through LOA test. 
The plot will also provide information relating the size of the differences between 
two variables, distribution around the absolute zero and distribution with 
increasing mean values. If the mean difference is smaller and the range between 
the upper and lower LOA is narrower, the measurements are of better 
agreement. However, the decision on whether it is a good agreement is often a 
matter of clinical judgement [61]. 
5.3 Method 
This section is divided into three parts. The first part details the patient 
recruitment criteria, scanning protocol and the technique used in image analysis 
(computational program). The second part details the approach undertaken to 
test the reliability and reproducibility of the techniques used to study placental 
blood flow. The final part details the approach taken to measure placental 
perfusion and diffusion, along with placental volume, in non-diabetic and diabetic 
pregnancies. 
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5.3.1 Recruitment Criteria 
Following Nottingham Research Ethics Committee approval, Dr Ruta Deshpande 
conducted the search for participants with pre-gestational diabetes and non-
diabetic controls. Diabetic participants were first approached by their usual 
clinician and requested to participate in the study, while non-diabetic controls 
were recruited by using posters and leaflets in the Ultrasound Department, 
Queen's Medical Centre (QMC), Nottingham. Only participants aged 18 years or 
over, with a viable singleton pregnancy and registered to deliver at QMC were 
eligible to participate in this study. All the participants were matched for age, 
parity and maternal Body Mass Index (BM!); these details along with ethnicity 
were noted at the initial recruitment stage. All participants gave informed 
written consent to participate in the study. Participant's height, weight and 
glycated haemoglobin Alc (HbA1c) levels were noted at each scan session. In 
addition, birth weights and gender of the participants' babies, gestation at 
delivery and mode of delivery were collected following their delivery. In line with 
the hospital policy at the time of recruitment, gestational age was calculated from 
the crown rump length measurement in the first trimester of pregnancy. 
5.3.2 Scanning Protocol 
All women underwent two scans, at 22 - 26 weeks and 33 - 37 weeks. For 
simplicity, these gestational time points will henceforth be referred to as 24 
weeks and 3S weeks gestational age (GA), respectively. Scans were performed on 
a 1.5 Tesla Philips Achieva MRI system equipped with a body transmit coil and 
either a S-element SENSE cardiac or 4-element SENSE torso receive coil, 
depending on the woman's size. These coils were usually placed between the 
mother's umbilicus and pubic symphysis. Women were placed in the scanner feet 
first and lay on their right side in the decubitus position to avoid vena caval 
compression. All these scans were conducted with a specific absorption rate of 
< 2.0 W kg· I . 
Non-breath hold HAlf Fourier Single Shot Turbo Spin-Echo (HASTE) and 
Balanced Fast Field Echo (bFFE) were applied to acquire images encompassing 
the whole foetus in three orthogonal planes. These images were used to assist in 
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identifying the location of umbilical cord insertion in the placenta. It was also 
used in measurement of the placental volume. 
The HASTE sequence acquired 123 slices over all three orthogonal 
directions in 147 seconds (TE = 120 ms, flip angle = 90°, 0.78 x 0.78 x 
6.00 mm 3 and FOV = 400 x 300 x 400 mm3) 
The bFFE sequence acquired 130 slices in 167 seconds (TR = 5.8 ms, 
TE = 2.3 ms, flip angle = 70°, 0.78 x 0.78 x 6.00 mm3 and FOV = 400 x 
300 x 400 mm3) 
The placental perfusion studies were conducted using the EPI technique. 
Respiratory-gated standard pulsed gradient spin echo sequence (PGSE) was 
applied. 
The PGSE sequence acquired 5 transverse slices encompassing the 
placenta in 108 seconds (TR = 3000 ms, TE = 95 ms, slice gap = 18 
mm, 1.46 x 1.46 x 7 mm3, FOV = 350 x 350 x 107 mm3 and 12 b 
values = 0, 1, 3, 15,47,80,115,206,246,346,468 and 800 s mm·2) 
This acquisition was repeated five times for each patient to average out the 
motion artefacts. All patients were requested to remain as still as possible during 
these acquisitions to avoid motion artefacts. 
5.3.3 Data Analysis 
The MR images acquired using HASTE and bFFE sequences were used in 
measuring placental volume. This measurement was conducted by drawing an 
approximate freehand mask around the placenta using Analyze 9.0 (Mayo Clinic, 
Rochester, MN, USA). Figure 5.1 shows a HASTE image in the sagittal plane. 
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Figure 5.1: The ROI of placenta drawn (yellow line) on the HASTE image. 
All the PGSE data acquired for this study were analysed using a computational 
program developed on MATLAB (R2010a; MathWorks Inc, Natick, MA, USA). This 
program was developed based on the IVIM principle discussed in the 
introduction, section 5.2.1 and theory, section 2.3.3.5. Initially, this program was 
developed with the aim of measuring perfusion in the whole placenta. However, 
the program has since been modified to restrict the perfusion measurement to 
either the basal plate or chorionic plate only. Moreover, the program was also 
modified to simultaneously measure the perfusion in the same slice of all the five 
acquisitions acquired from a single patient. 
Although the PGSE data acquired for this study was respiratory-gated, gross 
movement occasionally occurred. Since image registration was not possible, 
other pragmatic solutions were used. This will be discussed in detail in the 
section 5.5, discussion and conclusion. 
5.3.3.1 Motion Correction 
Prior to data analysis, each observer inspected all the placental images (all the b-
value images) of the selected slice acquired using different diffusion weighting. In 
most cases, the central slice with the largest placental area was selected for data 
analysis. This is demonstrated in figure 5.2 and 5.3. The inspection was 
conducted on all five acquisitions to identify gross movement in the placenta. If 
there was no obvious movement in the placenta between acquisitions, the 
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volumes of all the acquisitions of one slice were concatenated together for the 
data analysis. However, if there was noticeable movement between the 
acquisitions, the observers selected and grouped together slices corresponding to 
different positions. Regions of interest were drawn separately in each group and 
separate maps were produced for each group. Later, the histograms of each 
individual maps were averaged together for the purpose of data analysis. 
Central Slice 
12 Diffusion Parameter, b (s mm-Z) 
Figure 5.2: Placenta images of all 5 slices acquired with increasing diffusion 
weighti ng parameter (b). The diffusion weighting parameter increases gradually 
from image labelled as 0 to 11. 
Figure 5.3 : The central slice of the placenta images of a single PGSE acquisition 
with increasing diffusion weighting parameter (b). The diffusion weighting 
parameter increases gradually from image labelled as 0 to 11. 
Following this, the acquisitions consisting of the selected slice were loaded into 
the IVIM program. In the IVIM program, the observers were expected to draw the 
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region of interest (ROI) for the basal plate and chorionic plate in a single 
intermediate b volume (figure 5.4). The region sandwiched between these two 
plates was automatically computed as the ROI of the entire placenta. 
Figure 5.4: The representation of ROls drawn on the intermediate b volume 
image of the placenta. The yellow line represents the ROI of basal plate, red line 
represents the ROI of chorionic plate and the region between the yellow and red 
li ne represents the ROI of the entire placenta. 
Subsequently, these three ROls were fitted into the signal attenuation equation 
(Eq 5.1) on a voxel by voxel basis. This fitting appears strongly bi-exponential, as 
shown in figure 5.5 and 5.6. The modified program detects data points corrupted 
by excessive motion, identified as lying more than 2 standard deviations from the 
fitted li ne of the ROI 's averaged signal. These data sets were excluded from the 
data analysis and the data was refitted accordingly (figure 5.5). 
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Figure 5.5: The bi-exponential signal decay curve of the ROI obtained through 
application of different di ffusion weighting, b (red line). Images corrupted by 
excessive movement and artefact, identified as lying more than 2 standard 
deviation of the fitte d line would be excluded from data analysis (representation 
shown by the arrow). This data would be refitted accordingly to produce a new 
bi-exponential signal attenuation curve (blue line). 
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Figure 5.6: Bi-exponential signal decay plot of the (a) placenta, (b) basal plate and 
(c) chorionic plate of 5 different acquisition of a single slice. 
Once the signal decay curves have been fitted, the program proceeds to produce 
four maps of colour coded ROIs with respect to the amplitude, fitting parameters 
of So, f, D and D*. These perfusion maps give a graphical view of perfusion 
variations, signifying the changes in signal intensities of each pixel within the ROI 
allowing visual and statis tical comparison of the fraction of placenta, basal plate 
and chorionic plate with low perfusion, which is useful in visually studying the 
perfusion in normal and abnormal placentae. Figure 5.7 shows the maps for So./. 
D and D* of a diabetic subject. 
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Figure 5.7: Colour map of placenta (a - d), basal plate (e - h) and chorionic plate 
(i -I) of 50 Ca, e and i)./(b, fand j), D Cc, g and k) and D* Cd, h and I) for a diabetic 
subject at 35 weeks. 50./, D and D*were scaled between 0 and 1. 
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Figure 5.8: Averaged histograms of (a) So, (b)f, (c) D and (d) D* of the placenta 
from a healthy pregnant patient at 24 weeks. 
The averaged histograms of the five acquisitions for So, f, D and D* were then 
displayed as shown in figure 5.8. The histogram off, interpreted as the fraction of 
moving blood volume, is used to evaluate the mode f, mean f and fraction of 
pixels withf> 0.8 in the histogram. The fractional ratio with value more than 0.8 
represents the placental region with highest blood flow. This value was chosen 
following on from earlier work on the differences in the blood flow of placentae 
of normal pregnancy and pregnancies affected by pre-eclampsia and growth 
restriction, where there were more areas with reduced perfUSion in the latter 
pregnancies if < 0.2) [13]. Our hypothesis was that diabetic placenta would have 
increased perfusion, and hence the decision to measure the fraction of pixels with 
f> 0.8. 
Similarly, the histogram of D, interpreted as apparent diffusion coefficient rising 
from non-blood spins moving between and within the cells, was used to evaluate 
the mode D, mean D and fraction of pixels with D > 0.0025 in the histogram. The 
mode D represents the peak diffusion within the ROls, mean D representing the 
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averaged diffusion within the ROIs and D > 0.0025 represents the region with 
highest diffusion in the ROIs. 
Prior to applying the IVIM program to study the effect of maternal diabetes on 
placental blood flow, three reliability and reproducibility tests were conducted to 
study the reliability of the IVIM program in assessing blood flow in the entire 
placenta, basal plate and chorionic plate. The results obtained from the reliability 
test were used in selecting the best method and best slice for placental perfusion 
measurements. The details of the reliability test are described in depth in section 
5.3.3.2. 
5.3.3.2 Reliability and Reproducibility Assessment of the 
Measurement Analysed on the IVIM Program 
The three reliability and reproducibility tests conducted here are: (1) intra and 
inter-observer reliability test of the method used in placental perfusion analYSis 
(as described in section 5.3.3.1), (2) comparison between two techniques 
employed in placental perfusion analysis (single versus multiple masks) and (3) 
inter-slice comparison of placental perfusion measurement between two slices 
adjacent to each other. 
Three observers performed the reliability and reproducibility study of placental 
perfusion analyses: the author (observer 1), Dr Nia Wyn Jones (observer 2) and 
Dr Ruta Deshpande (observer 3). Due to time constraint, the reliability and 
reproducibility test were only conducted based on values for mode J, mean f and 
fraction of pixels with f > 0.8. For the purpose of consistency throughout the 
reliability study, the PGSE data of five pregnant subjects were randomly selected: 
two controls and three diabetic women. Moreover, the reliability tests were 
conducted using the PGSE data obtained from both 24 weeks and 35 weeks, 
resulting in 10 sets of data. This was to avoid potential bias resulting from the 
pregnancy conditions and gestational age at the time of the scan. All the analyses 
were performed blind to gestational age, maternal 8M!, diabetic status, 
complications of pregnancy, the other observers' results and the observer's own 
previous measurement results. 
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The results from all the reliability tests were statically computed using the 
Statistical Package for the Social Sciences (SPSS: Version 17.0; Chicago, IL, USA). 
The distribution of the data obtained from all the individual reliability tests were 
assessed using the Kolmogorov-Smirnov test. Following this, the reliability of the 
measurements and methods used in the study were assessed using two-way 
mixed ICCs with absolute agreement and 95% confidence intervals. Then, the 
LOA were computed and the Bland Altman graphs were plotted to express the 
differences as percentage of the mean measurements based on measurements 
done by the three observers. 
The intra-observer reliability was assessed by comparing the differences in the 
two measurements made by the same observer for each data set. Inter-observer 
reliability test was assessed by comparing the first measurement of each 
observer against the first measurement of the other observers' measurements. 
5.3.3.2.1 Intra-observer and Inter-observer Reliability Test 
Three observers conducted the intra and inter-observer reliability test using the 
analysis method demonstrated in section 5.3.3.1. Each observer repeated the 
placental perfusion measurement twice for data sets at each gestation for all five 
subjects. As a result, each observer conducted the analysis twice for all the 10 
data sets. The reliability test was conducted on the measurement of mode, mean 
and fraction of pixels with f > 0.8, which were obtained from the averaged 
histogram. The measurement of mean f and fraction of pixels with f> 0.8 were 
compared and the measurement with best reliability was used in single versus 
multiple masking comparison and slice-by-slice comparison reliability study, 
along with mode f. 
5.3.3.2.2 Comparison between Single and Multiple Masking 
Motion will cause exact ROI delineation to vary between repeats, but human 
error in drawing ROIs will increase if more ROls need to be drawn. Therefore, 
two methods of drawing ROIs (for the placenta, basal plate and chorionic plate) 
were investigated. In the first method, the same set of ROIs was used for all 
repeats (subject to correction for gross motion as explained in section 5.3.3.1). In 
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the second method, a different ROI was drawn for each repeat. In both cases, the 
maps were created for each set separately and the histograms were averaged. 
The measurement was conducted by a single observer who repeated the 
measurement twice for both masking methods, for each gestation for all five 
subjects. The intra-observer reliability was found for each masking method by 
comparing the two repeated masking measurements. Then, the ICC and LOA 
results were compared to identify the most reliable masking method. 
5.3.3.2.3 Slice-by-Slice Comparison 
Two slices of placenta adjacent to each other (the slice with the largest placental 
area and the slice next to it) were selected by an observer to study the differences 
in the placental perfusion. For each slice of a particular subject, all the volumes of 
the five acquisitions were combined. Then, the data analysis was conducted as 
described in section 5.3.3.1. For both the slices, the mode, mean and fraction of 
pixels with f > 0.8 were computed from the averaged histogram. These values 
were used in the slice-by-slice comparison test. 
5.3.3.3 The Application of the IVIM Program to Study the 
Effect of Maternal Diabetes on Placental Blood Flow 
The best method and best slice for reproducible placental perfusion analysis 
were identified from the results of the reliability tests. These approaches were 
applied in conjunction with the method described in section 5.3.3.1 to study the 
effect of maternal diabetes on placental blood flow. For the purpose of this study, 
perfusion analysis was only done on a single slice for each subject at each 
gestational time point. The data analysis was conducted on all the data collected 
from both diabetic and non-diabetic control pregnant women at 24 weeks and 35 
weeks gestational age. The averaged histograms of fraction of moving blood 
volume (f) and apparent diffusion coefficient rising from non-blood spins moving 
between and within the cells (D) were used in evaluation of mode f, mean f, 
fraction of pixels with f > 0.08, mode D, mean D and fraction of pixels with D > 
0.0025. 
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The distributions ofmodef, mean!, fraction of pixels with!> 0.08, mode D, mean 
D and fraction of pixels with D > 0.0025 along with clinical data were tested for 
normality using the Kolmogorov-Smirnov test on SPSS software. The normally 
distributed results were expressed by their mean and standard deviation. Then, 
the statistical comparisons of clinical data between two groups at each gestation 
were performed using an independent samples t-test for normally distributed 
data and a Mann Whitney test for non-parametric data. Subsequently, statistical 
comparison for placental perfusion measurements was performed using the 
repeated measures analysis of variance CANOVA) to access the changes in the 
placental perfusion and diffusion with time. The results were presented as a ratio 
of variation explained by the model to unexplained factors. Statistically 
significant results were determined by using p-values. For the purpose of this 
study, p-values less than 0.05 were considered significant. These values were 
used in studying the placental perfusion difference in diabetic and non-diabetic 
control pregnant mothers. 
In addition, the placental volume was measured by drawing approximate 
freehand mask around the placenta using Analyze 9.0. This measurement was 
conducted on either HASTE or bFFE images acquired from all the diabetic and 
non-diabetic control pregnant women at 24 weeks and 35 weeks. 
5.4 Results 
5.4.1 Reliability and Reproducibility Assessment of 
the Measurement Analysed on the IVIM Program 
5.4.1.1 Intra-observer and Inter-observer Reliability Test 
Mean / measurements generally demonstrated the best intra and inter-observer 
reliability followed by mode/and fraction of pixels with/> 0.8, with most mean! 
ICCs demonstrating very good correlation (> 0.81). In general, observer 1 scored 
the best intra-observer results for mean f, fraction of pixels with /> 0.8 and mode 
/measurements for placenta, basal plate and chorionic plate across all gestations. 
This is evident from the narrower LOA for observer 1 compared to other 
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observers in the Bland Altman plots for all these measurements (figure 5.9, 5.10 
and 5.11). Observer l's LOA for mean / measurements: ± 5% for the whole 
placenta, ± 9% for the basal plate and ± 11 % for the chorionic plate, fraction of 
pixels with / > 0.8 measurements: ± 15% for the whole placenta, ± 38% for the 
basal plate and ± 23% for the chorionic plate and mode /measurements: ± 0.01 % 
for the whole placenta and ± 18% for the basal plate (observer 3 had narrower 
LOA at ± 39% for chorionic plate). 
The intra and inter-observer results were generally best for placenta and less 
consistent for basal plate and chorionic plate, with chorionic plate usually 
demonstrating the weakest ICC results and wider LOA. In addition, the LOA were 
generally wider at 35 weeks compared to 24 weeks. Table 5.1, 5.2 and 5.3 lists 
the ICC results for intra and inter-observer reliability for meanf, fraction of pixels 
with /> 0.8 and mode / measurements for placenta, basal plate and chorionic 
plate across all gestation, 24 weeks and 35 weeks. 
With the reliability test demonstrating weakest ICCs and LOA for fraction of 
pixels with/> 0.8, the subsequent reliability tests were only based on mean/and 
mode /measurements. 
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Region of Intra-observer ICCs for Mean[ofThree Observers Inter-observer 
Interest (95% CI) ICCs for Mean[of 
Observer 1 Observer 2 Observer 3 Three Observers (95% CI) 
All gestation 
Placenta 0.961 0.918 0.874 0.911 
(0.857 - 0.990) (0.706 - 0.979) (0.542 - 0.968) (0.745 - 0.975) 
Basal Plate 0.953 0.928 0.851 0.878 
(0.824 - 0.988) (0.739 - 0.982) (0.535 - 0.960) (0.546 - 0.969) 
Chorionic Plate 0.871 0.741 0.868 0.655 
(0.588 - 0.966) (0.287 - 0.927) (0.551 - 0.966) (0.311 - 0.887) 
24 weeks 
Placenta 0.956 0.879 0.715 0.784 
(0.642 - 0.995) (0.273 - 0.987) (-0.173 - 0.966) (0.344 - 0.972) 
Basal Plate 0.962 0.839 0.904 0.811 
(0.715 - 0.996) (0.001 - 0.982) (0.447 - 0.989) (0.380 - 0.976) 
Chorionic Plate 0.952 0.627 0.969 0.624 
(0.599 - 0.995) (-0.576 - 0.955) (0.779 - 0.997) (0.112 - 0.945) 
35 weeks 
Placenta 0.959 0.936 0.892 0.947 
(0.719 - 0.996) (0.607 - 0.993) (0.185 - 0.988) (0.789 - 0.994) 
Basal Plate 0.956 0.977 0.827 0.936 
(0.687 - 0.995) (0.801 - 0.998) (0.056 - 0.980) (0.542 - 0.993) 
Chorionic Plate 0.745 0.823 0.708 0.329 
(0.006 - 0.969) (0.012 - 0.980) (-0.214 - 0.965) (-0.033 - 0.848) 
Table 5.1: Intra-observer and inter-observer reliability results (ICC) for mean/of 
placenta, basal plate and chorionic plate computed from two measurements 
made by each observer at different gestational stage. 
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Figure 5.9: Bland Altman plots ofmeanJofthe whole placenta (a and d), basal 
plate (b and e) and chorionic plate (c and f). These Bland Altman plots express 
the intra-observer (a - c) or inter-observer (d - f) mean percentage differences 
based on measurements made by three observers. The solid lines refer to mean 
percentage diffe rences (1st measurement - 2nd measurement), whereas dotted 
lines refer to LOA between measurements. 
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Region of Intra-observer ICCs for Fraction of Pixels with f> 0.8 of Inter-observer 
Interest Three Observers (95% CI) ICCs for Fraction 
of Pixels with 
Observer 1 Observer 2 Observer 3 f> 0.8 ofThree 
Observers 
(95% CI) 
All gestation 
Placenta 0.988 0.886 0.971 0.218 
(0.953 - 0.997) (0.629 - 0.970) (0.869 - 0.993) (-0.029 - 0.602) 
Basal Plate 0.900 0.928 0.339 0.204 
(0.650 - 0.974) (0.739 - 0.982) (-0.198 - 0.765) (-0.034 - 0.587) 
Chorionic Plate 0.868 0.639 0.486 0.014 
(0.564 - 0.965) (0.054 - 0.897) (-0.223 - 0.846) (-0.143 - 0.369) 
24 weeks 
Placenta 0.989 0.924 0.967 0.486 
(0.923 - 0.999) (0.441 -0.992) (0.757 - 0.996) (0.010 - 0.909) 
Basal Plate 0.830 0.763 * 0.055 
(0.203 - 0.980) (-0.50 - 0.972) (-0.028 - 0.473) 
Chorionic Plate 0.874 0.914 0.377 0.001 
(0.339 - 0.986) (0.503 - 0.990) (-0.767 - 0.914) (-0.376 - 0.727) 
35 weeks 
Placenta 0.979 0.797 0.981 0.068 
(0.852 - 0.998) (0.107 - 0.976) (0.866 - 0.998) (-0.066 - 0.587) 
Basal Plate 0.917 0.989 0.792 0.239 
(0.511 - 0.991) (0.911 - 0.999) (-0.186 - 0.977) (-0.086 - 0.843) 
Chorionic Plate 0.818 0.107 0.706 0.226 
(-0.012 - 0.979) (-0.641 - 0.834) (-0.166 - 0.964) (-0.119 - 0.811) 
Table 5.2: Intra-observer and inter-observer reliability results (ICC) for fraction 
of pixels with/> 0.8 of placenta, basal plate and chorionic plate computed from 
two measurements made by each observer at different gestational stage. (Note: * 
indicates that the author failed to do conduct the reliability test due to a negative average 
covariance among the data. This violates the reliability model assumptions.) 
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Figure 5.10: Bland Altman plots of fraction of pixels with/> 0.8 of the whole 
placenta (a and d), basal plate (b and e) and chorionic plate (c and f). These Bland 
Altman plots express the intra-observer (a - c) or inter-observer (d - f) mean 
percentage differences based on measurements made by three observers. The 
solid lines refer to mean percentage differences (1st measurement - 2 nd 
measurement), whereas dotted lines refer to LOA between measurements. 
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Region of Intra-observer ICCs for Mode /ofThree Observers Inter-observer 
Interest (95% CI) ICCs for Mode/of 
Observer 1 Observer 2 Observer 3 Three Observers (95% eI) 
All gestation 
Placenta 1.000 0.925 0.594 0.748 
(0.744 - 0.981) (0.051 - 0.877) (0.455 - 0.922) 
Basal Plate 0.925 0.566 0.698 0.661 
(0.728 - 0.981) (-0.081 - 0.873) (0.204 - 0.914) (0.284 -0.892) 
Chorionic Plate 0.000 0.135 0.752 0.110 
(-0.772 -0.575) (-0.531 - 0.686) (0.310 - 0.931) (-0.214 - 0.576) 
24 weeks 
Placenta 1.000 1.000 0.789 0.816 
(0.049 - 0.975) (0.373 - 0.977) 
Basal Plate 0.947 0.504 0.708 0.719 
(0.653 - 0.994) (-0.505 - 0.934) (-0.053 - 0.963) (0.185 - 0.962) 
Chorionic Plate 0.759 0.853 0.883 0.538 
(-0.010 - 0.971) (0.048 - 0.984) (0.186 - 0.987) (-0.070 - 0.931) 
35 weeks 
Placenta 1.000 0.900 0.430 0.710 
(0.438 - 0.989) (-0.556 - 0.920) (0.239 - 0.960) 
Basal Plate 0.577 0.740 0.717 0.371 
(-0.447 - 0.946) (-0.155 - 0.969) (-0.144 - 0.966) (-0.153 - 0.887) 
Chorionic Plate • 0.000 0.372 * 
(-0.947 - 0.818) (-0.288 - 0.894) 
Table 5.3: Intra-observer and inter-observer reliability results (ICC) mode f of 
placenta, basal plate and chorionic plate computed from two measurements 
made by each observer at different gestational stage. (Note: * indicates that the 
author failed to do conduct the reliability test due to a negative average covariance 
among the data. This violates the reliability model assumptions.) 
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Figure 5.11: Bland Altman plots of mode f of the whole placenta (a and d), basal 
plate (b and e) and chorionic plate (c and f). These Bland Altman plots express 
the intra-observer (a - c) or inter-observer (d - f) mean percentage differences 
based on measurements made by three observers. The solid lines refer to mean 
percentage differences (1st measurement - 2nd measurement), whereas dotted 
lines refer to LOA between measurements. 
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5.4.1.2 Comparison between Single and Multiple Masking 
Both masking methods showed very good intra-observer ICCs for all ROIs, with 
the exception of intra-observer comparison for mode f of the basal plate using 
method 1 which only showed good correlation (> 0.72). However, the results 
show that motion effects exceed human error with multiple masking scoring 
slightly better ICC and narrower LOA compared to single masking. Nonetheless, 
the single masking method was more time efficient, with processing time 
reduced by one-third of mUltiple masking method's processing time (5 minutes 
versus 15 minutes). Given that the differences between the methods was not very 
big, method 1 was used in analysing placental perfusion to study the effect of 
maternal diabetes on placental blood flow. 
Region of Interest Intra-observer ICCs (95% CI) 
Method 1 Method 2 
Mean! 
Placenta 0.908 (0.680 - 0.976) 0.972 (0.898 - 0.993) 
Basal Plate 0.941 (0.782 - 0.985) 0.965 (0.874 - 0.991) 
Chorionic Plate 0.873 (0.588 - 0.966) 0.889 (0.615 - 0.971) 
Mode! 
Placenta 0.922 (0.735 - 0.980) 0.981 (0.928 - 0.995) 
Basal Plate 0.721 (0.192 - 0.923) 0.837 (0.495 - 0.956) 
Chorionic Plate * 0.808 (0.400 - 0.949) 
Table 5.4: Intra-observer reliability results (ICC) for method 1 and method 2 for 
mean f and mode f of placenta, basal plate and chorionic plate computed from 
measurements made by an observer using two different methods. (Note: * 
indicates that the author failed to do conduct the reliability test due to a negative average 
covariance among the data. This violates the reliability model assumptions.) 
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Figure 5.12: Bland Altman plots ofmeanf(a - c) and modeJ(d - f) of the whole 
placenta (a and d), basal plate (b and e) and chorionic plate (c and f). These Bland 
Altman plots express the differences in percentage of their means and done 
based on measurements made by a s ingle observer, the author. The solid lines 
refer to mean percentage differences (1st measurement - 2 nd measurement), 
whereas dotted lines refer to LOA between measurements. 
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5.4.1.3 Slice-by-Slice Comparison 
The measurements for mean / and mode / measured on two adjacent slices 
showed good ICC correlation for the placenta and basal plate, but weaker 
reliability for the chorionic plate. Similarly, the LOA was better for the placenta 
compared to the basal plate and chorionic plate, with narrower LOA for mean / 
(± 13%) compared to mode/(± 28%) of the placenta. However, compared to the 
intra-observer ICCs and LOA for the first slice (from section 5.4.1.1), the 
reliability is worse for inter-slice comparison between adjacent slices. This is 
evident in figure 5.13, where the mean differences for mean / and mode / deviates 
from the value zero on the Bland Altman plots but this falls within the scatter of 
the data and is not statistically significant implying no systematic difference 
between central and peripheral slices. For this reason, only the slice with the 
largest placental area was used in analysing placental perfusion. 
Region of Interest Intra-class Correlation Coefficient (95% CI) 
MeanJ ModeJ 
Placenta 0.689 (0.119 - 0.914) 0.847 (0.521 - 0.959) 
Basal Plate 0.695 (0.203 - 0.912) 0.610 (-0.001 - 0.887) 
Chorionic Plate 0.479 (-0.105 - 0.834) 0.110 (-0.424 - 0.646) 
Table 5.5: Inter-slice reliability results (ICC) for mean/and mode/of placenta, 
basal plate and chorionic plate computed from measurements made by an 
observer on two different slices. 
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Figure 5.13: Bland Altman plots ofmeanJ(a - c) and modeled - f) of the whole 
placenta (a and d), basal plate (b and e) and chorionic plate (c and f). These Bland 
Altman plots express the differences in percentage of their means and done 
based on measurements made by a single observer, the author. The solid lines 
refer to intra-slice mean percentage differences (measurement of 1st slice-
measurement of 2 nd slice), whereas dotted lines refer to LOA between 
measurements. 
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5.4.2 The Application of the IVIM Program to Study 
the Effect of Maternal Diabetes on Placental Blood 
Flow 
5.4.2.1 Study Population 
A total of 26 pregnant women with singleton pregnancy, 14 diabetic (13 Type 1 
Diabetes and 1 Type 2 Diabetes) and 12 controls, matched for age, parity and 
maternal Body Mass Index (BMI) were recruited. There was one smoker in the 
diabetic group and no smokers in the non-diabetic control group. Table 5.6 
demonstrates the basic and clinical characteristics of the participants of this 
study. 
Characteristic Control (n = 12) Diabetes (n = 14) 
Mean SD Range Mean SD Range 
Maternal age 29 4.3 19 - 35 30 4.4 19 - 34 
(years) 
Weight (kg) 71.7 10.8 55 - 94 70.9 10.2 56 - 90 
Height (cm) 164.6 7.0 155 - 180 163.9 5.2 153-173 
BMI 26.3 3.1 20.5 - 31 26.2 3.5 22 - 34 
Parity 0 0.39 0-1 1 0.65 0-2 
Gestational age 40.1 1.5 (37+0) - 37.48 1.33 (35+4) -
at delivery (41+4) (39+4) 
(weeks + days) 
Birth weight (g) 3418 496 2350 - 4070 3419 641 1800 - 4280 
Table 5.6: Basic and clinical characteristics of participants of this study. 
The Kolmogorov-Smirnov test confirmed normal distribution for all the 
demographic data, with exception to parity, birth weight centiles and HbAlc in 
first trimester. There was no significant difference in any of the demographic 
characteristics (age, BMI, parity and ethnicity) between groups. The range of the 
gestational ages at the time of scans was 22 - 26 weeks and 33 - 37 weeks. The 
average gestational ages for the scans was 24 weeks + 1 day (SO = 5 days) and 34 
weeks + 4 days (SO = 4 days) in the non-diabetic control group and 24 weeks + 2 
days (SO = 5 days) and 34 weeks + 3 days (SO = 7 days) in the diabetic group. 
Seven pregnant subjects withdrew from the study after their first scan: one 
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control pregnant woman (did not attend second scan) and six pregnant women 
with diabetes. The pregnant women with diabetes who withdrew from the study 
were either too big for the magnet bore (one pregnant women), were 
experiencing morning sickness during the second scan (one pregnant women), 
delivered before scan (one pregnant women) or failed to attend second scanning 
session (three pregnant women). However, there were no differences in the 
demographics or delivery outcomes between women who completed the study 
and those who withdrew. 
5.4.2.2 Clinical Outcomes 
For birth weight, there was no significant difference (p = 0.395) between the two 
groups. The average birth weight of babies born to pregnant mothers in the 
control group was 3418 g (SO = 496 g) and diabetic group was 3419 g 
(SO = 641 g). Nonetheless, the mothers with diabetes delivered their babies at a 
significantly earlier gestation (p < 0.001), 37 weeks + 4 days (SO = 9 days), 
whereas control mothers delivered their babies at 40 weeks + 0 days (SO = 10 
days). Moreover, after correcting for gestational age, babies born to mothers with 
diabetes were significantly larger than controls (median birth weight centile 88 
for diabetes group and 33 for control group; p = 0.009). Oata also shows that 
there was a higher number of deliveries by caesarean section (CS) in the diabetes 
group (five emergency and two elective CS in diabetic versus one elective CS in 
the controls, Fisher's exact test p = 0.036). 
5.4.2.3 The Application of the IVIM 
For the purpose of this study, only one of the five placental slices was assessed to 
investigate placental perfusion and diffusion. The most commonly used slice for 
this study was the central slice with the largest placental area compared to all the 
five slices. 
Figure 5.14,5.15 and 5.16 demonstrates the difference in meanf, mode f, mean D, 
fraction of pixels with D:> 0.0025 and mode D of placenta, basal plate and 
chorionic plate for the control and diabetic group across gestation, while figure 
5.17 demonstrates the comparison between average measurements for mean f, 
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mode f, mean D, fraction of pixels with D > 0.0025 and mode D of placenta, basal 
plate and chorionic plate for the control and diabetic group at 24 weeks and 35 
weeks. 
The statistical test conducted on mode f, mean f, mode D, mean D and fraction of 
pixels with D > 0.0025 confirmed that the data were normally distributed for 
both diabetic and control groups at 24 weeks and 35 weeks. Although the 
statistical test conducted on fraction of pixels withf> 0.08 showed that the data 
were normally distributed, these data were not used in investigating the effect of 
maternal diabetes on placental perfusion, since this element failed to 
demonstrate reliability and reproducibility in the placenta, basal plate and 
chorionic plate. The average value for all the measurements made for diabetic 
and control groups across the two gestations is demonstrated in tables 5.7 and 
5.8. These tables also contain p-values obtained from statistical comparison 
performed using repeated measures analysis of variance (AN OVA). These values 
provide information on the effect of gestation and group on placental perfusion 
and diffusion. 
There was no significant difference in the mean f measurements of the diabetic 
and control group across gestation. Conversely, for mode f, there was a 
significant increase in the mode f of both basal plate and chorionic plate across 
gestation, suggesting increase in the peak blood flow within these regions across 
gestation. Moreover, the mode f measurements were generally higher in the 
control group at 24 weeks but at 35 weeks, the mode f measurements were 
usually higher in the diabetic group. This was not Significant but similar trends 
were seen for all regions. 
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Region of Group 24 weeks 35 weeks p-value 
Interest Mean (SO) Mean (SO) 
Across Gestation Group 
Gestation and Group 
Mean! 
Placenta Diabetic 0.3546 (0.0379) 0.3577 (0.0332) 0.445 0.632 0.490 
Control 0.3781 (0.0502) 0.3637 (0.0393) 
Basal Plate Diabetic 0.3932 (0.0422) 0.4124 (0.0826) 0.441 0.270 0.270 
Control 0.4369 (0.0581) 0.4264 (0.0714) 
Chorionic Diabetic 0.4386 (0.0664) 0.4644 (0.0621) 0.166 0.390 0.591 
Plate 
Control 0.4276 (0.0662) 0.4404 (0.0421) 
Mode! 
Placenta Diabetic 0.2714 (0.0533) 0.3300 (0.0393) 0.586 0.065 0.850 
Control 0.3267 (0.0672) 0.3000 (0.0632) 
Basal Plate Diabetic 0.3657 (0.1201) 0.4738 (0.1103) 0.003" 0.113 0.375 
Control 0.4200 (0.1100) 0.4618 (0.1141) 
Chorionic Diabetic 0.4596 (0.1103) 0.5988 (0.1351) 0.012" 0.339 0.952 
Plate 
Control 0.4817 (0.1573) 0.5609 (0.1583) 
Table 5.7: The average measurement and standard deviation for the mean/and 
mode f of placenta, basal plate and chorionic plate for the control and diabetic 
group computed from measurements made by one observer using method 
described in section 5.3.3.1. (Note: * indicates statistically significant p-values.) 
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Figure 5.14: Scatter plot of the difference in meanf(a - c) and modef(d - f) of 
the whole placenta (a and d), basal plate (b and e) and chorionic plate (c and f) 
across two gestations for diabetic and control mothers. Marker lines are added 
allowing comparison of the two measurements for each individual subject. The 
mean value and the standard deviation are also displayed for the two groups on 
the left and right of the image [red - diabetic; blue - control]. 
The repeated measures of ANOVA confirmed that there were significant changes 
in D across gestation in both diabetic and control groups. There were Significant 
decreases in mean D, fraction of pixels with D> 0.0025 and mode D in the 
placenta and chorionic plate across gestation, with a slight trend for mean D and 
mode D to be greater in the control subjects. In addition, ANOVA test confirmed 
there was a significant change in the mean D measurement of the placenta and 
basal plate across gestation and group. Moreover, mode D of basal plate 
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demonstrated a trend suggesting an increase in mode D of control group and 
decrease in mode D of diabetic group across gestation. However, there was no 
significant difference in these measurements between diabetic and control 
groups. 
Region of Group 24 weeks 35 weeks p-value 
Interest Mean (SD) Mean (SD) Across Gestation Group 
Gestation and Group 
Mean D (mm2 5-1) 
Placenta Diabetic 0.0021 (0.0003) 0.0017 (0.0003) 0.009" 0.015" 0.344 
Control 0.0021 (0.0002) 0.0018 (0.0002) 
Basal Plate Diabetic 0.0022 (0.0003) 0.0017 (0.0004) 0.001" 0.020" 0.299 
Control 0.0023 (0.0004) 0.0021 (0.0004) 
Chorionic Diabetic 0.0028 (0.0004) 0.0021 (0.0003) 0.001" 0.440 0.845 
Plate 
Control 0.0029 (0.0006) 0.0022 (0.0005) 
Fraction of pixels with D > 0.0025 (mm2 51) 
Placenta Diabetic 0.2660 (0.1214) 0.1732 (0.0782) 0.002" 0.110 0.325 
Control 0.2403 (0.0877) 0.1868 (0.0564) 
Basal Plate Diabetic 0.2952 (0.1120) 0.2030 (0.1054) 0.013" 0.062 0.748 
Control 0.2873 (0.0854) 0.2625 (0.0722) 
Chorionic Diabetic 0.4681 (0.0999) 0.2822 (0.0651) 0.001 " 0.718 0.748 
Plate 
Control 0.4970 (0.1245) 0.2817 (0.0907) 
Mode D (mm2 5.1) 
Placenta Diabetic 0.0019 (0.0003) 0.0017 (0.0002) 0.015" 0.346 0.617 
Control 0.0019 (0.0003) 0.0017 (0.0002) 
Basal Plate Diabetic 0.0018 (0.0003) 0.0016 (0.0004) 0.044· 0.056 0.440 
Control 0.0018 (0.0003) 0.0018 (0.0002) 
Chorionic Diabetic 0.0019 (0.0005) 0.0014 (0.0003) 0.001· 0.983 0.578 
Plate 
Control 0.0021 (0.0007) 0.0015 (0.0003) 
Table 5.8: The average measurement and standard deviation for mean D, fraction 
of pixels with D > 0.0025 and mode D of placenta, basal plate and chorionic plate 
for the control and diabetic group computed from measurements made by one 
observer using method described in section 5.3.3.1. (Note: * indicates statistically 
significant p-values.) 
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Figure 5.15: Scatter plot ofthe difference in mean D (a - c) and fraction of pixels 
with D > 0.0025 (d - f) of the whole placenta (a and d), basal plate (b and e) and 
chorionic pla te (c and f) across two gestations for diabetic and control mothers. 
Marker lines are added allowing comparison of the two measurements for each 
individual subject. The mean value and the standard deviation are also displayed 
for th e two groups on the left and right of the image [red - diabetic; blue -
control]. 
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Figure 5.16: Scatter plot of the difference in mode D of the whole placenta (a), 
basal plate (b) and chorionic plate (c) across two gestations for diabetic and 
control mothers. Marker lines are added allowing comparison of the two 
measurements for each individual subject. The mean value and the standard 
deviation are also displayed for the two groups on the left and right of the image 
[red - diabetic; blue - control]. 
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Figure 5.17: Boxplots of the effect of maternal diabetes on the mean and standard 
deviation ofmeanf(a), modef (b), mean D (c), fraction of pixels with D > 0.0025 
(d) and mode D (e) value of the whole placenta, basal plate and chorionic plate 
across two gestations fo r diabetic and control mothers [red - diabetic; blue -
control]. 
As expected, the placental volume measurements demonstrated an increase from 
411 cm 3 (SD = 93 cm3) to 80S cm3 (SD = 198 cm3) in the controls and 459 cm3 
(SD = 141 cm3) to 800 cm3 (SD = 143 cm3) in the diabetic group at 24 weeks and 
35 weeks, respectively. However, there was no significant different in the 
placenta volume between the groups at 24 weeks (p = 0.374) or 35 weeks 
(p = 0.960). Figure 5.18 demonstrates the placental volume across the two 
gestations in diabetic and non-diabetic pregnancies. 
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Figure 5.18: Scatter plot of the placental volume at two gestations for fo etuses of 
diabetic and control mothers. Marker li nes are added allowing comparison of the 
two measurements for each individual subject. The mean value and the standard 
deviation are also displayed for the two groups on the left and right of the image 
[red - diabetic; blue - control; open circles at 2 nd time point: caesarean delivery]. 
5.4.2.4 Comparison of Mean/and Mean D Measurements 
Direct comparison of the results obtained from mean / and mean D 
measurements in the placenta showed that mean D increases with increasing 
mean f There were significant posi tive linear correlations between mean / and 
mean D for the placenta, basal plate and chorionic plate at both time points, with 
exception of the chorionic plate measurement at 35 weeks. The strongest 
correlation was between mean / and mean D measurement in the basal plate, 
followed by placenta at 35 weeks. These correlations are shown in table 5.9. 
Region of Interest Relationship between Meanfa nd Mean D, R2 (p) 
24 weeks 35 weeks 
Placenta 0.244 (p = 0.010) 0.463 (p = 0.001) 
Basal Plate 0.359 (p = 0.001) 0.62 0 (p < 0.001) 
Chorionic Plate 0.465 (p - 0.001) 0.088 (p = 0.141) 
Table 5.9: Relationship between mean/and mean D for placenta, basal plate and 
chorionic plate: linear correlatio n statistics (R2 value of the goodness of fit) 
together with the p values. 
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Similarly, there were significant positive linear correlations between the 
different regions in the placenta for mean / and mean D. The correlations were 
stronger in the mean D measurements compared to mean! The linear regression 
with its R2 value of goodness offit is demonstrated in table S.10. 
Region of Interest Relationship between Region of Interest, R2 (p) 
Mean! MeanD 
24 weeks 35 weeks 24 weeks 35 weeks 
Placenta versus Basal Plate 0.381 0.265 0.488 0.449 
(p = 0.001) (p = 0.024) (p < 0.001) (p = 0.002) 
Placenta versus Chorionic Plate 0.146 0.388 0.442 0.524 
(p = 0.054) (p = 0.004) (p < 0.001) (p < 0.001) 
Basal Plate versus Chorionic 0.010 0.075 0.252 0.163 
Plate (p = 0.633) (p = 0.257) (p = 0.009) (p = 0.086) 
Table S.10: Relationship between region of interest for mean/and mean D: linear 
correlation statistics (R2 value of the goodness of fit) together with the p values. 
5.5 Discussion and Conclusion 
The placenta is a unique foetal organ separating the foetal and maternal 
circulation. It plays a vital role in foetal development by conducting functional 
activities for most foetal organs (except central nervous system and locomotor 
apparatus) from its early development until birth [67]. The placental structure is 
large with a fetal vascular bed that comprises a tree-like network. A mature 
placenta is composed of a basal plate and chorionic plate that border the 
intervillous space. The basal plate is the region embedded into the maternal 
uterine wall, where the spiral arteries and veins are located, establishing the 
intimate relationship between blood flow in the fetal and maternal circulation in 
the intervillous space. Initially, the maternal spiral arteries are transformed into 
inelastic tubes, where the maternal blood spurts in a jet like manner through 
these vessels to produce the low pressure in the intervillous space. The jets of 
blood flow are dependent on placental structure [37]. The maternal and foetal 
blood is in close proximity, with the vascular villous tree projecting from the 
chorionic plate into the intervillous space [67]. 
The placentae of patients suffering from intrauterine growth restriction and 
maternal diabetes are often associated with abnormal placental perfusion. In 
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maternal diabetes, the placenta is often linked to increased villous volume 
histologically. However, studies have shown that there is no difference in 
fetoplacental angiogenesis in diabetic pregnancies with or without complications 
[68]. Hence, antenatal assessment of placental vascular function will be valuable 
in assessment of foetal well-being. 
In recent years, non-invasive MRI has been acknowledged as a diagnostic tool in 
the study of the fetoplacental environment to improve the understanding of 
pathophysiological mechanisms [35; 69]. MRI employs ultrafast imaging 
sequences that can effectively suppress foetal motion artefacts without sedation. 
Moreover, it is capable of producing images with high tissue contrast that enables 
simultaneous visualisation of fetomaternal structure in larger field of view using 
the multiplanar reconstruction capabilities [69; 70; 71; 72; 73]. This is 
advantageous in imaging the placenta, uterine wall, amniotic fluid and foetus [35; 
74;75]. 
Placental MRI is normally conducted using Tl and T2 weighted sequences, with 
placental images appearing more informative in T2-weighted images with 
relatively higher signal intensity compared to Trweighted images [35]. It is 
useful in the assessment and documentation of placental location, structure, 
perfusion and its alterations in compromised pregnancy [76]. In this study, we 
applied EPI to study placental perfusion in non-diabetic and diabetic pregnancy. 
EPI can be conducted in a short imaging time, allowing the whole scanning 
procedure to be quick and comfortable for the patient. 
All the data acquired using EPI were analysed based on the IVIM technique. 
Standard image registration could not be applied to the acquired data due to 
several factors: (1) dramatic change in image contrast with increasing diffusion 
parameter (b), (2) non-rigid body distortion of the abdomen in general and the 
placenta which is relatively amorphous in shape and very distortable, unlike 
other organs (eg: brain, kidney and liver) where image registration has been 
possible and (3) separate movement of the mother and foetus. So, a pragmatic 
approach was taken (as discussed in section 5.3.3.1). Ideally, the placental image 
could be manually segmented for each acquisition and each outlined ROI could be 
co-registered together. Unfortunately, this would be very time consuming and 
additional work is required to understand how manual outline of the high b-
value ROis relate to the outline of low b-value ROIs. 
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5.5.1 Reliability and Reproducibility of the IVIM 
Program 
Prior to applying the IVIM program to study the effect of maternal diabetes on 
placental blood flow, the program was tested for reliability and reproducibility of 
the perfusion measurements based on the fraction of moving blood (f) within the 
placenta. This study was conducted due to lack of published literature exploring 
the reliability of MRI perfusion measurements. The average blood flow 
distribution (mean j), high blood flow region associated with upper end of the 
flow distribution (fraction of pixels with f> 0.8) and peak blood flow (mode f) 
were investigated, since preliminary work suggested that there were difference 
in these elements between the non-diabetic and diabetic placentae [77]. 
Moreover, it has been published [51] that perfusion factor (f) and apparent 
diffusion coefficient (D) results are more reproducible compared to pseudo-
diffusion coefficient (D*). It has previously been reported that five acquisitions of 
placental data are required to achieve results with 15% confidence for the SNR 
achievable at 0.5 T [51]. However, this should be explored again at 1.5 T in future 
studies. 
The data showed that mean and mode f were more reliable parameters for 
placental perfusion assessment compared to fraction of pixels with f > 0.8. The 
LOA for fraction of pixels with f> 0.8 were also wider and the ICCs demonstrated 
poor reliability. This is possibly because regions with high blood flow may 
include data points affected by noise and physiological variation (maternal and 
foetal heart rate along with maternal breathing). For this reason, the subsequent 
reliability studies were conducted based on mean and mode f measurements. 
Overall, observer 1 showed the best intra-observer reliability with narrowest 
LOA. This is reasonable since observer 1 had significantly more experience in 
examining the placental images acquired using PGSE sequence and conducting 
placental perfusion analysis on the IVIM program. However, the LOA of the 
measurements made by other observers were not too discrepant, suggesting that 
the reliability could be improved with possible further training. It is also 
important to note that the LOA were wider for all observers for basal plate and 
chorionic plate. The ROI of basal plate and chorionic plate were small, mostly five 
to six voxels in depth in the MRI images. Hence, movements along these plates 
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could cause errors in the perfusion measurement in these regions and is a 
possible explanation for the lower degrees of reliability seen. 
The inter-observer reliability test showed narrower range of LOA for mode and 
mean [compared to the fraction of pixels with [> 0.8 of the placenta at both 24 
weeks and 35 weeks. The LOA were generally wider at 35 weeks, suggesting less 
reliability at this gestation. This may be because the placental images appear 
much darker and more distorted at 35 weeks compared to 24 weeks, making ROI 
masking more difficult at 35 weeks. In comparison to a reliability test conducted 
on renal perfusion measurement that demonstrated a coefficient of variance of 
42% for mean [[78], the inter-observer reliability of mean and mode [showed a 
better reliability at ± 5% and ± 9% for the placenta, ± 15% and ± 23% for the 
basal plate and ± 15% and ± 30% for the chorionic plate, respectively. As for 
measurements of fraction of pixels with[> 0.8, the inter-observer reliability was 
reduced with LOA closer to ± 100%. 
Both single and multiple masking methods showed good intra-observer 
reliability. While the single masking method demonstrated better ICCs and 
narrower LOA compared to multiple masking method, the inter-method 
comparison demonstrated reasonably narrow LOA, with narrowest LOA for the 
placenta. As expected, the LOA were wider in the basal plate and chorionic plate 
since the slightest movement in the abdomen can compromise the placental 
perfusion measurements in these regions. While multiple masking method is 
more reliable in measuring placental perfusion in the basal plate and chorionic 
plate since it involves drawing the ROIs on each repeat separately, overcoming 
motion issues within this region, multiple masking method is time inefficient and 
prone to human error. Therefore, single masking method was employed in this 
study. 
A similar trend was seen for slice-by-slice comparison, with mean and mode [ 
measurement demonstrating the best LOA for the placenta, followed by the basal 
plate and then chorionic plate. In this study,S slices of 7 mm thickness with an 
18 mm slice gap were acquired. As observed, poorer reliability is expected in the 
chorionic plate since the vessels spread out from the cord and their distribution 
may vary greatly across the surface of the placenta, resulting in different 
perfusion measurements. These results give an indication as to how sensitive the 
results are to the positioning of slice by the radiographer. One major limitation in 
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the reliability and reproducibility study is the small number of data included in 
this test (data of 5 subjects scanned at 24 weeks and 3S weeks) and further 
subjects would strengthen the findings. 
To conclude, IVIM provides a robust method for studying the unique physiology 
of the placenta. Its intervillous space filled with voluminous maternal blood 
increases the sensitivity of the PGSE sequence to f and D. These parameters 
provide reliable information to study the in-vivo hemodynamic environment of 
the placenta. Strategically, since the reliability of f has been investigated, 
reliability of D should also be investigated in future. 
5.5.2 The Application of the IVIM Program to Study 
the Effect of Maternal Diabetes on Placental Blood 
Flow 
There were no significant differences in the mean f measurements of the 
placenta, basal plate and chorionic plate across gestation or between the two 
groups, whereas, the mode f demonstrated significant increase in the peak blood 
flow in the chorionic plate and basal plate across gestation. This may be because 
pixels with very large values of f create noise in the mean f, which does not 
propagate into the mode f. The blood flow is expected to increase in the chorionic 
plate as the foetus grows. This is an adaptation to sustain foetal growth. Our 
finding agrees with this expectation and it is the first study attempting to 
measure chorionic plate flow, which has a potential to provide valuable 
information to study pregnancy complicated by placental vascular dysfunction, 
such as is the case in foetal growth restriction. Similarly, the blood flow in the 
basal plate (representing spiral artery blood flow) is also expected to increase to 
sustain growing foetus and maintain blood flow in the growing placentae. 
Conversely, the lack of change in placental blood flow is anticipated since the 
placenta grows with gestation, increasing the area for feto-maternal exchange 
but the perfusion per unit volume is likely to be optimised for exchange 
throughout pregnancy. 
Blood flow is generally expected to be greater in larger blood vessels; for 
instance, flow in the spiral arteries in the basal plate is likely to physiologically 
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vary across gestation, as indicated by mean f and fraction of pixels with f> 0.8, 
compared to mode! The high variability infmay be a useful biomarker in future 
data analysis. The mode [was generally higher in the control group at 24 weeks, 
but at 35 weeks, mode fwas usually higher in diabetic subjects. This result may 
be a statistical fluke but could also indicate adaptation to large foetal demands 
(macrosomic foetuses). 
The IVIM measurements of D showed striking and significant decrease across 
gestation for the placenta, basal plate and chorionic plate with a trend for D to be 
higher in the control group for the basal plate and chorionic plate. However, 
there was no significant difference in these measurements between diabetic and 
control groups. The value D is related to molecular mobility of water. This 
depends on physical characteristics of the tissue such as cell size and membrane 
permeability that affects the random Brownian motion of water within the 
placenta [37]. 
Studies have suggested a significant increase in the villous tissue in the placenta 
across gestation [79; 80; 81]. Therefore, increased villous branching could 
increase tissue density and hence, decrease effective mean free path of blood 
movement within the intervillous space. This would result in dephasing of the 
IVIM signal and hence, reduced D. In comparison to normal placentae, there is 
evidence of more voluminous foetal capillary beds with greater diameter, length 
and surface area in the diabetic placentae [19]. Moreover, studies have reported 
evidence of fibrinoid necrosis and atherosis in the decidual bed of diabetic 
placentae [82], that could possibly be the cause of even shorter diffusion distance 
within the diabetic placentae. This could explain our findings that show a more 
pronounced decrease in the D of the diabetic placentae. Histological examination 
of the placentae of these subjects after birth and correlation to the MRI findings 
would strengthen the findings of this study and is a limitation of this work. 
In the chorionic plate, the blood vessels are expected to expand with increasing 
placental size to sustain the needs of the growing foetus. So, the blood vessels per 
unit volume are expected to decrease, which might result in decreased D since 
blood has greater diffusion coefficient from the tissue. In the basal plate region, 
the spiral arteries are expected to open wider with increasing gestation allowing 
blood flow to increase across gestation, possibly causing diffusion to increase 
across gestation. However, the data here indicates that diffusion in this region 
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decreases with gestation. It is important to note that the D measurement can be 
contaminated by flow due to data points used for the IVIM fitting, and additional 
methods of acquiring and fitting the data should be used to investigate this. 
Direct comparison of the mean f and mean D measurements showed that there 
was significant positive correlation between these two measurements, 
suggesting mean D increases with mean f in the placenta, basal plate and 
chorionic plate regardless of the gestational stage; the strongest correlation was 
in basal plate at 35 weeks. There was also a significant positive correlation 
between the mean f and mean D measurements between the different regions of 
the placenta. However, these correlations were not strong and the statistical 
analysis may be misleading since it looks for an association between 
measurements rather than agreement. It does not take into account any 
systematic bias between two elements. Moreover all these measurement points 
were not evenly scattered. Future work using simulations could investigate 
whether such correlations will arise due to biases in the fitting process. 
Foetal growth depends on two factors: the foetal nutrient demand and maternal-
placental supply. These factors are related to placental size, utero-placental blood 
flow and placenta's transfer capabilities. If the maternal-placental supply is less 
than the demand, the foetus adapts by increasing the placental size in order to 
achieve sufficient nutrient supply [83] and hence, the increase in placental 
weight. The MR measurements of placental volume in this study indicated that 
there was no significant difference between the diabetic and control groups. 
Nonetheless, several studies have documented an increase in the placental size, 
placental weights [84; 85] and placental ratios [86] (placental weight to birth 
weight) in pregnancies complicated by gestational diabetes to sustain the large 
demands of macrosomic foetuses [21; 83]. With this understanding, it would be 
tempting to speculate that increased placental weight, with a lack of change in 
placental volume in diabetic pregnancies explains the mechanism of decreased D 
and increased f (due to increased resistance following villous branching) in 
diabetic placentae, since tissue will be denser and blood must flow faster to 
percolate through the diabetic placentae. However, this speculation may be 
fictitious since Clarson et al. [87] reported that there was no difference in the 
placental weight of diabetic and normal pregnancies. 
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Whilst this work presents a novel technique for placental perfusion and diffusion 
measurements, there are three major problems. Firstly, from the reliability 
assessment, differences between intra and inter-observer variability (where 
latter was calculated based on first set of intra-observer variability results) 
indicates an effect of fatigue in the intra-observer results even though analysis 
was conducted in a period of several days and was blinded to gestational age, 
maternal BMI, diabetic status, complications of pregnancy, other observers' 
results and observer's own previous measurement results. Moreover, variability 
between slices (measured by one observer: the author) was more than the intra-
observer variability indicating that variability was not due to errors in drawing 
the ROJ. To determine whether this variability is due to biological variability or 
variation between slices, repeated measurements need to be compared. 
Secondly, the [and D measurements for basal plate and chorionic plate regions 
are made from ROls of only five to six voxel in depth in the placental images 
acquired using PGSE sequence. In reality the placenta has no clear-cut margins 
and we are, in essence, speculating where the basal plate and chorionic plate are 
located for the purpose of data analysis. Moreover, even though the IVIM 
program was modified to identify and exclude images corrupted by excessive 
movement and artefact (data points lying more than 2 standard deviations), 
these regions are prone to be affected by tissue movement due to breathing and 
foetal movement. 
Thirdly, 2-dimensional images of the placenta were acquired for this study, while 
the placenta is actually a 3-dimensional organ. Although the sampling of the 
placenta was predetermined before the study, with the radiographer required to 
image the central slice closest to the cord insertion transversely, it raises the 
question as to how representative the imaged placental region is to the entire 
placental volume. Five slices of 7 mm thickness with 18 mm slice gap were 
acquired in this study. A comparison of the measurements between the central 
slice and a peripheral slice demonstrated a decrease in the [measurement in the 
peripheral slices. Whilst this was not statistically significant in the small data set 
(5 subjects scanned at 24 weeks and 3S weeks), one should consider performing 
a 3D acquisition and analysiS of the placenta in order to overcome concerns 
about the representativeness of the analysed area. 
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At present, the ROJ of each acquisition is fitted individually before averaging the 
histogram of the five acquisitions to measure f and D. Whilst this method is more 
time efficient than the mUltiple masking method, ideally the data analysis could 
be improved by fitting a different ROJ for all the five acquisition. Alternatively, 
signals could be averaged over the ROJ's pixel in five acquisitions together before 
fitting the ROJ into the signal attenuation equation (Eq 5.1). This would reduce 
the processing time and average out the movement or noise in the ROI for all the 
acquisitions. 
Future work will correlate MR measures with maternal levels of hyperglycemia 
and will further investigate the use of the IVIM model in the placenta, basal plate 
and chorionic plate to understand how changes in flow and diffusion may affect 
the modelled parameters: f, D and D*. This work provides a novel technique that 
has a potential to be employed as a clinical and research tool to study the 
development of placental perfusion and diffusion in pregnancies complicated by 
maternal diabetes, JUGR and pre-eclampsia. Jt will also be useful in assisting 
obstetricians to understand the functionality of placenta in normal pregnancy. 
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Chapter 6 
The Effect of Maternal 
Diabetes on Foetal Adiposity 
6.1 Overview 
The chapter starts with a short literature review detailing the effect of maternal 
diabetes on foetal growth and the adverse outcome in these pregnancies, namely 
macrosomia (foetuses considered large for their gestational age). For this reason, 
the ability to detect foetal adiposity is highly desirable to make prenatal 
diagnosiS and expedite delivery or pre-arrange caesarean section for foetuses in 
compromised pregnancies. Here, the author describes the present ultrasound 
techniques available to identify foetuses exposed to the risk of macrosomia 
before birth. Following these discussions, the chapter will progress to detail the 
techniques applied by the author to acquire, process and estimate foetal 
adiposity using MRI sequence and MATLAB codes developed by the author with 
the guidance of Professor Penny Gowland. 
This chapter is divided into two sections. The first part aims to investigate the 
reliability and reproducibility of the measurements of foetal adiposity using the 
MATLAB program. The author, with the help of three other observers, Professor 
Penny Gowland, Dr Nia Wyn Jones and Dr Ruta Deshpande, conducted the data 
analysis for the reliability tests. The second part demonstrates the application of 
the foetal adiposity measuring technique to study the effect of maternal diabetes 
on foetal adiposity. The author will address the methods used to acquire, process 
and statistically analyse foetal adiposity. In addition, the author with the help of 
Kirsty Allcock, a medical student at the University of Nottingham, conducted 
other data analyses such as measurement of shoulder width, foetal length, 
placental (reported in Chapter 5) and foetal volume to demonstrate the effect of 
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maternal diabetes on foetal growth. Finally, the chapter is concluded by 
demonstration and discussion of the results obtained from analysing the data of 
both the non-diabetic control and diabetic patients involved in this study (the 
same group of patients as in chapter 5). 
6.2 Introduction 
Pregnancy complicated by diabetes, either pre-existing or diagnosed during 
gestation, often results in macrosomic infants with increased body fat [1; 2; 3]. 
These infants usually have abnormally broader shoulders that expose them to an 
increased risk of shoulder dystocia [4; 51 and brachial plexus injury, which may 
be permanent. They are also exposed to the risk of clavicular and humeral 
fracture, hypoxic brain damage, birth asphyxia, hypoglycemia and foetal death. 
These infants often suffer prolonged labour that may require caesarean section 
delivery [6; 7; 8; 9; 10; 11; 12; 13]. 
The term macrosomia refers to foetuses that are large for their gestational age or 
infants with birth weight more than 4000 g (above the 90th percentile for birth 
weight) at delivery, irrespective of their gestational age, gender or birth order 
[10; 14; 15]. For all the reasons discussed above, obstetricians pay great 
importance to the accurate estimation of foetal weight to predict and prepare for 
the birth of macrosomic infants. Unfortunately, macrosomia can only be 
determined with certainty after delivery. Hence, it would be highly deSirable to 
make a prenatal diagnosis to expedite the delivery or pre-arrange for caesarean 
section to reduce the risk of birth trauma. 
In current clinical practice, ultrasonography is the most commonly employed tool 
to estimate foetal weight. This estimation is done based on measurement of 
segments of the body such as biparietal diameter, head circumference, abdominal 
circumference and femur length. Unfortunately, even with the most ideal 
ultrasound conditions, these measurements are subject to inevitable 
inaccuracies, with a mean percentage error of 7% - 10%. Low birth weights tend 
to be overestimated and high birth weights underestimated [16; 17]. 
6.2 Introduction 184 
Ultrasound as described in section 3.1 uses a high frequency sound pulse 
transmitted into the body and detects sound waves that are partially reflected 
from layers between different tissues. The estimation of foetal adiposity becomes 
very challenging with penetration of ultrasound beams constrained by fatty 
maternal structures, especially when the foetal head is buried deep inside the 
maternal pelvis [18]. Furthermore, obtaining clear ultrasound images becomes 
significantly more difficult in patients suffering from oligohydramnios or 
maternal obesity. With all these limitations, ultrasound, of course, does not 
permit direct determination of foetal fat content or body composition. 
Whilst ultrasound remains the predominant modality for foetal assessment in 
pregnancy due to its availability and low cost, MagnetiC Resonance Imaging 
(MRI) has been emerging as a complementary non-invasive choice of 
investigation. To date, MRI has been operated clinically in compromised 
pregnancies to image abnormal structures that could not be adequately 
visualised using ultrasound or are better visualised by MRI, for example 
abnormalities related to the central nervous system (particularly 
ventriculomegaly), thoracic anomalies, pulmonary malformations, 
gastrointestinal tract and genitourinary system [19; 20; 21]. Furthermore, MRI 
has been employed as a research tool to measure placental blood flow in 
pregnancy complicated by pre-eclampsia and foetal growth restriction [22]. 
MRI is a promising tool in measuring foetal anthropometry, and could potentially 
be used to detect macrosomia. It is a fast imaging modality with an ability to 
obtain images in any orientation with excellent tissue contrast; enabling us to 
differentiate fat from lean body mass accurately [23; 24]. The water and fat 
composition in the body can be differentiated by using water suppression or by 
Tl weighting (as fat has a short TI ). Here, both these techniques were combined 
to obtain a fat-only image. While these techniques were used in this study, there 
are other alternative methods to measure fat in MRI, in particular Dixon's 
method. 
Dixon's method relies on acquiring images at carefully chosen echo times by 
using pixel-by-pixel image algebra to calculate the fat or water only image. The 
basic idea of Dixon is two images are acquired: one at a TE when fat and water 
are in phase and the other when fat and water are out of phase. These two images 
can either be added or subtracted to calculate the water or fat only image, 
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respectively. While this technique seems straightforward, in practice variation in 
static field (Bo), presence of eddy current and susceptibility effects will need to be 
considered along with variation in echo amplitudes. These will possibly give rise 
to shimming problems. 
Studies have previously observed a marked increase in the prevalence of 
macrosomia in diabetic pregnancies [14]. Therefore, in this study, a scanning and 
analysis protocol was developed to estimate foetal fat composition, which would 
potentially allow clinicians to identify foetuses at risk of complicated delivery due 
to the fat distribution. Two approaches were considered: measuring foetal fat 
across the abdomen or across the whole body, with the objective to produce, 
quantify and study foetal adiposity distribution in non-diabetic control and 
diabetic pregnancies. While the protocol and the reliability of the foetal adiposity 
quantification program will be discussed in detail in the next section, readers are 
directed to section 5.2.2 of Chapter 5 for more information about reliability and 
reproducibility tests. 
In addition, data from other secondary in-utero anthropometric measurements 
such as foetal volume, foetal length and shoulder width will also be presented to 
study the effect of maternal diabetes on foetal growth. The hypothesis for this 
study was that the foetal adiposity, foetal volume, foetal length and shoulder 
width would be greater in foetuses of diabetic mothers. 
6.3 Method 
This section is divided into three parts. The first part details the patient 
recruitment criteria, scanning protocol and the technique used to analyse foetal 
adiposity (computational program). The second part details the approach 
undertaken to test the reliability and reproducibility of the techniques used to 
measure foetal adiposity. The final part details the approach taken to measure 
foetal fat volume, foetal volume, foetal length and shoulder width in normal and 
diabetic pregnancies. 
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6.3.1 Recruitment Criteria 
Following Nottingham Research Ethics Committee approval, Dr Ruta Deshpande 
conducted the search for participants with pre-gestational diabetes and non-
diabetic controls. Diabetic participants were first approached by their usual 
clinician who proposed participation in the study, while non-diabetic controls 
were recruited by using posters and leaflets at the Ultrasound Department, 
Queen's Medical Centre (QMC), Nottingham. Only participants aged 18 years or 
over, with a viable singleton pregnancy and registered to deliver at QMC were 
eligible to participate in this study. All the participants were matched for age, 
parity and maternal Body Mass Index (BMI); these details along with ethnicity 
were recorded at the initial recruitment stage. All participants gave informed 
written consent to participate in the study. Participant's height, weight and 
glycated haemoglobin Ale (HbA1c) levels were recorded at each scan session. In 
addition, birth weights and gender of the participants' babies and the gestation 
and mode of delivery were collected following their delivery. In line with the 
hospital policy at the time of recruitment, gestational age was calculated from the 
crown rump length measurement in the first trimester of pregnancy. 
6.3.2 Scanning Protocol 
Prior to MR scans at each visit, ultrasound scans were conducted to measure 
foetal head circumference, abdominal circumference and femur length. FollOWing 
this, the MR scans were performed on a 1.5 Tesla Philips Achieva MRI system 
based on the initial scanning procedure mentioned in section 5.3.2: the patient 
was positioned in the scanner with receiver coil placed between the mother's 
umbilicus and pubic symphysis. 
All women underwent two scans, at 22 - 26 weeks and 33 - 37 weeks. For 
simplicity, these gestational time points will henceforth be referred to as 24 
weeks and 35 weeks gestational age (GA), respectively. All the MR scans 
conducted in this study are with a specific absorption rate of < 2.0 W kg·1• Non-
breath hold HAlf Fourier Single Shot Turbo Spin-Echo (HASTE) and balanced Fast 
Field Echo (bFFE) were applied to acquire images encompassing the whole 
foetus in three orthogonal planes. These images were used to assist in identifying 
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the location and orientation of the foetus. They were also used in measurement of 
the foetal volume, placental volume (which was reported in Chapter 5), foetal 
length and shoulder width. 
The HASTE sequence acquired 123 slices over all three orthogonal 
directions in 147 seconds (TE = 120 ms, flip angle = 90°, 0.78 x 0.78 x 
6.00 mm 3 and FOV = 400 x 300 x 400 mm3) 
The bFFE sequence acquired 130 slices in 167 seconds (TR = 5.8 ms, 
TE = 2.3 ms, flip angle = 70°, 0.78 x 0.78 x 6.00 mm3 and FOV = 400 )( 
300 x 400 mm3) 
The Tl-weighted water suppressed images offat (FAT images) based on chemical 
shifts method were acquired in a breath hold to reduce the effect of foetal motion 
(Figure 6.1). Two sequences were applied. 
Twelve slices were acquired at regular intervals encompassing the 
whole foetus (head to rump) in 13.5 seconds, (TR = 147 ms, TE = 4.6 
ms, 1.875 x 1.875 )( 6.00 mm3, slice gap = 20 mm and FOV = 402 )( 292 
)( 450 mm 3). This sequence will henceforth be referred to as TOTAL 
sequence. 
Twelve contiguous slices were acquired over the foetal abdomen 
(shoulders to rump) in 13.5 seconds (TR = 147 ms, TE = 4.6 ms, 1.875 
x 1.875 x 6.00 mm3, slice gap = 0 mm and FOV = 402 )( 72 )( 450 mm3) 
to allow the subjective assessment of intra-abdominal fat. This 
sequence will henceforth be referred to as ABDO sequence. 
In both cases, the regularly spaced slices were positioned randomly with respect 
to the foetus to allow an unbiased estimate of the fat in the volume of interest. All 
patients were requested to remain as still as possible during these acquisitions to 
avoid motion artefacts. 
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6.3.3 Data Analysis 
6.3.3.1 Foetal Adiposity Quantification Program 
Image Analysis 
The FAT images, acquired using the TOTAL and ABDO sequences, showed foetal 
and maternal fat and little else (Figure 6.1) but the foetal fat distribution was too 
complex to allow manual segmentation. Hence, the fat volume was quantified 
using a semi-automated approach based upon pixel intensity, taking account of 
partial volume effects. 
The FAT images were loaded into GIMP 2.2.13 (GNU Image Manipulation 
Program, www.gimp.org) allowing the observer to draw an approximate 
freehand mask around the foetus to segment the region of interest from the 
maternal fat, as shown in Figure 6.2b. This avoided the results being dominated 
by the maternal fat and reduced the effect of image inhomogeneity (as seen in 
Figure 6.1), which occurred at late gestation when the mother's subcutaneous fat 
was located close to the edge of the transmit coil, or during foetal motion, as seen 
in Figure 6.2a. The mask and images were then loaded into a MATLAB (R2009b, 
The MathWorks fnc, Natick, MA, USA) program written in-house to compute the 
intensity histogram in Nbins (Nbins = 200) within the masked region, which was 
then smoothed (rectangular window of width 5 points). 
Figure 6.1: Image of an MRI acquisition using the FAT protocol of a transverse 
plane through the foetal thorax. Maternal subcutaneous (red arrow) and intra-
abdominal fat can be seen surrounding the pregnancy sac. Foetal fat surrounding 
the foetal abdomen and legs (green arrow) and foetal intra-abdominal fat (yellow 
arrow) can be seen. 
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Figure 6.2: (a) FAT image of a transverse plane through the foetal thorax showing 
intra-abdominal fat around kidney (b) Fat roughly masked around the foetus . (c) 
Fat image after scaling of intensity histogram. 
The resulting histogram (hj ) was bimodal with a large peak corresponding to 
background noise and a smaller second peak for fat voxels. Initially, the large 
background noise peak was removed from the histogram (red line on Figure 6.3) 
and the position of the second peak was established (ipeak, Figure 6.3). Following 
this, a scaling function (blue dashed line on Figure 6.3) was then designed using 
the equation below: 
_(1- 2i .... ] i,... 
S = l-e 2 1 for 2ipeok < j < Nb1ns 
CEq 6.1) 
for 0 < j < 2ipeok 
This scaling factor was designed to suppress noise signal enabling the 
measurement of zero fat in images, which clearly contained no fat. A scaled 
histogram was obtained from the product of the histogram and scaling function 
(black dotted line on Figure 6.3). The masked image was remapped with pixel 
values given by the value in the scaled histogram to give a foetal fat image (Figure 
6.2c). 
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Figure 6.3: Raw histogram of the pixel intensity showing peak due to noise and 
high intensity tail due to foetal fat signal (red solid line); scaling function to 
determine the threshold separating fat and background noise signals (blue 
dashed line - increased scaling by 60) and scaled histogram (black dotted line). 
The Estimated Fat Volume (EFV) was then calculated from the following 
equation: 
Nbins 
EFV=XxYx(Z+G)x .Lhj xS j 
j (Eq 6.2) 
where X, Y and Z are voxel dimensions in mm, and G = slice gap. Subsequently, 
the estimated fat volume was divided by the foetal volume and converted into a 
percentage to compensate for variation in fat volume secondary to foetal size. 
Validity of the Foetal Adiposity Quantification Program 
Prior to the data analysis, the procedure detailed in the image analysis section 
was validated using a phantom. This phantom was made up of 250 ml saline and 
150 ml goose fat placed in a glove that was tied tightly to exclude air bubbles. It 
was placed into a plastic box containing 1600 ml of saline and scanned using the 
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respiratory induced ABDO protocol (figure 6.4). The resulting FAT image was 
analysed using the procedure detailed in the image analysis section, with 
(method 1) and without (method 2) the semi-automated technique. 
Figure 6.4: (a) MRI image of a FAT only scan image from fat phantom (b) Fat only 
image analysed using Foetal Adiposity Quantification Program 
The FAT images were loaded into GIMP 2.2.13, and an approximate freehand 
mask was drawn around the phantom to segment fat as shown in figure 6.4. 
Then, this mask was loaded into the MATLAB program where the fat images were 
analysed to estimate fat volume. In the first method, the semi-automated 
technique described in the image analysis section was employed to segment the 
phantom's fat. The second method required the observer to manually select the 
minimum fat threshold associated with the fat images. Since the resulting 
histogram (hj) was usually bimodal with one large peak corresponding the 
background noise and a second smaller peak for the fat voxels (figure 6.3), the 
observer was requested to manually select the second peak or subsequent peaks 
possibly relating to the fat pixels. This was done to segment the fat images from 
the selected minimum threshold onwards. Then, the estimated fat of the phantom 
from method 1 and method 2 were compared to the actual fat volume of the 
phantom. 
Reliability and Reproducibility of the Foetal Fat Measurement 
Analysed Using the Foetal Adiposity Quantification Program 
A reliability and reproducibility test was conducted on the estimated foetal fat 
measurement computed from the Foetal Adiposity Quantification Program. This 
assessment was conducted with the aim to establish if the measurement errors 
from the test were small enough for the program to be used in a clinical 
environment. It is also an assessment undertaken to check on the validity of the 
Foetal Adiposity Quantification Program. 
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Four observers, who have experience in looking at foetal MRI scans, conducted 
foetal fat measurements: the author (DA), Professor Penny Gowland (PG), Dr Nia 
Wyn Jones (NJ) and Dr Ruta Deshpande (RD). For the purpose of consistency 
throughout the reliability study, the TOTAL data sets obtained from five pregnant 
subjects scanned at 24 weeks and 3S weeks were randomly selected. This was to 
avoid potential bias resulting from the pregnancy conditions and gestational age 
at the date of scan. Each observer repeated the foetal fat measurements twice for 
each data set of all the ten TOTAL data sets. All the analyses were performed 
blind to gestational age, maternal 8MI, diabetic status, complications of 
pregnancy, the other observer results and their own previous measurement 
results. The measurements obtained from the Foetal Adiposity Quantification 
Program were tested for intra and inter-observer reliability using the Statistical 
Package for the Social Sciences (SPSS: Version 17.0; Chicago, IL, USA). 
The distribution of the data obtained from all the individual reliability tests were 
assessed using the Kolmogorov-Smirnov test. The normally distributed results 
were expressed by their mean and standard deviation. Then, the intra-observer 
reliability was assessed by comparing the differences in the two measurements 
made by the same observer for each data set. I nter-observer reliability test was 
assessed by comparing the first measurement of each observer against the first 
measurement of other observers' measurements. The results were studied using 
several indicators: intra-class correlation coefficient (ICC), limit of agreement 
(LOA) and Bland Altman plot. The ICC evaluates the proportion of variance 
between observations attributed to the measurement technique and also reflects 
the variability between subjects. They can be grouped with values less that 0.20 
representing poor correlation, 0.21 - 0.40 fair, 0.41 - 0.60 moderate, 0.61 - 0.80 
good and 0.81 - 1.00 very good correlation [25]. 
The intra-observer limits of agreement were calculated by estimating the mean 
and standard deviation of the difference between two measurements made by 
each observer. It gives a range where 95% of these differences lie within 1.96 
standard deviations of the mean. Once the LOA is calculated, the results are 
graphically illustrated using the Bland Altman plots. The Bland Altman graph 
plots the mean of two measurements on the x-axis and the differences between 
the two measurements on the y-axis (expressed as a percentage of their means in 
this thesis). 
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6.3.3.2 The Application of Foetal Adiposity Quantification 
Program to Study the Effect of Maternal Diabetes on Foetal 
Adiposity 
Following the reliability test, the method described in section 6.3.1.1 was applied 
in conjunction with the Foetal Adiposity Quantification Program to study the 
effect of maternal diabetes on foetal adiposity. The data analysis was conducted 
on all the TOTAL data collected from both diabetic and non-diabetic control 
pregnant women at 24 weeks and 35 weeks gestational age (GA). Again all 
analyses were performed blind to gestational age, maternal 8MI, diabetic status 
and complications of pregnancy. 
6.3.3.3 Intra-abdominal Fat 
In addition to the foetal fat measurement, three observers conducted an intra-
abdominal fat analysis independently: the author, Professor Penny Gowland and 
Dr Ruta Deshpande. This subjective assessment was conducted on the 12 
contiguous slices acquired over the foetal abdomen using the ABDO protocol 
(figure 6.5). Each observer examined whether the images showed evidence of 
intra-abdominal (visceral) fat in the foetus. A score of 2 was given for FAT images 
with definite intra-abdominal fat, a score of 1 for possible and 0 for no intra-
abdominal fat. The predominant score (2 or 3 out of 3 independent observers) 
was taken to represent the existence of intra-abdominal fat in the foetus . 
Figure 6.5: Fat only image of a transverse plane through the foetal thorax: (a) 
Control, (b) Diabetic and (c) Intra-abdominal fat visible around the foetal kidney. 
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6.3.3.4 Foetal Volume 
The MR images acquired using bFFE sequence was used in measuring foetal 
volume. This measurement was conducted by drawing an approximate freehand 
mask around the foetus using Analyze 9.0 (Mayo Clinic, Rochester, MN, USA). 
From the foetal volume measurement, the fat free volume of the foetus is 
computed: foetal volume - foetal fat volume. All the analyses were performed 
blind to gestational age, maternal BMI, diabetic status and complications of 
pregnancy. 
6.3.3.5 Foetal Length and Shoulder Width 
The MRI images acquired using HASTE and bFFE were also used in the 
measurement of foetal length and shoulder width. The foetal length was 
measured as crown to heel distance: the length of the skull (crown to base of the 
brain stem), foetal spine, thigh and lower leg to the heel. Initially, the scans were 
rotated to obtain the best possible coronal view of the head and spinal column. 
Then, the distance from the crown to the coccyx was measured by following the 
curvature of the spine. Occasionally, observer had to make partial measurement 
on separate images from the crown to the base of the lungs and then to the 
coccyx (6 cases at 24 weeks and all cases at 35 weeks). The femur length was 
measured from the hip to the centre of the knee, while the lower leg length was 
measured from the centre of the knee to the heel. The shoulder width was 
determined as the maximum transverse width on the MR images at the level of 
the head of the humerus. The shoulder width measurements were only 
conducted on data collected at 35 weeks. All the measurements were conducted 
using Analyze 9.0; the observer blinded to gestational age, maternal BMI, diabetic 
status and complications of pregnancy. 
6.3.3.6 Foetal Volume Index 
Foetal volume and length information were used to compute the foetal volume 
index, FVI (1 m·3) akin to the ponderal index, PI (kg m·3) used in neonatal practice 
to standardise the foetal size according to length. 
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FVI = Volume x Length-3 
(Eq 6.3) 
PI = Weight x Length-3 
(Eq 6.4) 
The FVI will differ numerically to the PI, since the density of the foetal fat is 
estimated as 0.9 kg 1-1 and the fat free tissue at birth is 1.064 kg 1-1 (lower than in 
adults due to the differences in hydration) [26]. 
6.3.3.7 Statistical Analysis to Study the Effect of Maternal 
Diabetes on Foetal Growth 
The distributions of the measurements obtained from all the individual analyses 
and clinical outcomes were tested for normality using the Kolmogorov-Smirnov 
test in the SPSS software. The normally distributed results were expressed using 
the mean and standard deviation. Then, statistical comparisons between two 
groups at each gestation were performed using an independent samples t-test for 
normally distributed data and a Mann Whitney test for non-parametric data. 
Fisher's exact test was used for comparison of two dichotomous variables with 
small numbers. The statistically significant results were determined by using the 
p-values. For the purpose of this study, the p-values less than 0.05 were 
considered significant. These values were used in studying the effect of maternal 
diabetes on foetal growth by reviewing the results obtained from diabetes and 
control pregnant mothers. 
In addition, correlation statistics were performed to study the relationship 
between MR and clinical measurements. 
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6.4 Results 
6.4.1 Foetal Adiposity Quantification Program 
6.4.1.1 Validity of the Foetal Adiposity Quantification 
Program 
Using the semi-automated method described in the image analysis of section 
6.3.3.1, the Foetal Adiposity Quantification Program measured a fat volume of 
133.01 ml for the fat only phantom. However, without the semi-automated 
approach, where the observer chooses the minimum threshold to estimate fat, 
the Foetal Adiposity Quantification Program measured a fat volume of 144.06 ml 
for the fat only phantom. This calculated volume equates to 88.7% and 96.0% of 
the true fat volume, respectively. 
6.4.1.2 Reliability and Reproducibility of the Foetal Fat 
Measurement Analysed Using the Foetal Adiposity 
Quantification Program 
Four observers analysed ten datasets: five datasets acquired at 24 weeks and five 
datasets acquired at 35 weeks gestation. All the measurements were normally 
distributed. The intra-observer and inter-observer reliability test for estimated 
foetal fat volume produced by the Foetal Adiposity Quantification Program 
demonstrated very good reliability for all four observers at all gestations and at 
35 weeks, with ICC results> 0.99. However, measurement ofthe estimated foetal 
fat volume at 24 weeks demonstrated a slightly poorer reliability. The ICC results 
of intra and inter-observer reliability tests for estimated foetal fat volume are 
given in table 6.1. 
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Gestational Intra-observer ICCs for Estimated Foetal Fat Volume for Four Observers Inter-observer 
Age (95% CI) ICCs for 
Estimated Foetal 
Observer 1 Observer 2 Observer 3 (N/) Observer 4 Fat Volume 
(DA) (PG) (RD) 
All 1.000 0.997 0.998 0.998 0.998 
Gestations (0.999 - 1.000) (0.988 - 0.999) (0.991- 0.999) (0.991- 0.999) (0.996 - 1.000) 
24 weeks 0.985 0.730 0.830 0.681 0.513 
(0.885 - 0.998) (-0.102- (0.169 - 0.980) (-0.117 - (0.087 - 0.917) 
0.968) 0.960) 
35 weeks 1.000 0.992 0.993 0.994 0.996 
(0.897 - 1.000) (0.939 - 0.999) (0.952 - 0.999) (0.953 - 0.999) (0.985 - 1.000) 
Table 6.1: Intra-observer and inter-observer reliability results (ICC) for 
estimated foetal fat volume computed from two measurements made by each 
observer at the two different gestational ages. 
Overall, observer 1 had the best ICCs for the intra and inter-observer reliability 
test compared to the other observers across all gestations. This is also evident 
from observing the narrower LOA for observer 1 compared to other observers in 
the Bland Altman plots for estimated foetal fat volume measurements (figure 
6.6c). While the intra-observer LOA for observer 1 was ± 5% for 35 weeks, this 
reliability was reduced at 24 weeks with LOA closer to ± 300%. Similarly, the 
inter-observer LOA for estimated foetal fat volume were narrower at 35 weeks 
compared to 24 weeks. These LOA results are demonstrated using Bland Altman 
plots in figure 6.6. 
Based on ICC and LOA results, it can be summarised that the reliability of the 
program is better at 35 weeks, when foetal fat is more distinctive. Moreover, at 
35 weeks, there were no bias between observers and clinically acceptable limits 
of agreement were seen. 
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Figure 6.6: Bland Altman plots of estimated foetal fat volume at 24 weeks (a 
and b) and 35 weeks (c and d) . These Bland Altman plots express the intra-
observer (a and c) or inter-observer (b and d) mean percentage differences based 
on measurements made by three observers. The solid lines refer to mean 
percentage differences (1st measurement - 2nd measurement), whereas dashed 
lines refer to LOA between measurements. 
6.4.2 The Effect of Maternal Diabetes on Foetal 
Growth 
6.4.2.1 Study Population 
A total of 26 pregnant women with singleton pregnancies: 14 pre-gestational 
diabetics (13 Type 1 Diabetes and 1 Type 2 Diabetes) and 12 non-diabetic 
controls, matched for age, parity and maternal Body Mass Index (BMI) were 
recruited. There was one smoker in the diabetic group and no smokers in the 
non-diabetic control group. Table 6.2 demonstrates the basic and clinical 
characteristics of the participants of this study. 
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Characteristic Control (n = 12) Diabetes (n = 14) 
Mean SD Range Mean SD Range 
Maternal age 29 4.3 19 - 35 30 4.4 19 - 34 
(years) 
Weight (kg) 71.7 10.8 55 - 94 70.9 10.2 56 - 90 
Height (cm) 164.6 7.0 155 - 180 163.9 5.2 153-173 
BMI 26.3 3.1 20.5 - 31 26.2 3.5 22 - 34 
Parity 0 0.39 0-1 1 0.65 0-2 
Gestational age 40.1 1.5 (37+0) - 37.48 1.33 (35+4) -
at delivery (41 +4) (39+4) 
(weeks + days) 
Birth weight (g) 3418 496 2350 - 4070 3419 641 1800 - 4280 
Table 6.2: Basic and clinical characteristics of participants of this study. 
The Kolmogorov-Smirnov test confirmed normal distribution for all the 
demographic data, with exception to parity, birth weight centiles and HbAlc in 
the first trimester. There was no significant difference in any of the demographic 
characteristics (age, BMI, parity and ethnicity) between groups. The range of the 
gestational ages at the time of scans was 22 - 26 weeks and 33 - 37 weeks. The 
average gestational ages for the scans was 24 weeks + 1 day (SO = 5 days) and 34 
weeks + 4 days (SO = 4 days) in the non-diabetic control group and 24 weeks + 2 
days (SO = 5 days) and 34 weeks + 3 days (SO = 7 days) in the diabetic group. 
Seven pregnant subjects withdrew from the study after their first scan: one 
control pregnant woman (did not attend second scan) and six pregnant women 
with diabetes. The pregnant women with diabetes who withdrew from the study 
were either too big for the magnet bore (one pregnant women), experiencing 
morning sickness when the second scan was due (one pregnant women), 
delivered before the scan (one pregnant women) or failed to attend the second 
scanning session (three pregnant women). However, there were no differences in 
the demographics or delivery outcomes between women who completed the 
study and those who withdrew. 
6.4.2.2 Ultrasound Measurements and Clinical Outcomes 
The foetal abdominal circumference was measured using ultrasound prior to the 
MR scans at 24 weeks and 35 weeks. The mean foetal abdominal circumference 
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at 24 weeks was not significantly different (p = 0.72) for pregnancies complicated 
by diabetes at 19.6 cm (SO = 1.1 cm) compared to controls at 19.4 cm 
(SO = 1.1 cm). However, at 35 weeks, the foetal abdominal circumference was 
significantly larger (p = 0.021) in the diabetes group at 32.6 cm (SO = 2.5 cm) 
compared to controls at 30.7 cm (SO = 0.8 cm), with significantly more babies 
with foetal abdominal circumference above the 95th centile for gestational age (9 
foetuses of diabetic mothers versus 0 foetuses of control mothers; p = 0.001, 
Fisher's exact test). 
The mothers with diabetes delivered their babies at a significantly earlier 
gestation (p < 0.001), 37 weeks + 3 days (SO = 9 days), whereas control mothers 
delivered their babies at 40 weeks + 0 days (SD = 10 days). As for the birth 
weight, there was no significant difference between the two groups with 
p = 0.994. The average birth weight of babies born to pregnant mothers of the 
control group was 3418 g (SD = 496 g) and diabetic group was 3419 g 
(SO = 641 g). However, after correcting for gestational age, babies born to 
mothers with diabetes were significantly larger than controls (median birth 
weight centile 88 for the diabetes group and 33 for the control group; p = 0.009). 
Data also shows that there was a higher number of deliveries by caesarean 
section (CS) in the diabetes group (five emergency and two elective CS in diabetic 
versus one elective CS in control, Fisher's exact test p = 0.036). The caesarean 
sections are indicated in figure 6.7. However, only four CS are labelled in these 
figures since three diabetic (two emergency and one elective CS) and one control 
pregnant (elective CS) woman who underwent CS did not attend a second scan 
session. There was one case of shoulder dystocia in the diabetes group where the 
baby weighed 4200 g at 37 weeks + 1 day. This baby also suffered a fractured 
humerus. Conversely, there was no cases of shoulder dystocia in the control 
group, although one woman sustained a third degree tear while delivering a baby 
weighing 3400 g at 41 weeks + 1 day. 
6.4.2.3 Foetal MR Measurements 
Very little foetal fat (generally less than 2% volume) was observed at 22 - 26 
weeks of gestation. In addition, the measurement of estimated foetal fat volume 
and percentage foetal fat volume is not normally distributed at 24 weeks. For this 
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reason, the statistical analysis of these two measurements across gestation was 
not perform ed. At 35 weeks, mean foetal fat measurements were significantly 
greater (p = 0.009) in foetuses of diabetic mothers at 1090 cm3 (SO = 420 cm3) 
compared to fo etuses of controls 540 cm3 (SO = 350 cm3). The corresponding 
mea n fo etal fat percentages at 35 weeks were significantly higher (p = 0.012) in 
foetuses of diabetic mothers at 40.4% (SO = 11.9%) compared to foetuses of 
controls 22.5% (SO = 13.8%). 
The data showed increased foetal fat volume and percentage foetal fat across 
gestation and to a greater extent in foetuses of diabetic mothers compared to 
controls. Figure 6.7 and 6.8 demonstrates the total foetal fat volume and 
percentage fo etal fat volume across two gestations for foetuses of diabetic and 
control mothers. 
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Figure 6.7: Scatter plot of the difference in foetal fat volume across two gestations 
for foetuses of diabetic and control mothers. Marker lines are added allowing 
comparison of the two measurements for each individual subject. The mean 
value and the standard deviation are also displayed for the two groups on the 
right of the image, [red - diabetic; blue - control; open circles at 2nd time point: 
caesarean delivery] 
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Figure 6.8: Scatter plot of the difference in percentage foetal fat volume across 
two gestations for foetuses of diabetic and control mothers. Marker lines are 
added allowing comparison of the two measurements for each individual subject. 
The mean value and the standard deviation are also displayed for the two groups 
on the right of the image, [red - diabetic; blue - control; open circles at 2nd time 
point: caesarean delivery]. 
It was possible to conduct measurements of foetal volume, foetal length (except 
for one diabetic pregnant women who underwent CS) and shoulder width on all 
scans. All these measurements were normally distributed. Table 6.3 
demonstrates the correlation between all the MR measurements made in this 
study. 
MR Gestations Relationship between MR Measurements, RZ (p) 
Measurements 
Foetal Volume Foetal Length Shoulder Width 
Foetal Fat 24 weeks 0.060 (p = 0.229) 0.173 (p = 0.035) -
35 weeks 0.474 (p = 0.001) 0.303 (p = 0.022) 0.365 (p = 0.006) 
Percentage Foetal 24 weeks 0.024 (p - 0.449) 0.126 (p = 0.075) -
Fat 
35 weeks 0.208 (p = 0.049) 0.130 (p = 0.155) 0.208 (p = 0.050) 
Foetal Volume 24 weeks N/A 0.400 (p - 0.001) -
35 weeks 0.590 (p < 0.001) 0.493 (p = 0.001) 
Foetal Length 24 weeks 0.400 (p = 0.001) N/A -
35 weeks 0.590 (p < 0.001) 0.101 (p = 0.215) 
Table 6.3: Correlation statistics between MR measurements collected for this 
study. 
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Although there was a trend suggesting foetuses of diabetic mothers had greater 
foetal volume at 640 cm3 (SO = 80 cm3) and 2650 cm3 (SO = 470 cm3) compared 
to controls at 620 cm3 (SO = 90 cm3) and 2360 cm3 (SO = 270 cm3) at 24 weeks 
and 35 weeks respectively, this data did not show significant difference 
(p = 0.494 at 24 weeks and p = 0.112 at 35 weeks) between the groups. Similarly, 
the resulting fat free volume of the foetus (foetal volume - foetal fat volume) did 
not demonstrate significant difference between the diabetic and control group. 
However, there was a trend suggesting reduced fat free volume in foetuses of 
diabetic mothers at 1730 cm3 (SO = 340 cm 3) compared to controls at 1760 cm 3 
(SO = 320 cm3) . As expected, there was a significant positive linear correlation 
between the foetal fat volume and percentage foetal fat volume with foetal 
volume at 35 weeks, while poorer non-significant correlations were observed at 
24 weeks . Figure 6.9 demonstrates the foetal volume of foetuses of diabetic and 
control mothers. 
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Figure 6.9: Scatter plot of the difference in foetal volume at two gestations for 
foetuses of diabetic and control mothers. Marker lines are added allowing 
comparison of the two measurements for each individual subject. The mean 
value and the standard deviation are also displayed for the two groups on the 
right of the image, [red - diabetic; blue - control; open circles at 2nd time point: 
caesarean delivery]. 
Similarly, the length of foetuses of diabetic mothers was greater at both time 
points but the data only confirmed this to be significant at 35 weeks (p = 0.625 at 
24 weeks and p = 0.029 at 35 weeks): mean foetal length was 32.9 cm 
(SO = 1.0 cm) and 48.2 cm (SO = 0.9 cm) in the control group and 33.1 cm 
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(SO = 1.1 cm) and 49.6 cm (SO = 1.1 cm) in the diabetic group at 24 weeks and 35 
weeks, respectively. The fo etal length measurements demonstrated significant 
positive correlation to the fo etal fat vol ume and foetal volume at 24 weeks and 35 
weeks. Figure 6.10 demonstrates the foetal length of foetuses of diabetic and 
control mothers. 
In addition. the foetuses ' shoulde r width a t 35 weeks demonstrated a trend to be 
greater in the fo etuses of diabetic mothers at 12.8 cm (SO = 1.8 cm) compared to 
fo etuses from control pregnancies at 11.9 cm (SO = 1.3 cm), but this difference 
was not statis tically significant (p = 0.248) . However. significant positive 
correla tion was seen between shoulder width and foetal fat volume. percentage 
fat volume and foetal volume. 
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Figure 6.10: Scatter plot of the difference in foetal length at two gestations for 
foetuses of diabetic and control mothers. Marker lines are added allowing 
comparison of the two measurements for each individual subject. The mean 
va lue and the standard deviation are also displayed for the two groups on the 
right of the image, [red - diabetic; blue - control; open circles at 2 nd time point: 
caesarean delivery]. 
From the foeta l volume and foetal length measurements, the foetal volume index 
(FVI) was computed. The results demonstrated no significant differences 
(p = 0.624 at 24 weeks and p = 0.866 at 35 weeks) between the two groups with 
values of 17.3 L m-3 (SO = 1.7 L m-3) and 21.2 L m-3 (SO = 2.0 L m-3) in the control 
and 17.7 L m-3 (SO = 2.1 L m-3) and 21.4 L m-3 (SO = 3.1 L m-3) in the diabetic 
group at 24 weeks and 35 weeks, respectively. 
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6.4.2.4 Correlation between Clinical Measurements and 
Foetal MR Measurements 
MR Gestations Relationship of Clinical Measure to MR Measurement. R2 (p) 
Measurements 
Birth Weight HbA1c First HbAlc Third 
Centile trimester trimester 
Foetal Fat 24 weeks 0.012 (p - 0.606) 0.021 (p = 0.620) 
-
35 weeks 0.496 (p = 0.001) - 0.056 (p = 0.609) 
Percentage Foetal 24 weeks 0.015 (p = 0.555) 0.024 (p = 0.600) 
-
Fat 
35 weeks 0.362 (p = 0.008) - 0.092 (p = 0.508) 
Foetal Volume 24 weeks 0.010 (p = 0.634) 0.001 (p = 0.954) 
-
35 weeks 0.559 (p < 0.001) - 0.001 (p = 0.987) 
Foetal Length 24 weeks 0.001 (p - 0.896) 0.018 (p - 0.651) -
35 weeks 0.428 (p = 0.006) - 0.030 (p = 0.742) 
Birth Centile 24 weeks NjA 0.035 (p = 0.520) -
35 weeks - 0.017 (p = 0.671) 
Table 6.4: Relationship between clinical measurements and MR measurements 
collected for this study. 
As expected. there was a significant positive linear correlation between the birth 
weight centile and foetal fat volume, percentage foetal fat, foetal volume and 
foetal length at 35 weeks. However, these relationships were much weaker and 
non-significant at 24 weeks. Indeed there was no significant correlation between 
HbAlc at either time point to any parameter studied. 
At 35 weeks, the single case of shoulder dystocia had one of the highest measured 
foetal fat volumes of all the subjects included in this study and the percentage 
foetal fat was higher than any other subject who delivered vaginally. However, 
the MR measures for this subject at 24 weeks did not appear greater than other 
subjects. In addition, there was one subject in the control group who had foetal 
fat volumes and percentage foetal fat similar to the diabetic macrosomic infants. 
This subject had a normal delivery of a 3520 g female foetus at 39 weeks. This 
baby had not been anticipated to be macrosomic and birth weight was on the 
70th centile. 
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6.4.2.5 Intra-abdominal fat 
The foetal fat images at 24 weeks did not show convincing intra-abdominal fat. 
However, at 35 weeks, the intra-abdominal scores were more defined and 
significantly greater (p = 0.047) in foetuses of diabetic mothers: 6 scored definite, 
1 scored possible and 1 scored zero intra-abdominal fat. In controls, 2 scored 
definite, 6 scored possible and 3 scored zero abdominal fat. At 35 weeks, the fat 
scores showed a significant but weak positive linear correlation with foetal fat 
volume (R2 = 0.349, P = 0.008), percentage fat volume (R2 = 0.317, p = 0.012), 
foetal volume (RZ = 0.244, P = 0.032) and birth centile (R2 = 0.493, P = 0.001). 
6.5 Discussion and Conclusion 
Macrosomia remains a significant obstetric problem that occurs in 6% - 10% of 
all pregnancies [12; 27; 28]. The risk of macrosomia is particularly high in 
pregnancies associated with maternal diabetes, with 50% of babies born to 
mothers with maternal diabetes being above the 90th centile for birth weight [29; 
30]. With increasing birth weight, there is an increasing risk of birth trauma to 
both mother and baby, in particular shoulder dystocia leading to foetal clavicular 
and humeral fractures, brachial nerve palsies and occasionally cerebral hypoxic 
damage [4J. Consequently, the risk of shoulder dystocia is much higher in women 
with diabetes, despite the increased rate of caesarean sections [31J. For this 
reason, it would be ideal to determine and prepare for the delivery of 
macrosomic infants before birth. 
At present, foetal growth during pregnancy is assessed by ultrasound scanning, 
with the risk of macrosomia being related to the foetal abdominal circumference. 
However, although ultrasound is useful in monitoring intra-uterine growth 
retardation, foetal size is often underestimated particularly when the foetus is 
large and the technique is therefore not sensitive in the detection of the 
macrosomic foetus. In contrast to ultrasound, it has been reported that birth 
weight estimation is more accurate using MRI compared to ultrasound for infants 
at term, although no attempt was made to overview foetal fat [32]. Since there 
currently is no validated or accepted method of accurately diagnosing 
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macrosomia antepartum, MR techniques potentially provide an attractive 
development to study foetal anthropometry. 
Foetal MRI represents a non-invasive imaging technique that allows a detailed 
visualisation of the foetus in the utero-maternal environment. It is credited for its 
ability to produce images of foetus in any orientation with excellent soft tissue 
contrast, enabling us to differentiate fat from lean body mass accurately. 
Learning this, Peterson et al. [24] and Deans et al. [23] designed methods to 
measure subcutaneous foetal fat at term to either predict an infant's birth weight 
or assess percentage foetal fat with respect to other foetal tissue. While their 
work was novel, these studies were not quantitative and lacked sensitivity in 
measuring foetal fat. In addition, these studies were only conducted on pregnant 
patients at late gestations (36 weeks - 41 weeks) and thus, failed to observe 
foetal fat at all gestations to compile growth curves. Therefore, TJ weighted water 
suppression scans were designed to measure foetal adiposity in utero at 24 
weeks and 35 weeks. The resulting images clearly showed foetal and maternal fat 
and little else. 
Although there are other alternative methods to measure fat with MRI, in 
particular Dixon's method, Tl weighted water suppression is more advantageous 
in overcoming shimming errors. While shimming is not really a problem in the 
foetus since amniotic fluid ensures that the foetus is well matched to its 
surroundings and the near spherical shape of the uterus ensures a relatively 
homogeneous field within, maternal bowel gas can perturb the local magnetic 
field. In addition, although TJ weighting is not sensitive to shimming effects, it can 
be perturbed by radio frequency pulse errors, especially when the foetus is lying 
away from the isocentre near term. Therefore, the water suppressed TJ weighted 
imaging along with histogram based image analysis (Foetal Adiposity 
Quantification Program) is ideal to minimise this effect. 
The foetal fat volume measured using the Foetal Adiposity Quantification 
Program demonstrated very good intra-observer and inter-observer reliability at 
third trimester and poorer reliability at second trimester, with observer 1 
demonstrating the best ICCs and LOA. This is expected since observer 1 had most 
experience looking at foetal fat images and developed the Foetal Adiposity 
Quantification Program. Nonetheless, the foetal fat measurements made by other 
observers were not too discrepant, suggesting that the reliability could be 
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improved with possible further training. The reliability was poorer at 24 weeks 
because the amount of foetal fat present at this stage was very small. 
In addition, the techniques employed here clearly identify the expected excess 
body fat in the foetuses of mothers with diabetes, which adds to the validity and 
potential clinical utility of this technique. However, the absolute accuracy of the 
fat volumes measured with this method remains unproven since the validity of 
the program was conducted based on a fat only phantom containing a fairly 
irregular block of fat and water. Ideally, the phantom should have included 
distributed fat, bone and other tissue along with saline to possibly create a better 
model of the intra-uterine environment to validate the program. Nevertheless, 
the semi-automated method used here provided a reasonable measure of the 
phantom fat volume, in comparison to the actual phantom fat volume. In 
addition, the measurement from semi-automated method was reasonably good 
with respect to the program requiring user inputs to measure foetal fat volume. 
Besides foetal fat volume measurements, it was also possible to measure foetal 
volume, foetal length and shoulder width from the HASTE and bFFE images 
acquired for this study. These are promising foetal anthropometry measures that 
can potentially be used by a clinician to identify macrosomic foetuses with excess 
fat accumulation. The data shows that there was very little fat present at 24 
weeks, but a considerable quantity was present at 35 weeks (sometimes a litre or 
more). It was also possible to identify intra-abdominal fat in some FAT images at 
35 weeks. 
At 3S weeks, the data demonstrates a significant increase in the foetal fat volume, 
percentage foetal fat, foetal length, abdominal circumference and birth weight 
centiles in the foetuses of diabetic mothers compared to controls. Similar trends 
were noticed in measurements of foetal volume, shoulder width and FVI. The MR 
scans obtained for the current study shows that the foetuses of diabetic mothers 
were of increased size (volume), predominantly due to accelerated fat 
accumulation in the third trimester of pregnancy and not due to increased fat-
free tissue. This was confirmed by a significant positive linear correlation 
between foetal fat volume and percentage foetal fat with foetal volume at 35 
weeks. It is also important to note that there were positive linear correlation 
between foetal fat volume and percentage foetal fat with birth centile and intra-
abdominal fat. However, all these correlations were not strong and even much 
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weaker at 24 weeks, possibly because very little foetal fat is present at 24 weeks 
and the foetuses are much smaller at this stage. 
While the data clearly shows significant increase in the foetal length of foetuses 
of diabetic mothers compared to controls at 35 weeks, this data contradicts the 
large published study by Persson et al. [29] that suggested that maternal diabetes 
does not have an effect on actual foetal length at birth. However, the difference in 
this study was clinically small at, on average, 1.4 cm. In addition, the 
measurement of foetuses shoulder width was higher in the diabetic group 
compared to controls, although the differences were not significant. However, the 
limitation of this study is that it deals with a small number of subjects in 
assessing any possible differences in the foetal length and shoulder width. 
Nonetheless, it is of interest that the foetus with the greatest shoulder width in 
this study is from a pregnancy complicated by diabetes and suffered the 
consequence of shoulder dystocia. 
Foetal length varies conSiderably and has a modulatory influence on the 
interpretation of foetal volume and foetal weight. In this study, the foetal length 
showed a weak positive correlation with foetal volume (R2 = 0.590, P < 0.001) 
and birth centile (R2 = 0.428, P = 0.006). In neonatal practice, ponderaI index 
(weight + height3) is used as an index of foetal adiposity, instead of body mass 
index (weight + height2). However, de Bruin et al. [33] commented on the 
moderate association between ponderal index and fat content in infants, with a 
closer association with weight + height. 
While it is reasonable to assume pregnancies complicated by diabetes might 
provide an initial group to trial the efficacy and accuracy of MR scanning in the 
detection of the macrosomic foetus, it is of interest to correlate the foetal fat 
volume at 35 week to maternal glycaemic control in the third trimester, albeit a 
non-significant very weak correlation (R2 = 0.056, P = 0.609). This contradicts a 
published work that reported a strong positive correlation between foetal 
adiposity and insulin resistance, even with adjustment of potential confounders 
[34]. The results here may be related to the small number included in this study. 
Moreover, it is also clear that the intra-abdominal fat is associated with insulin 
resistance and type II diabetes in adults [35], and at a greater extent in offspring 
of mothers with type II maternal diabetes, a mechanism that cannot be explained 
by a genetic basis alone [36]. In this study, there was a significant detection of 
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foetal intra-abdominal fat in foetuses of diabetic mothers. This observation of 
foetal intra-abdominal fat being more prevalent in foetuses of diabetic mothers is 
in accordance with the concept of the in-utero foetal metabolic programming of 
adults [36]. So, it would be of interest to prove the value of researching the 
pathogenesis of the 'metabolic syndrome' and type II diabetes in infants of the 
diabetic group. While this observation clearly needs confirmation, it suggests that 
the mechanism of foetal programming may be amenable to investigation using 
foetal MRI. 
Some studies have reported that the overall fat distribution in different region of 
body is an important predisposition to aberrancies in lipid and glucose 
metabolism [37]. In addition, central adiposity has been associated with high 
triglyceride levels, low high density lipoprotein levels [38] along with non insulin 
dependent diabetes and glucose intolerance [39]. Therefore, it would be 
interesting to use the ABDO protocol instead of the TOTAL protocol to determine 
the foetal fat volume around the foetal abdominal region. This will potentially 
provide an insight into the future metabolic programming of the infant. However, 
a possible limitation for this imaging technique would be the inconsistency in 
positioning the slab of interest around the foetal abdominal region in foetuses 
that are often lying in any random orientation. 
One limitation of the current study is that foetal length at birth was not 
measured, as this is not current practice in the investigating obstetric unit. 
Therefore, no attempt was made to correlate the MR measures to the gold 
standard foetal length. Moreover, due to this limitation, ponderal index at birth 
could not be computed as an independent index of foetal adiposity. A second 
issue is that the study is conducted with a relatively small number of volunteers. 
However, this study was simply designed as a feasibility study to validate and 
assess the reliability and potential of the technique, and even with these small 
numbers, some indicative findings have emerged. Foetal size is of course only one 
part of the equation in determining possible difficulties at delivery and the risk of 
shoulder dystocia, but MR scans could also be used to determine the anatomy of 
the maternal birth canal. 
This preliminary study has demonstrated that TJ weighted water suppressed MRI 
scans provide a convenient and reliable method for measuring foetal fat volume 
in-utero. The combination of foetal fat volume with foetal volume measurements 
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strengthens the reliability of the present study to allow detection of a 
macrosomic foetus with excess foetal growth due to adipose tissue and may 
assist in the identification of foetuses at risk of birth trauma. This technique 
clearly illustrates the differences in body composition between foetuses of 
mothers with and without diabetes. A larger study is now required to determine 
whether this MR technique can be prospectively used to screen women at 
increased risk of delivering macrosomic infants, in particular pregnant women 
with gestational diabetes. Another promising area for this application is the 
ability to distinguish small foetuses suffering from IUGR from normal foetuses 
considered small for their gestation. 
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Chapter 7 
The Effect of Maternal 
Smoking on Foetal Organ 
Growth 
7.1 Overview 
This chapter starts with a short literature review detailing the effect of maternal 
smoking on foetal growth and the adverse outcome in these pregnancies, 
highlighting the long-term health risks to foetuses exposed to maternal smoking. 
Following these discussions, this chapter will progress to describe the techniques 
applied to acquire, process and estimate foetal organ volumes using MRI 
sequences and two segmentation methods: a semi automatic approach based on 
the concept of edge detection and a stereological method, the Cavalieri technique. 
The author will address the individual method used to measure and statistically 
analyse the effect of maternal smoking on foetal brain, lungs, liver and kidneys 
volumes. In addition, the foetal volume, placental volume, foetal length and 
shoulder width will also be reviewed. The author conducted these measurements 
with the assistance of Alexander Joseph Parker, a medical student at University of 
Aberdeen and Kirsty Allcock, a medical student at the University of Nottingham. 
Finally, the chapter is concluded by a demonstration and discussion of the results 
obtained from analysing the data of both the smoker and control mothers 
involved in this study. 
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7.2 Introduction 
In recent years, data collected through clinical and experimental studies, 
including epidemiologic data, indicates foetal development and the intrauterine 
environment plays an important role in determining one's health later in life [1]. 
Although the foetal development stage is known to be fairly adaptive to exposure 
to adverse environmental conditions, such as maternal smoking, it may affect the 
structure, physiology and function of various organ systems, since human growth 
and development rates are highest during foetal life, when essential foetal organs 
are being developed [2]. This may lead to foetal growth restriction and increased 
the risk of metabolic and cardiovascular diseases during childhood and 
adulthood [3; 4]. 
For decades, both the United States of America and Great Britain have been 
continuously admonishing the adverse effects of maternal cigarette smoking 
during pregnancy through the media and counter-advertising. Although these 
public health campaigns have successfully persuaded 20% of pregnant women to 
quit smoking before the initial prenatal visit, approximately 15% - 20% of 
pregnant women still continue to smoke [5; 6; 7). Moreover, smoking habits are 
growing among women who are of childbearing age, pregnant and breastfeeding 
[6; 8; 9]. 
Prenatal exposure to maternal cigarette smoking (PEMCS) is associated with 
miscarriage, gestational bleeding, placental abruption, placenta praevia, sudden 
infant death syndrome (SIDS) and respiratory disorders [10; 11; 12; 13]. In 
addition, follow up studies of children exposed to maternal smoking in utero 
show evidence suggesting an increased incidence of psychiatric disorders, 
behavioural problems and neonatal altered auditory responsiveness [14; 15; 16]. 
Recent studies conducted on children born to smoking and non-smoking 
mothers, demonstrated poorer performance on cognitive tasks and language 
development among children of smoking mothers [17; 18; 19]. There was also 
evidence of attention deficit hyperactivity [20]. 
Furthermore, PEMCS is also known to be a major risk factor for intrauterine 
growth restriction (IUGR) and small for gestational age (SGA) [12; 21; 22; 23). 
The exposed infants are often at risk of perinatal mortality and reduced birth 
weight [23; 24; 25; 26]. These individuals born smaller at birth are usually of 
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decreased fat free mass [27]. However, they are categorised as a high-risk group 
for obesity and obesity-associated disorders such as cardiovascular problems 
and diabetes, during childhood and adolescence [28; 29; 30]. 
Cigarette smoke contains thousands of different compounds that may be harmful 
to the human body. Nicotine and carbon monoxide have been identified as two 
major compounds that may have harmful effects on the developing foetus during 
pregnancy. They cross the placenta and can be detected in the foetal circulation, 
amniotic fluid and breast milk of smoking mothers. There is evidence of an 
increased concentration of nicotine and carbon monoxide in the foetal 
circulation; which exceed the maternal concentration by 15% [31; 32]. In 
addition, studies have shown an increased concentration of nicotine within the 
amniotic fluid, which is 88% higher than maternal plasma [5; 32]. 
Nicotine is an active element that has a half-life of 1 to 2 hours. It can be 
metabolised into many different compounds by the liver and is eliminated by the 
kidney. One of the major metabolites is cotinine, which is excreted with a half-life 
of 15 to 20 hours [33]. Nicotine can affect the foetus in many ways: (a) maternally 
inhaled nicotine induces vasoconstriction of the uteroplacental vasculature, 
subsequently leading to uteroplacental under-perfusion which can result in a 
reduction in nutrient and oxygen flow to the foetus causing a decrease in foetal 
heart rate and an increase in mean arterial pressure; [34] (b) nicotine suppresses 
the mother's appetite, leading to poor nutrition and energy intake and results in 
reducing the energy supply to the foetus; and (c) nicotine causes alterations in 
the cellular growth and activity of the central and peripheral nervous system [14; 
35]. 
Conversely, carbon monoxide binds with haemoglobin to form 
carboxyhaemoglobin that leads to depletion in the level of oxygen supplied for 
foetal tissue oxygenation, causing hypoxia-ischemia. Recent studies in animal 
models demonstrate evidence of ischaemic injury in the foetal lungs, liver, 
kidneys and placenta. It is suggested that the intracellular damage is secondary to 
an increase in the production of oxygen-derived free radicals in the reperfused 
hypoxic tissues [36; 37]. Moreover, there is published work suggesting maternal 
smoking decreases foetal lung and liver volume [38], as well as kidney weight 
(rat studies) [39]. It also causes foetal resorption and brain cell damage in 
offspring exposed to nicotine [35; 40; 41; 42]. There is also evidence of reduced 
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perfusion in the placenta of women who smoke [43; 44; 45], possibly because of 
reduced capillary volume fraction and increased thickness of villous membranes 
in the placental tissues of smokers, increasing the resistance within the placenta 
that decreases uterine blood flow [43; 46]. For all these reasons, clinicians should 
promote smoking cessation and educate pregnant patients on the adverse effects 
of smoking to prenatal and perinatal outcomes [5]. 
In this study, Magnetic Resonance Imaging (MRI) was used to investigate the 
effect of maternal smoking on foetal growth restriction having previously learnt 
of its ability to produce detailed visualisation of foetus in utero and maternal 
structures, including the birth cavity. Moreover, echo planar imaging has been 
used to estimate foetal volume and foetal organ volume [47; 48]. It has also been 
possible to use MRI to study growth patterns of the foetal brain, lungs and liver 
[49]. The motivation for this study originated from a lack of published studies 
investigating the effect of maternal smoking on foetal organ growth in human 
subjects. Here, a description of methods used to acquire, process and statistically 
analyse the data of foetal brain, lungs, liver and kidneys is presented. In addition, 
the measurements of foetal volume, placental volume, foetal length and shoulder 
width in both exposed and non-exposed infants is presented. These data are used 
in evaluating foetal growth from the second to the third trimester. The 
hypothesis for this study was that the foetal organ volume, foetal and placental 
volume, foetal length and shoulder width would be reduced in foetuses exposed 
to maternal smoking. In addition, a further hypothesis was made that the major 
effect would be on the brain and kidney volume. 
7.3 Method 
7.3.1 Recruitment Criteria 
Following Nottingham Research Ethics Committee approval, Dr Nia Wyn Jones 
conducted the search for smoking and non-smoking pregnant participants by 
using posters and leaflets at the Ultrasound Department, Queen's Medical Centre 
(QMC), Nottingham. Only participants aged 18 years or over, with a viable 
Singleton pregnancy with maternal Body Mass Index (BMI) less than 3S and 
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registered to deliver at QMC were eligible to participate in this study. All the 
participants were matched for age, parity, maternal BMI and education level (not 
reported here); these details along with ethnicity were recorded at the initial 
recruitment stage. All participants gave informed written consent to participate 
in the study. Participant's height and weight were recorded at each scan session. 
In addition, birth weights and sex of the participants' babies and the gestation 
and mode of delivery were collected following their delivery. For simplicity, 
foetuses exposed to maternal smoking will be referred to as the exposed group 
and foetuses of control mothers will be referred to as the non-exposed group. 
7.3.2 Scanning Protocol 
Prior to MR scans at each visit, ultrasound scans were conducted to measure 
foetal head circumference, abdominal circumference and femur length. Following 
this, the MR scans were performed on a 1.5 Tesla Philips Achieva MRI system 
based on the initial scanning procedure mentioned in section 5.3.2: the patient 
was positioned in the scanner with receiver coil placed between the mother's 
umbilicus and pubic symphysis. 
In line with the hospital policy at the time of recruitment (which was earlier than 
the diabetic study), the gestational age was calculated from the last menstrual 
period and confirmed at 13 weeks of gestation by using Crown Rump Length 
(CRL) measurements. All women underwent two scans, at two time pOints of 22 -
27 weeks and 33 - 38 weeks. For simplicity, these gestational time pOints will 
henceforth be referred to as 25 weeks and 36 weeks gestational age (GA), 
respectively. 
Non-breath hold HAlf Fourier Single Shot Turbo Spin-Echo (HASTE) and 
Balanced Fast Field Echo (bFFE) were applied to acquire images encompassing 
the whole foetus in three orthogonal blocks (figure 7.1) without a breath hold to 
allow for motion effects to be averaged out. All these scans were conducted with 
a specific absorption rate of < 2.0 W kg· t • 
The HASTE sequence acquired 123 slices over all three orthogonal 
directions in 147 seconds (TE = 120 ms, flip angle = 90°, 0.78 )( 0.78 )( 
6.00 mm3 and FOV = 400 )( 300 x 400 mm3) 
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The bFFE sequence acquired 130 slices in 167 seconds (TR = 5.8 ms, 
TE = 2.3 ms, fl ip angle = 70°, 0.78 x 0.78 x 6.00 mm3 and FOV = 400 x 
300 x 400 mm3) 
To study the brain, three high resolution HASTE were applied in 
transverse, sagittal and coronal planes (HASTEbrain, 34 slices in 35.8 
seconds, TE = 120 ms and 0.59 x 0.59 x 4.50 mm3 voxels) 
Figure 7.2 shows the MR images of a foetus acquired using HASTE, bFFE and 
HASTEbrain sequence in a sagittal plane. Patients were also requested to remain 
as still as possible during th ese acquisitions to avoid motion artefacts. 
Figure 7.1 : Magnetic Resonance Images through foetus (HASTEbrain sequences): 
(a) Sagittal plane; (b) Coronal plane and (c) Transverse plane 
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Figure 7.2: MR images acquired in sagittal plane using (a) HASTE, (b) bFFE and 
(c) HASTEbrain sequences. 
7.3.3 Data Analysis 
7.3.3.1 Foetal Organ, Placenta and Foetal Volume 
The resulting images (Figure 7.3) showed clear delineation of foetal organs in the 
maternal womb. Two approaches were employed to measure foetal organ 
volumes, placental volume and foetal volume: a semi automatic segmentation 
method using an image processing software, Analyze 9.0 (Mayo Clinic, Rochester, 
MN, USA) for regular shaped objects and a stereological method, the Cavalieri 
technique using EasyMeasure software (University of Liverpool, Liverpool, UK) 
for less regular objects. In both cases, the region of interest for all the organs 
were defined in each slice and the total organ volumes were computed by 
multiplying the area of the organ summed over all slices by the slice thickness. 
Figure 7.3: MR Image through foetus (HASTEbrain sequences) in sagittal plane. 
The image clearly shows foetal brain, lung, liver, kidney and placenta. 
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The semi automatic approach is based on the concept of edge detection. In this 
technique, the observer initially places the cursor on the image at any point on 
the edge that needs to be traced. Then, the cursor is dragged around the 
approximate boundary of the target organ; the program will detect edges of 
similar contrast to the initial point, snapping the line to the best estimate of the 
boundary to define a region of interest. This method reduces inter-observer 
variability due to inconsistent human interference. The semi automatic approach 
was employed in measuring the volumes of foetal kidneys and lungs on at least 
two sets of images. Measurements were generally conducted in the coronal and 
sagittal planes of HASTEbrain for foetal lungs and bFFE for foetal kidneys. In 
addition, the semi automatic approach was also employed in measuring foetal 
volume and placental volume by drawing mask around the foetus and placenta 
on bFFE images. In all these measurements, HASTEbody was used if HASTEbrain 
and bFFE data sets were affected by significant artefact (generally motion or 
image non-uniformity artefacts). 
The Cavalieri technique is a stereological method based on a set of parallel, 
systematic plane sections that are separated at a known distance apart. A grid is 
superimposed on the image and the volume can be estimated by selecting points 
lying on the region of interest in the image. Then, the volume of the region of 
interest in that slice is estimated by multiplying the fraction of points within the 
area of interest by the total area of the whole image [50]. Here, the Cavalieri 
technique with a 20 x 20 pixels grid along with point counting techniques was 
employed to measure the volumes of the foetal liver and brain in three 
orientations of the HASTEbrain images [51; 52]. These measurements were 
conducted using the EasyMeasure software [53]. The Cavalieri technique was 
chosen as the method of segmentation of the brain and liver due to the 
inconsistent shape and pattern of folding in various areas of the brain, while the 
contrast of the liver was generally qUite poor on MR images (darker organ), 
making segmentation using the edge detection method too difficult. 
The estimated organ volumes were also divided by the foetal volume and 
converted into a percentage to compensate for variation in organ volume 
secondary to foetal size, irrespective of gestational age, sex and maternal 
complication. 
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7.3.3.2 Foetal Length and Shoulder Width 
The foetal length and shoulder width were measured at 2S weeks and 36 weeks 
using the method described in section 6.3.3.5. All the measurements were 
conducted using Analyze 9.0; the observer blinded to gestational age, maternal 
BMI, smoking status and complications of pregnancy. 
7.3.3.3 Statistical Analysis to Study the Effect of Maternal 
Smoking on Foetal Growth 
The distributions of the measurements obtained from all the individual analyses 
were tested for normality using the Kolmogorov-Smirnov test in the SPSS 
software. The normally distributed results were expressed by their mean and 
standard deviation. Then, the clinical outcomes and ultrasound measurements 
were compared between groups at each gestational age using an independent t-
test for normally distributed data and a Mann Whitney test for non-parametric 
data. Subsequently, statistical comparison was performed using the repeated 
measures analysis of variance (ANOVA) to assess the changes in the foetal organ 
volumes, foetal and placental volume, foetal length and shoulder width between 
the two groups (smokers and controls) across two separate time points. The 
results were presented as a ratio of variation explained by the model to 
unexplained factors. The statistically significant results were determined by 
using the p-values. To counteract the potential problem of multiple comparisons, 
a post hoc Bonferroni correction was applied. The correction was made based on 
n dependent or independent hypotheses on the data of foetal organ volumes, 
foetal and placental volume, foetal length and shoulder width. The Bonferroni 
correction is one way of checking for probability of making one or more false 
discoveries (familywise error rate). Each individual statistical significance was 
corrected ~ times and checked if the statistical hypotheses for maternal smoking 
n 
effects persisted for individual measurements. For the purpose of this study, p-
values less than 0.05 after application of the Bonferroni correction were 
considered significant. 
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7.4 Results 
7.4.1 The Effect of Maternal Smoking on Foetal 
Growth 
7.4.1.1 Study Population 
A total of 18 healthy pregnant women with a singleton pregnancy, 10 smokers 
and 8 controls, matched for age, parity and maternal Body Mass Index (BMI) 
were recruited. Table 7.1 demonstrates the basic and clinical characteristics of 
the participants of this study. 
Characteristic Normal (n = 8) Smoker (n = 10) 
Mean SD Range Mean SD Range 
Maternal age 29.5 4.9 20 - 36 24.7 4.2 18 - 29 
(years) 
Weight (kg) 71.1 11.2 59 - 92 65.9 13.8 48 - 88 
Height (cm) 167.5 6.5 157-176 166.4 4.1 160 - 175 
BM. 24.5 3.7 23 - 30 23.4 5.5 17 - 33 
Parity 0.5 0.8 0-2 1.2 1.2 0-3 
Gestational age 39.9 1.4 (37+2) - (41+6) 39.6 1.0 (37+5) -
at delivery (41+4) 
(weeks + days) 
Birth weight (g) 3586 485 2880 - 4220 3005 542 2500 - 4140 
Table 7.1: Basic and clinical characteristics of participants of this study. 
The Kolmogorov-Smirnov test confirmed a normal distribution for all the 
demographic data, with the exception of height, parity and gestational age at 
delivery. There was no significant difference in any of the demographic 
characteristics (BMI, parity and ethnicity) between groups. The range of the 
gestational ages at the time of scans was 22 - 27 weeks and 33 - 38 weeks. The 
average gestational ages for the scans were 24 weeks + 5 day (SO = 6 days) and 
36 weeks + 0 days (SO = 8 days) in the control group and 24 weeks + 0 days 
(SO = 5 days) and 35 weeks + 2 days (SO = 6 days) in the smoker group. These 
differences in gestational ages between groups were not statistically significant 
at 25 (p = 0.075) or 36 weeks (p = 0.122). 
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7.4.1.2 Ultrasound Measurements and Clinical Outcomes 
The foetal head and abdominal circumference along with femur length were 
measured using ultrasound prior to the MR scans at 25 weeks and 36 weeks. The 
mean foetal head circumference (FHC) at 25 weeks was significantly smaller 
(p = 0.05) in exposed foetuses at 21.9 cm (SO = 0.9 cm) compared to the non-
exposed at 22.7 cm (SO = 0.6 cm). Similarly, at 36 weeks, the mean FHC was 
significantly smaller (p = 0.031) in the exposed group at 31.2 cm (SO = 0.9 cm) 
compared to the non-exposed group at 32.8 cm (SO = 1.8 cm). Figure 7.4 (a) 
demonstrates the foetal head circumference of exposed and non-exposed 
foetuses at two gestations. 
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Figure 7.4: Scatter plot of the difference in foetal (a) head circumference and (b) 
abdominal circumference across two gestations for exposed and non-exposed 
foetuses. Marker lines are added allowing comparison of the two measurements 
for each individual subject. The mean value and the standard deviation are also 
displayed for the two groups on the left and right of the image, [red - non-
exposed foetuses; blue - exposed foetuses). 
The mean foetal abdominal circumference (FAC) at 25 weeks was significantly 
smaller (p = 0.025) in exposed foetuses at 18.8 cm (SO = 1.2 cm), compared to the 
non-exposed foetuses at 20.3 cm (SO = 1.3 cm). A similar significant trend was 
observed at 36 weeks (p = 0.006): mean FAC of exposed foetuses was 30.1 cm 
(SO = 0.6 cm) and non-exposed was 32.2 cm (SO = 1.9 cm). Figure 7.4 (b) 
demonstrates the foetal abdominal circumference of exposed and non-exposed 
foetuses at two gestations. 
At 25 weeks, the femur lengths were significantly smaller (p = 0.006) in exposed 
foetuses at 4.2 cm (SO = 0.2 cm) compared to the non-exposed at 4.6 cm 
(SO = 0.2 cm). However, at 36 weeks, there were no significant differences 
(p = 0.112) in femur length of exposed and non-exposed at 6.7 cm (SO = 0.2 cm) 
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and 7.0 cm (SO = 0.5 cm), respectively. Figure 7.5 demonstrates the femur length 
of exposed and non-exposed foetuses at two gestations. 
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Figure 7.5: Scatter plot of the difference in foetal femur length across two 
gestations for exposed and non-exposed foetuses. Marker lines are added 
allowing comparison of the two measurements for each individual subject. The 
mean value and the standard deviation are also displayed for the two groups on 
the left and right of the image, [red - non-exposed foetuses; blue - exposed 
foetuses]. 
As for birth weight, exposed infants were significantly smaller (p = 0.031) at 
3000 g (SO = 540 g) compared to the non-exposed infants at 3590 g (SD = 490 g). 
However, there was no significant difference (p = 0.651) in the average 
gestational age at delivery, with exposed foetuses delivered at 39 weeks + 4 days 
(SD = 7 days), while non-exposed foetuses were delivered at 39 weeks + 6 days 
(SO = 10 days) . 
7.4.1.3 Foetal MR Measurements 
It was possible to conduct measurements of organ volumes (brain, lungs and 
kidneys), placental volume, shoulder width, foetal volume and length using the 
data acquired from all the participants of this study. However, it was not possible 
to measure liver volume using the data acquired from all the participants of this 
study. Since foetal organ measurements (brain, lungs, liver and kidneys) were 
conducted on at least two sets of images, these measurements for each organ 
were averaged; the individual measurements varied by approximately 0% - 11 % 
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of the mean across all foetuses. All these measurements were normally 
distributed. 
As expected, the MR measurements confirmed that all the organ volumes (brain, 
lungs, liver and kidneys), foetal volume and foetal length increased significantly 
across gestation. Significant differences were also seen for these parameters 
between the two groups, with exposed foetuses demonstrating significantly 
lower measurements compared to non-exposed foetuses. Conversely, although 
the placental volume and shoulder width measurements demonstrated a 
significant increase across gestations, there was no significant difference 
between exposed and non-exposed groups. Only two measurements, kidney and 
foetal volume demonstrated a significant interaction between gestation and 
group, with the measurements significantly lower in the exposed group 
compared to non-exposed group. 
The average value for all the measurements made on exposed and non-exposed 
foetuses across the two gestations is demonstrated in table 7.2. This table also 
contains the p-values obtained from statistical comparison performed using 
repeated measures analysis of variance (ANOVA). These values provide 
information on the effect of maternal smoking at each gestation and group for 
foetal organ growth, foetal growth and placental growth. 
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Measurements Group 25 weeks 36 weeks p-value 
Mean ± SD Mean ± SD Gestation Gestation Group 
and Group 
Brain Volume Smoker 65.4 ± 7.9 242.2 ± 18.8 < 0.001' 0.134 0.001' 
(em3) 
Control 81.2 ± 14.0 282.8 ± 39.5 
Lung Volume Smoker 33.8 ± 4.7 95.4 ± 19.3 < 0.001* 0.159 0.002' 
(em3) Control 46.8 ± 7.8 124.4 ± 25.6 
Liver Volume Smoker 52.0 ± 8.7 189.7 ± 34.1 <0.001' 0.076 0.035' 
(em') Control 60.7 ± 9.4 212.6 ± 60.4 
Kidney Volume Smoker 12.9 ± 4.5 32.4 ± 9.1 < 0.001* 0.004' 0.001' 
(em3) 
Control 19.4 ± 3.8 51.0±10.2 
Foetal Volume Smoker 569.9 ± 88.6 2186.5 ± 156.3 <0.001" 0.004' 0.001' 
(em3) 
Control 749.3 ± 105.5 2890.7 ± 440.7 
Placenta Smoker 317.9 ± 127.0 759.0 ± 177.8 < 0.001* 0.690 0.118 
Volume (em3) 
Control 422.6 ± 111.6 823.7 ± 169.6 
Shoulder Smoker 7.1 ± 0.8 
Width 
11.0 ± 1.0 < 0.001* 0.431 0.290 
(em) Control 7.3 ± 0.5 11.8 ± 1.2 
Foetal Length Smoker 32.1 ± 1.6 47.4 ± 1.9 < 0.001' 0.646 O.OOZ· (em) 
Control 35.Z ± 2.0 49.7 ± 1.9 
Table 7.2: The mean measurement and standard deviation for absolute organ 
volumes (brain, lungs, liver and kidneys), placental volume, shoulder width, 
foetal volume and length at 25 weeks and 36 weeks. Comparisons are made using 
repeated measures ANOVA with the Bonferroni correction applied across ROIs. 
(Note: * indicates statistically Significant p-values.) 
Figure 7.6 and 7.7 demonstrates the effect of maternal smoking on foetal organ 
volumes (brain, lungs, liver and kidneys), while figure 7.8 and 7.9 demonstrates 
the effect of maternal smoking on foetal volume, placental volume, foetal length 
and shoulder width at two gestations. 
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Figure 7.6: Scatter plot of the difference in foetal organ volumes: (a) brain, (b) 
lungs, (c) liver and (d) kidneys for exposed and non-exposed foetuses across two 
gestations. Marker lines are added allowing comparison of the two 
measurements for each individual subject. The mean value and the standard 
deviation are also displayed for the two groups on the left and right of the image, 
[red - non-exposed foetuses; blue - exposed foetuses]. 
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Figure 7.7: Boxplots of the effect of maternal smoking on foetal organ volumes: 
the mean and standard deviation of the brain, lungs, liver, and kidneys volume 
for exposed and non-exposed foetuses at 25 weeks and 36 weeks are plotted 
separately. 
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Figure 7.8: Scatter plot ofthe difference in (a) foetal volume, (b) placental 
volume, (c) foetal length and (b) shoulder width for exposed and non-exposed 
foetuses across two gestations. Marker lines are added allowing comparison of 
the two measurements for each individual subject. The mean value and the 
standard deviation are also displayed for the two groups on the left and right of 
the image, [red - non-exposed foetuses; blue - exposed foetuses]. 
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Figure 7.9: Boxplots of the effect of maternal smoking on foetal volume, .pl~cental 
volume, foetal length and shoulder width. The mean and standard deViatIOn of 
each individual measurement for exposed and non-exposed foetuses at 25 weeks 
and 36 weeks are plotted separately. 
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After correcting the foetal organ volume measurements (brain, lungs, liver and 
kidneys) to foetal volume at each gestation, it was confirmed that the data were 
normally distributed. The data showed that the percentage brain volume was 
significantly higher in the exposed foetuses (11.1 ± 1.1%) compared to non-
exposed foetuses (9.8 ± 1.1%) at 36 weeks (p = 0.027). Other data did not show 
any significant difference in the percentage organ volumes between the exposed 
and non-exposed foetuses at 25 weeks or 36 weeks. However, there was a trend 
suggesting a decrease in the percentage organ volume across gestation. Table 7.3 
contains the average and standard deviation of the percentage organ volumes 
(brain, lungs, liver and kidneys) and p-values obtained from statistical 
comparison at each gestation using an unpaired t-test. Figure 7.10 and 7.11 
demonstrates the effect of maternal smoking on percentage foetal organ volumes 
(brain, lungs, liver and kidneys) at the two gestations. 
Percentage Organ Group 25 weeks 36 weeks p-values oft-test at Volumes (%) 
each gestation 
Mean ± SO Mean ± SO 25 weeks 36 weeks 
Percentage Brain Smoker 11.8 ± 1.1 11.1 ± 1.1 0.113 0.027* Volume (%) 
Control 10.8 ± 0.8 9.8 ± 1.1 
Percentage Lung Smoker 6.0 ± 0.8 4.4 ± 0.7 0.468 0.900 Volume (%) Control 6.3 ± 1.0 4.3 ± 0.6 
Percentage Liver Smoker 9.2 ± 1.2 8.6 ± 1.5 0.229 0.315 
Volume (%) Control 8.4 ± 1.2 7.7 ± 1.9 
Percentage Kidney Smoker 2.3 ± 0.6 1.5 ± 0.3 0.184 0.084 
Volume (%) Control 2.9 ± 0.3 1.8 ± 0.5 
Table 7.3: The man measurement, standard deviation and p-values obtained from 
statistical comparison for percentage organ volumes (brain, lungs, liver and 
kidneys) at 25 weeks and 36 weeks. (Note: * indicates statistically Significant p_ 
values.) 
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Figure 7.10: Scatter plot of the difference in foetal organ volumes: (a) brain, (b) 
lungs, (c) liver and (d) kidneys for exposed and non-exposed foetuses across two 
gestations_ Marker lines are added allowing comparison of the two 
measurements for each individual subject. The mean value and the standard 
devia tion are also displayed for the two groups on the left and right of the image, 
[red - non-exposed foetuses; blue - exposed foetuses]. 
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Figure 7.11: Boxplots of the effect of maternal smoking on percentage foetal 
organ volumes: the mean and standard deviation of the brain, lungs, liver, and 
kidneys volume for exposed and non-exposed foetuses at 25 weeks and 36 weeks 
are plotted separately. 
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MRI has been emerging as a complementary non-invasive imaging technique that 
allows a detailed visualisation of foetus in utero. With this ability and the advent 
of fast imaging sequences, MRI is playing an increasingly important role in 
diagnosing foetal abnormalities [54; 55; 56; 57]. Moreover, it has also been 
possible to study growth patterns of the foetal brain, lungs and liver using echo 
planar imaging [47; 48; 49]. With this knowledge, MR imaging was employed 
here to study the effect of PEMCS on foetal organ growth and foetal volume. 
The MR images obtained for this study clearly illustrate the foetal organs and 
placenta in the maternal uterus. However, there was a small sample set that was 
significantly affected by artefacts (generally motion or image non-uniformity 
artefacts); whilst it was always possible to measure organ volumes on other 
HASTE or bFFE images in such cases, there will have been some errors in the 
final results. In addition, even though MRI techniques are robust in acquiring 
anatomical images, foetal imaging is more challenging with unpredictable foetal 
positions and some foetal parts can lie outside the selected field of view of the MR 
image (especially at third trimester). However, this was overcome by effectively 
oversampling and routinely acquiring repeated data in different orientations. 
Measurements of each organ were made on at least two planes (sagittal, coronal 
or transverse), with the individual averaged measurements for each organ 
varying by approximately 0% - 11 %. 
There were a few limitations in the edge detection and Cavalieri techniques used 
in estimating foetal organ volume. The edge detection technique involved 
dragging a cursor around the approximate boundary of the target organ and 
edges with similar contrast to the initial point would be detected and defined as 
the ROJ. Although this was reasonably straight forward, boundary detection 
could be difficult in images of organs with reduced contrast (liver) or irregular 
shaped organs (brain). While this problem was overcome by using the Cavalieri 
technique, the stereology method can be tricky since observers need to decide 
how to assign points at the organ boundaries. 
The results from the present study demonstrate that PEMCS affects the growth of 
the foetus. In general, the ultrasound data demonstrated that the head 
circumference and abdominal circumference of exposed foetuses were 
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significantly lower compared to non-exposed foetuses at 25 weeks and 36 weeks. 
A similar trend was observed for femur length, where exposed foetuses had 
shorter femur lengths compared to non-exposed foetuses. However, the data only 
showed a significant difference between the groups at 25 weeks. These data 
contradict previous published work, which suggests PEMCS has a greater effect 
on peripheral tissues; where the significant decrease seen in the femur length of 
exposed foetuses at mid-pregnancy persisted across gestation [58]. Our data may 
be affected by the trend for the exposed group to have been scanned earlier than 
the non-exposed group, although statistical analysis failed to demonstrate a 
significant difference in the timing of the MR scans. 
In addition, the birth weights of exposed foetuses were significantly lower 
compared to non-exposed foetuses. This study confirms that smoking during 
pregnancy increases the risk of low birth weight. Other studies investigating the 
effect of passive and active smoking during pregnancy have proposed foetal 
weight reduction is secondary to a decrease in fat free mass [27; 59; 60; 61; 62]. 
Ideally, this can be investigated in future using the techniques described in 
Chapter 6. In addition, it has been reported that PEMCS enhances the risk of low 
birth weight in infants of twin pregnancies [63]. However, as expected studies 
have proposed that infant's birth weight can be improved by reducing the level of 
exposure (less than 8 cigarettes per day) [64]. 
Correspondingly, although the MR measurements suggest that the foetal volume 
and length increases significantly across gestation in both groups, the exposed 
foetuses demonstrated a significantly reduced foetal volume and length 
compared to non-exposed foetuses at both gestations. These data suggest that 
foetuses exposed to maternal smoking are at risk of being small for gestational 
age. This agrees with the work of Mitchell et al. [22] and Fortier et al. [65], which 
independently proposed that PEMCS increases the risk of delivering babies who 
are small for gestational age. In addition, despite a trend suggesting that foetal 
shoulder widths were reduced in foetuses of the exposed group, this data did not 
demonstrate significant difference between the exposed and non-exposed 
groups. 
While foetal organ volumes increase across gestation, the data show that PEMCS 
has a negative effect on foetal organ volumes. Here, the exposed foetuses had 
significantly lower absolute brain, lungs, liver and kidneys volumes compared to 
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non-exposed foetuses. When the organ volumes were corrected to foetal volume, 
the percentage volume of brain, lungs, liver and kidneys demonstrated a decrease 
across gestation. This is understandable since foetal organs are expected to grow 
with the foetal size at each gestation. In addition, at 36 weeks, the data showed a 
significantly lower percentage of brain volume in foetuses not exposed to 
maternal smoking. This may indicate that although absolute brain volume 
measurements are reduced, brain size and growth is relatively preserved 
compared to other organ volumes in the exposed group and reflected by the 
higher percentage brain volume. 
The data suggest that PEMCS predominantly affects the growth of the foetal 
kidney; with absolute kidney volume significantly reduced in foetuses exposed to 
maternal smoking. This result is supported by findings presented by Pausova et 
al. [39] that documented a decrease in the kidney weight in pups of pregnant rats 
exposed to nicotine. Similarly, it is reported that there is a positive association 
between kidney malformation and maternal smoking [66]. Whilst the interaction 
of carbon dioxide and nicotine in kidney organogenesis is not clear, maternal 
smoking can cause disturbances in the interaction between the ureteric bud and 
the metanephric mesenchyme. Moreover, numerous immature renal corpuscles 
have been observed in foetuses exposed to maternal smoking, suggesting a 
disturbed kidney development [67]. 
The absolute foetal brain volume results agree with the clinical results of 
decreased head circumference. This is possibly due to interference of nicotine 
with foetal brain development that results in synaptic dysfunction and increased 
cell damage, loss and death in cortex and cerebellum [35; 68; 69]. In addition, 
PEMCS is also reported to cause reduction in corpus callosum of female foetuses 
[14]. With this set of data, it is tempting to speculate that reduced growth of the 
foetal brain and head circumference is one of the mediators in the relationship 
between PEMCS and behaviour in offspring, as several studies have 
demonstrated poorer cognitive function and neuropsychological abilities at early 
stages of school in infants exposed to PEMCS [70; 71]. 
PEMCS also affects the growth of foetal lungs, where exposed foetuses have 
reduced absolute lung volume compared to the non-exposed foetuses. This 
agrees with animal studies demonstrating reduced lung weight in rat pups, 
possibly due to reduction in the airway size [72]. While it is not clear how carbon 
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dioxide interferes with foetal lung growth, recent studies have suggested nicotine 
interferes with the integrity of the alveoli [33]: increasing the number of foetal 
alveolar type II pneumocytes and decreasing the alveolar type I pneumocytes in 
the foetal lung. Moreover, studies have reported the absence of microvilli in the 
exposed alveolar surface where gas exchange occurs and increased numbers of 
lamellar bodies in type II cells. These lamellar bodies serve to package the 
surfactant that plays a role in decreasing surface tension in the alveolar 
membrane that is required to assist neonatal respiration [73]. In addition, 
nicotine is also reported to interfere with the elastic tissue formation in the rat 
neonatal lung, with subsequent development of emphysema like damage in the 
neonatal lungs [74]. 
While there are very few studies on the effect of PEMCS on human foetuses, a 
study on exposed human foetal lung showed changes in the connective tissue, 
evidence of hyperplasia of the bronchi muscular membrane and intensified 
apoptosis of lung parenchyma cells [67]. Cellular differentiation in these tissues 
usually occurs during the canalicular stage that takes place around 17th-
26 th weeks of gestation, which would possibly cause a prolonged slow down in 
foetal lung growth across gestation. There is also evidence suggesting increased 
risk of reduced respiratory function in infants exposed to maternal smoking 
during pregnancy [75]. With all these findings, it would be interesting to study 
the dynamics of foetal lung fluid production and its retention within the future 
airway in foetuses exposed to maternal smoking. This will assist in characterising 
foetal breathing movement in association with PEMCS since these functions are 
considered to be major determinants of foetal lung growth [76]. 
In studying the effect of PEMCS on the foetal liver, the MR measurements of foetal 
liver showed significant decrease in the absolute liver volume of exposed 
foetuses compared to non-exposed foetuses. This is possibly due to pronounced 
abnormal changes in the haematopoiesis (blood formation) and cell proliferation 
around the liver tissues, as seen in liver tissues of exposed rat pups [67]. In 
addition, PEMCS has also been associated with significantly altered transcript 
expression (mRNA) in the liver, with increased response in the male foetuses 
[77]. Moreover, it has been suggested that intracellular damage can occur in the 
liver due to increased production of oxygen-derived free radicals in the 
reperfused hypoxic tissues, which can possibly take place due to maternal 
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smoking [37]. All these effects might be contributing factors to reduced liver 
volume in foetuses exposed to maternal smoking. 
The placental volume data demonstrated a trend of reduced placental volume in 
PEMCS. However, this result did not show significant difference between the 
smoking and non-smoking mothers and agrees with the findings of Ellard et al. 
[62] that reported placental weights were unaffected by maternal smoking. 
However, several studies have documented a negative effect of PEMCS on 
placental structure (more obvious in placentae of heavy smokers): evidence of 
increased apoptotic and damaged cells and reduced invasion of cytotrophoblasts 
(CTB), which performs critical functions induding the generation of a 
syncytiotrophoblastic layer of transport epithelium and the generation of 
specialised CTB population that anchors the placenta to uterine wall and 
remodels the uterine vasculature [36; 78; 79]. Further studies are in progress 
and will involve relating placental diffusion in PEMCS to placental weight and 
morphology. 
In conclusion, the results of the present study demonstrate that intrauterine 
exposure to cigarette smoking significantly affects foetal organ growth, 
predominantly the foetal kidneys. Cigarette compounds possibly influence 
excessive cell death and inhibit general growth of foetal tissue within specific 
organs. Hence, the reduced organ volume and foetal size (volume and birth 
weight). Moreover, PEMCS could perhaps be the plaUSible mechanism behind the 
potential overall increased risk of miscarriage, sudden infant death syndrome 
and multiple malformations in infants of smoking mothers. 
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Chapter 8 
Conclusion 
The work described in this thesis was directed at investigating the effect of 
maternal diabetes and maternal smoking on foetal development using 
quantitative imaging techniques at 1.5 Tesla using a Philips Achieva MRI system. 
Chapter 5 presents a robust method of acquiring placental images using EPI and 
analysing placental blood flow using the IVlM technique based on perfusion,fand 
diffusion, D factors. The first part of the chapter investigates the reliability and 
reproducibility of the IVlM program in measuring placental blood flow in the 
placenta, basal plate and chorionic plate by reviewing the measurement of 
average blood flow distribution (mean 1), high blood flow region associated with 
upper end of the flow distribution (fraction of pixels withf> 0.8) and peak blood 
flow (mode 1). The data suggest that the IVlM program is a reliable method in 
measuring placental perfusion; with mean and mode f being more reliable 
measure for placental perfusion compared to the fraction of pixels with f > 0.8. 
This is possibly because regions with high blood flow may include data points 
affected by noise and physiological motion (maternal and foetal heart rate along 
with maternal breathing). For this reason, fraction of pixels with f > 0.8 was not 
used in investigating the effect of maternal diabetes on placental perfusion. 
The intra and inter-observer reliability based on intra-class correlation 
coefficient (ICC) and limit of agreement (LOA) results were comparable for all the 
observers, with observer 1 demonstrating the best reliability results. This is 
expected since observer 1 is the author who designed the program and had the 
most experience dealing with the data analysis of placental perfusion. However, 
measurements of other observers were not too discrepant, suggesting that the 
reliability could be improved with possible further training. In general, the 
reliability results were best in the placental region, followed by basal plate and 
chorionic plate. This is reasonable since the ROis of basal plate and chorionic 
plate were small, mostly five to six voxels in extent in the MR images. Hence, 
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movements along these plates could cause errors in perfusion measurements in 
these areas. This is possibly the reason for lower degree of reliability for basal 
plate and chorionic plate. 
In addition, two masking techniques were investigated: the single masking 
technique that involves drawing a different set of ROI for each repeat and 
multiple masking technique which uses a same set of ROI for all repeats. Both 
single and mUltiple masking techniques demonstrated very good intra-observer 
reliability. However, the multiple masking technique was employed to investigate 
the effect of maternal diabetes on placental blood flow since it was more time 
efficient compared to single masking technique. The placental perfusion 
comparison made on two adjacent slices demonstrated poor repeatability, but 
whether this is due to variations in placental structure between slices or whether 
it is due to the fundamental reproducibility of the data could only be proven by 
looking at intra-subject reprodUcibility. Therefore, placental perfusion 
measurement was only conducted on the MR images with the largest placental 
volume. 
In applying the IVIM program to investigate the effect of maternal diabetes on 
placental blood flow, the data showed that there were no significant difference in 
the mean [measurements of placenta, basal plate and chorionic plate across 
gestation between the diabetic and control groups. However, the peak blood flow 
(mode 1) increased significantly in the chorionic plate and basal plate of both 
groups across gestation. This is expected in chorionic plate since the growing 
foetus would require more nutrients and hence, the increased blood flow in this 
region. Similarly, the blood flow in basal plate (representing spiral artery blood 
flow) is expected to increase to sustain the growing foetus and maintain blood 
flow in the growing placentae. Moreover, there was a trend for mode f to be 
higher in the control group at second trimester, but at third trimester mode [was 
usually higher in the diabetic subjects. This result may be a statistical fluke but 
could also indicate adaptation to large foetal demand (macrosomic foetuses). 
As for diffusion measurements (D) related to molecular mobility of water, there 
was a significant decrease in D of placenta, basal plate and chorionic plate across 
gestation, with a trend for D to be slightly higher in the control group for the 
basal plate and chorionic plate. This is consistent with increased villous 
branching across gestation and at a greater extent in diabetic placentae, which 
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could cause a reduction in the effective mean free path of blood movement within 
the intervillous space. This is possibly the reason for reduced diffusion across 
gestation; with an even more pronounced effect in diabetic placentae. 
Chapter 6 describes the TJ weighted water suppressed MRI scans used to acquire 
foetal fat images in-utero and a MATLAB program developed to estimate foetal 
fat. The first part of the chapter investigates the reliability of the MATLAB 
program in measuring foetal fat adiposity. The foetal fat volume measured using 
the Foetal Adiposity Quantification Program demonstrates very good intra and 
inter-observer reliability at third trimester but poorer reliability at second 
trimester; possibly due to very small amount of foetal fat present at second 
trimester (namely 24 weeks). Although the ICCs and LOA were best for observer 
1, the author who designed the MATLAB program, the foetal fat volume 
measurements made by other observers were comparable, suggesting reliability 
could be improved with significant additional training. 
Following the reliability test, the Foetal Adiposity Quantification Program was 
used to measure foetal fat volume in foetuses of diabetic and control mothers. 
The data suggests that foetal fat volume and percentage foetal fat volume were 
significantly greater in foetuses of diabetic mothers at 35 weeks. Similarly, the 
measurement of foetal length and abdominal circumference at 35 weeks and 
birth centile were significantly greater in foetuses of diabetic mothers. Although 
similar trend was seen for foetal volume, shoulder width and foetal volume index , 
the difference was not statistically significant between the diabetic and control 
group. This preliminary study has demonstrated that the technique employed 
here is a convenient and reliable method for measuring foetal fat volume in-
utero. It clearly illustrates the differences in body composition between foetuses 
of mothers with and without diabetes. The combination of foetal fat volume with 
foetal volume measurements strengthens the reliability of the present study to 
allow detection of a macrosomic foetus with excess foetal growth due to adipose 
tissue and may assist in the identification of foetuses at risk of birth trauma. 
Chapter 7 details the HASTE and bFFE scans used to acquire foetal images 
encompassing the whole foetus in three orthogonal blocks. These images were 
used to investigate the effect of prenatal exposure to cigarette smoking on foetal 
and foetal organ growth. The work presented in chapter 7 shows that prenatal 
exposure to cigarette smoking has significant negative effect on foetal organ 
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growth and foetal growth, predominantly foetal kidney and foetal volume. The 
MR measurements conducted using edge detection method and Cavalieri 
technique demonstrated that foetal organ volume increases significantly across 
gestation in both exposed and non-exposed group. However, exposed foetuses 
had significantly lower absolute brain, lungs, liver and kidney volumes compared 
to non-exposed foetuses. When the organ volumes were corrected to foetal 
volume, the percentage volume of brain, lungs, liver and kidneys demonstrated a 
decrease across gestation; possibility because foetal organs are expected to grow 
accordingly with the foetal size at each gestation. In addition, at 36 weeks, the 
data showed a significantly lower percentage brain volume in foetuses not 
exposed to maternal smoking. This may indicate that although absolute brain 
volume measurements are reduced, brain size and growth is relatively preserved 
compared to other organ volumes in the exposed group and reflected by the 
higher percentage brain volume. 
Similarly, MR measurements of foetal volume and length demonstrated 
significant increase across gestation in both exposed and non-exposed group, 
with these measurements significantly reduced in foetuses exposed to maternal 
smoking. In addition, the birth weight of exposed foetuses was significantly lower 
than non-exposed foetuses. This suggests that exposed foetuses are at risk of 
being small for gestational age. Conversely, despite a trend suggesting that foetal 
shoulder width were reduced in foetuses of the exposed group, this data did not 
demonstrate significant difference between the exposed and non-exposed 
groups. 
As for the ultrasound measurements, the data showed that the head and 
abdominal circumference of exposed foetuses were significantly lower compared 
to non-exposed foetuses at 25 weeks and 36 weeks. A similar trend was observed 
for femur length, where exposed foetuses had shorter femur lengths compared to 
non-exposed foetuses. However, the data only showed a significant difference 
between the groups at 25 weeks. With all these data, cigarette compounds may 
possibly contribute to excessive cell death and inhibit general foetal tissue 
growth within specific organs resulting in reduced organ volume and foetal size 
(volume and birth weight). 
In conclusion, MRI techniques employed in this study have great potential in non-
invasive assessment of abnormal placental function and can be used to study 
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foetal development. This study shows that perturbations in the maternal womb, 
such as altered nutrition and exposure to harmful cigarette compounds can effect 
foetal development that may possibly program the foetus to develop disease in 
adult life. The programming effects on the foetus may be mediated by placental 
responses to these perturbations, which include abnormal villous branching and 
capillarisation. altered thickness of the placental barrier and increased toxicity 
stress in the placenta. Moreover. foetal nutrient consumption and exposure to 
toxic compound may hinder foetal growth. For these reason, it is important to 
manage maternal diabetes and cease maternal smoking. This will optimise 
placental structure and function, as well as foetal growth that are likely to 
promote lifelong health benefits for the offspring. 
8.1 Future Work 
At present, the reliability of lVIM program was conducted based on placental 
perfusion measurement. Ideally, the reliability of placental diffusion, intra-
subject reproducibility and the number of acquisition required for reliable 
placental perfusion measurement should be investigated. Moreover, future work 
will involve simplifying the IVIM program to reduce processing time and average 
out movement or noise in the ROI for all the acquisition. Instead of using the 
current program that fits a ROI to each placenta acqUisition, the data analysis can 
be improved by fitting the ROI once for all five acquisitions. This will involve 
averaging the ROl's pixel in all five acquisitions together before fitting the ROI to 
the signal attenuation equation. 
To further understand the effect of maternal diabetes in pregnancy, the placental 
perfusion and diffusion should be correlated with maternal levels of 
hypoglycemia and foetal growth. This will provide an insight to how placental 
function varies in diabetes pregnancies and its affects on foetal growth, especially 
the foetal fat composition. Furthermore, the fast decaying component arising 
from the effect of spins from blood, which is characterised as pseudo-diffusion 
coefficient (0·) should be investigated. 
The work presented in Chapter 6 should now be extended to a larger study to 
determine whether the TJ weighted water suppressed MRI scans and Foetal 
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Adiposity Quantification Program can be prospectively used to screen women at 
increased risk of delivering macrosomic infants, in particular women with 
gestational diabetes. 
Furthermore, while the results reported in Chapter 7 clearly shows that maternal 
smoking affects foetal growth and foetal organ growth, further studies are now in 
progress to relate the effect of maternal smoking on placental perfusion and 
diffusion. 
8.2 Final Overview 
With advent of fast imaging MR sequences, foetal MRI is playing an increasing 
important role as complementary diagnosis tool to ultrasound for prenatal 
management and foetal abnormalities assessment. Although at present, 
ultrasound still remains as the modality of choice for routine prenatal imaging, 
the future of foetal MRI may change with advancement in technology, knowledge 
and management as well as growing medicolegal and socioeconomic pressure. 
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